X-ray fluorescence for the determination of gold in vivo by Shakeshaft, John Thomas
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 23. May. 2019
X-RAY FLUORESCENCE FOR THE DETERMINATION 
OF GOLD IN VIVO
Submitted by John Thomas Shakeshaft for the degree 
of PhD of the University of Bath 1992
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its 
author. This copy of the thesis has been supplied on condition that 
anyone who consults it is understood to recognise that its copyright rests 
with its author and  that no quotation from the thesis and  no information 
derived from it may b e  published without the prior consent of the
author.
This thesis may be  m ade available for consultation within the University 




INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U601514
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
UNIVEHi, v OF BATH
LIBRARY
$ 4. 12 F E B  1993
+ M J 5
Summary
Gold salts have been used in the treatment of rheumatoid arthritis since the 
early part of this century, and are still in routine use in many centres, although 
their mode of action is still not fully understood. However it is well established 
that gold salts are nephrotoxic, which limits their use in the treatment of 
rheumatoid arthritis. Consequently it is of interest both to researchers in the 
field of rhuematoid arthritis and to rheumatologists to be able to measure the 
concentration of gold in various tissues and organs (for example kidneys) of 
patients who are receiving chiysotherapy, and a technique allowing 
quantitative measurements of gold in vivo, thus eliminating the need for 
traumatic biopsies would be of value.
After a review of some relevant clinical history of gold, and of some of the other 
techniques available that have been used for the monitoring of trace elements 
in vivo, the feasibility of using X-ray fluorescence analysis for the 
determination of gold in vivo is considered in detail. The features that occur in 
a typical spectrum are first discussed, followed by an overview of the factors 
that will effect the detection limit of gold in a clinical system.
A number of radiation sources are considered in detail, including radio-isotope 
sources and X-ray generators. The feasibility of using different source/detector 
geometries and sources both inside and outside the body are considered for the 
radio-isotope sources.
A Monte Carlo computer model was constructed, and is described, to help 
predict how sensitivity will vary both with kidney position, and within the 
kidney itself. The results of the latter study leading to the conclusion that the 
results from a clinical X-ray fluorescence system need interpreting with some 
caution.
A filtered 153Gd source was chosen as the system best suited to the local 
circumstances, and a prototype clinical system was constructed. The gold
content of the right kidney of a number of patients, with widely varying clinical 
histories, was determined using this system, and the results are presented to 
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1990 saw the publication of ICRP publication 60 (ICRP, 1990), which contains 
recommendations of the international commission regarding radiation 
protection, following a re-analysis of the data from Hiroshima and Nagasaki 
bombs. The contents of the document have a direct bearing on the results and 
conclusions of this project, particularly when considering dose calculations.
Therefore, the decision had to be made whether to ignore the contents of this 
document or take them into account. The decision that was made, was 
generally to adopt the recommendations contained in this report, since in due 
course they are likely to become statuatory. However it was not possible to re- 
analyse all the work that had already been done. The approach that has been 
adopted with regard to various recommendations is considered in the following 
paragraphs.
New terms
The commission recommended that the term “effective dose equivalent” should 
be dropped, and the term “effective dose” be substituted. This has been adopted 
throughout the thesis. Also the term equivalent dose has been (re)introduced to 
replace the term “weighted absorbed dose”. The radiation quality factor, Q, now 
becomes radiation weighting factor, w r .
N ew radiation weighting factors
The commission recommended that a new set of radiation weighting factors, 
w r ,  (used in calculating equivalent dose, Ht) should be adopted. These have 
been adopted throughout the thesis. In fact for gamma rays and X-rays this 
factor remained unchanged at unity.
N ew tissue  weighting factors
The commission recommended that a new set of tissue weighting factors, w t ,
(used in calculating effective dose, H e )  should be adopted. These have been 
adopted throughout the thesis. Of particular relevance has been the 
introduction of separate weighting factor for skin (0.01) and the revision of the 
way “other” organs are handled. Skin dose: In early work skin dose had been 
considered as the limiting factor, since the following paragraph from the 
Ionising Radiation Regulations (1985) was interpreted as meaning that skin 
should be averaged over the area irradiated rather the area of the whole skin 
surface: “In assessing the dose quantity to skin whether from contamination or 
external radiation, the area of skin over which the dose quantity is averaged 
shall be appropriate to the circumstances but in any event shall not exceed 
100cm2. ” However the report by the international commission clearly states 
that: “For stochastic effects the equivalent dose can be averaged over the whole 
sk in ” It is stochastic effects that we will always be concerned with, since we 
are not giving a dose sufficient to cause deterministic effects (0.5Sv y'1).
Therefore the early conclusions drawn on the basis of skin dose are obviously, 
at least to some extent flawed. However since kidney absorbed dose now 
becomes the major contribution to effective dose, and for a fixed geometry the 
absorbed dose to the kidney is related to the skin absorbed dose, this early 
discussion has been retained.
Chapter 1 
Introduction
The reader's attention is drawn to the glossary 
in Appendix C where many of the clinical 
terms and abbreviations used in the text of 
this chapter are defined.
1.1 Clinical History of Gold
Gold has been employed as a panacea for all diseases throughout recorded 
time: Since the Chinese used gold medicinally (Block and van Goor, 1956) gold 
has been used as a treatment at various points throughout history, for 
example, the alchemists attempted to prepare ‘an elixir of life’ from gold to 
cure all ills and confer eternal youth. For centimes gold was used as an anti­
pruritic. However untoward reactions were reported (Virgil, 19 BC).
Interest in the use of gold as a medicine more recently was initiated by Robert 
Koch, who observed gold cyanide arrested the growth of tubercle bacilli in vitro. 
However he was unable to demonstrate this effect in infected animals. Despite 
this gold began to be used for the treatment of tuberculosis and was extended 
to the treatment of arthritis, as some clinicians around the turn of century 
believed rheumatoid arthritis to be a tubercular joint disease. At the present 
time gold salts are employed widely in the treatment of rheumatoid arthritis.
There are two common modes of administration of gold: Either parenterally as 
aurothiomalate or aurothioglucose, or orally as auranofin. The former is 
preferred by clinicians as it is administered under controlled conditions. 
(Auranofin, which is taken in tablet form, by the patient has side effects such 
as mild diarrhoea, which has led to the patient not taking the whole of the 
prescribed dose.) A new method of treatment using a new form of gold, gold 
yeast, has been reported by Vinson (1990). It is claimed that, in rat models, this 
treatment has shown to be effective with no toxicity. This work, as all work on 
animals, involves an induced form of rheumatoid arthritis as the disease only
occurs in humans. This model of the disease is usually achieved by injection of 
mycobacterium or sodium urate into one of the limbs of the animal. The 
inflammation caused is then thought to be a good model of the symptoms of 
rheumatoid arthritis.
The use of gold based drugs to treat rheumatoid arthritis is an effective 
widespread treatment. It has an anti-inflammatory action, but the ability of 
gold to halt erosive changes in bone has not been proved. However the 
treatment, using commercially available drugs, although effective is not 
without side effects, some of which are discussed in the section 1.3. Gold also 
has some other medical applications including: use in dental alloys; as 
radioactive isotopes in cancer treatment; as gold leaf for neurosurgical 
procedures; and for accelerated healing of cutaneous ulcers, however the use of 
gold as an anti-arthritic drug is by far its most widespread use.
1.2 Mode and Site of Action of Gold
Despite its widespread use, the mode of action of gold is still unclear (Bacon 
and Salmon, 1987). It is known that, in vivo, sodium aurothiomalate (the most 
common form of gold) rapidly dissociates to form the gold moiety, which 
becomes strongly protein bound. This binding has been estimated to be around 
90% by Mascarenhas et al (1972). The molecule is taken up in macrophages 
and is selectively concentrated in the inflamed synovium (Vemon-Roberts et al, 
1976); it is this effect which may well account for the action of the drug.
There has been some speculation as to whether the effect of the gold salt is due 
to the thiol group in the drug. Clinical evidence in support of the importance of 
thiol groups for anti-rheumatic activity was found by Jellum et al (1980) who 
administered aurothiomalate labelled with the radio-isotopes 195Au and 14C to 
mice. The authors demonstrated that both groups had anti-rheumatic activity.
The site of action of the slow acting rheumatic drugs is also still unclear (Bacon 
and Salmon, 1987). Within the synovium, it is known that gold is deposited in
monocyte/macrophage cells, which indicates that the drug may have a direct 
effect at this site; but evidence for this is still thin.
1.3 Toxicities of Gold
Toxic side effects from gold treatment occur in approximately a third of 
patients. These effects are varied and include: exfoliative dermatitis; 
eosinophilia; thrombocytopenia; agranulocytosis and aplastic anaemia; 
jaundice; lung changes and proteinuria (Collins, 1987). Fatalities from gold 
treatment however are rare, although it has been suggested by Girdwood 
(1974) that deaths per number of prescriptions exceed that of any other drug. 
However, more recently, it was concluded by Lehtinen and Isomaki (1991) that 
large cumulative amounts of gold was not associated with premature death. 
The authors concluded that “the best way to prevent premature death is 
probably to treat RA effectively. Though the drugs have serious side effects, the 
benefits may outweigh the disadvantages.”
The most widely documented side effect of gold treatment is proteinuria 
(signifying renal damage), this occurs in 2-20% patients treated (Hall and 
Tighe, 1989) and occurs anytime between two weeks and six years after 
commencement of treatment, of these cases 10-30% have nephrotic syndrome. 
However proteinuria eventually resolved in all patients studied by Hall et al 
(1987) after discontinuation of gold therapy. It has also been reported by 
Silverberg et al (1970) that the severity and duration of proteinuria is not 
related to total gold administered, duration of treatment, the peak or mean 
serum gold levels or urinary gold excretion. However the fact that eventually 
proteinuria resolves in all patients has reassured clinicians: To quote Collins 
(1987): These new findings, which suggest a “sitting on hands approach” to 
proteinuria caused by gold while nature effects a cure, are reassuring*. 
Nevertheless it would be advantageous to develop a simple technique that 
could predict the onset of proteinuria, thus allowing renal failure to be 
prevented.
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Chrysiasis, another side effect of gold therapy, is a rare, long-lasting or 
permanent pigmentation of the skin brought about by the parenteral 
administration of gold preparations, and subsequent exposure of the skin to 
ultraviolet radiation (Schmidt, 1941). The chrysiasis is not in itself a problem, 
except that it is usually accompanied by dermatitis. Jeffrey et al (1975) studied 
skin gold levels in both chrysiasis and non-chrysiasis patients. The findings of 
this group were that in chrysiasis patients there was no correlation between 
dose rate and skin gold levels, however in non-chrysiasis patients the skin gold 
levels were proportional to the current dose rate. The other side effects of gold 
therapy are less well documented in the literature except that it has been 
reported that all patients undergoing treatment with gold eventually develop 
dermatitis with or without chrysiasis.
1.4 Aim of this proiect
Despite the fact that proteinuria eventually resolves itself in all patients, it 
would be useful to develop a non invasive technique that could measure the 
gold build up in the kidney and to try and relate this to the onset of 
proteinuria, in order to predict and prevent the onset of proteinuria. To this 
end this project was undertaken. The availability of data on gold levels in the 
kidney is limited to three sets of results taken by Gottlieb et al (1972), 
Vemon-Roberts et al (1976) and Basc6 et al (1988) from seven cadavers, 
undergoing gold therapy at the time of death. The samples of kidney tissue 
from these cadavers had gold concentrations between 45 and 175|ig gold (g 
kidney tissue)'1. From these figures it was concluded that any technique must 
be able detect concentrations of gold in the kidney at least as low as 40jig gold 
(g kidney tissue)*1. The technique used must also be specific to gold in the 
kidney as Gottlieb et al also found similar or greater concentrations of gold in 
many other parts of the body, as shown in table 1.4.1.
1.5 Possible measurement techniques
When measurements of potentially toxic trace elements are to be made in vivo,
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Specimen jig Gold (g wet tissue)*1
Lymph node 391 211
Liver 125 126
Bone Marrow (Sternal) 81
Spleen 77
Synovium 32




Muscle (Gluteus) 95 211
Renal Cortex 129
Skin (Dematitis, Forearm) 79
Renal Medulla 64
Thyroid 41
Skin (Normal, Forearm) 38
Ovary 23 21
Table 1.4.1 - Gold levels found In a  cadaver of a  Rheumatoid Arthritic by Gottlieb e t al
the usual constraints of keeping any radiation dose as low as possible, and the 
non-standard, extended shape of humans, are compounded by the fact that the 
target element is present, by definition, only in small quantities. The initial 
developments all used neutron activation analysis, in one form or another, as 
the basis of the analytical method. However the use of X-ray fluorescence is 
now increasingly widespread, and a few other distinct techniques have been 
reported for particular elements; such as y-resonance scattering for iron 
overload (Wielopolski et al, 1985). Cadmium, lead and platinum are three trace 
elements which have been most extensively studied, and a summary of 
techniques employed is given in the following sections.
1.5.1 Lead
Lead normally accumulates in bone and is therefore an archetypically high 
atomic number (Z) element embedded in a much lower Z matrix, lending itself 
to in vivo X-ray fluorescence. Three basic types of systems have been used for 
in vivo human studies, one based on the measurement of L X-rays (Wielopolski 
et al, 1989), the other two using K-rays, but with different y-ray sources and
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different source-detector geometries (Ahlgren and Mattsson, 1979; Somervaille 
et al, 1985; Price et al, 1984). For in vivo measurements of bone lead it seems 
that a K X-ray measurement of tibia lead using 109Cd is now the method of 
choice to meet the commonly identified need in toxicological research for an 
indicator of cumulative internal lead dose (Landrigan, 1989).
1.5.2 Cadmium
Cadmium has been measured in vivo by neutron activation, in which prompt 
y-rays are monitored, or by X-ray fluorescence. The first in vivo X-ray 
fluorescence systems used 59keV y-rays from an 241Am source (Ahlgren and 
Mattsson, 1981), a significant improvement was achieved by using the 
polarized output of an X-ray generator as the excitation source (Christoffersson 
and Mattsson, 1983). An important feature of these techniques, however, is the 
very rapid variation of signal strength with depth in tissue, due to the 
relatively low energy of the cadmium fluorescence photons (25keV).
Cadmium is measurable by neutron activation analysis largely because the 
12% abundant isotope, 113Cd, has an exceptionally high probability (20 000 
bams) for capture of thermal neutrons; the effective average cross section for 
the element is about 2500barns. The prominent prompt y-ray, at 559keV, is 
detected in high resolution solid state spectrometers; counting takes place 
simultaneously with neutron irradiation. Both 238Pu-Be and 252Cf neutron 
sources have been reported, although 262Cf is the preferred source because of its 
lower mean energy neutrons.
1.5.3 Platinum
In vivo measurements of platinum are designed to assist in the study of the 
pharmacokinetics of platinum containing drugs, used in the treatment of 
various cancers. As the side effects of these drugs include nephrotoxicity, 
measurements are made in the kidney as well as the tumour site. A detailed 
description of an X-ray fluorescence system based on a filtered and polarized
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X-ray generator has been described by Jonson et al (1988). An X-ray 
fluorescence system to measure both lead and platinum simultaneously has 
also been described by Todd (1989), following the report of unexpectedly high 
levels of lead in the kidneys, of patients undergoing cis-platin chemotherapy, 
by El-Sharkawi et al (1986).
1.5.4 Other elements
Another element that has been investigated is mercury (Bloch and Shapiro, 
1981). The motivation behind this was the determination of the mercury 
burdens of dentists, who had used mercury based amalgam. More recently a 
feasibility study was carried out by Scott and Lillicrap (1988) into whether 
X-ray fluorescence could be used for gold. The results of this study looked very 
promising and therefore work has been continued.
1.6 Description of Technique
The technique of X-ray fluorescence involves irradiating a sample with X-rays 
or gamma photons and recording the resultant spectra. These spectra contain 
peaks which are characteristic of each element present and the magnitude of 
these peaks is then related to the amount of the element present. (The details 
of this are discussed in later chapters.)
The apparatus for this project consisted of various radiation sources which 
were used to irradiate phantoms representing the gold containing kidney 
(represented by bottles containing a solution of chloroauric acid) and other body 
tissue (represented by water). In the first studies, the resultant spectra were 
recorded using an EG&G Ortec hyper-pure germanium detector (Model NQ 
1113-10205) which was 10mm in diameter and 7mm thick. This was biased to 
-1000V (as specified in the data sheet supplied with the detector) using an 
EG&G Ortec 459 bias supply and connected via EG&G Ortec 572 amplifier to 
an EG&G Ortec Multi Channel Analyser. Pulse pile up rejection was always 
used following the results of Chettle et al (1989). Initial settings on the
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amplifier were: Pulse shape timing of 6ps; coarse gain of 200; and fine gain of
0.6. This system gave a peak resolution of 500eV (FWHM) at 122keV. A 
schematic diagram of system inter-connections is shown in figure 1.6.1.













Figure 1.6.1 - Block diagram of apparatus
1.7 Conclusions
It is concluded from the above review that it  would be useful to develop a 
technique that can detect levels of gold in the kidney down to at least 
40pg gold (g tissue)'1, in order to study the relationship between the gold 
content of the kidney and the onset of proteinuria. It seems as though X-ray 
fluorescence would be a suitable technique to do this in vivo. In order to obtain 
maximum sensitivity it is important to understand all the features in the 
recorded spectrum, and to optimize the detection system to produce the 





In the spectrum of number of counts at each energy, it is important to 
understand where all the features come from so that we may minimise those 
components which are undesirable, and be aware of those which are inherent 
to the chosen experimental arrangement.
2.2 Interactions of X-rays with matter
X-rays undergo four types of interaction with matter:
• Inelastic or Compton scattering
• Absorption by the photoelectric effect
• Elastic scattering
• Absorption by pair production
Of these only the first three occur at photon energies up to IMeV. Therefore it 
is these three processes that are responsible for the features seen in the 
recorded spectra.
2.2.1 Compton scattering
In the Compton effect, an incoming photon imparts momentum to an initially 
bound electron. By consideration of conservation laws, it is clear that the 
momentum of the photon is reduced after the interaction. By consideration of 
an initially free electron at rest, it is possible to deduce the energy of the 
scattered photon at any particular chosen angle. Conservation of both energy 
and momentum give the following change in wavelength, AX, to the incoming 
photon:
9
AX = h (2 .2 .1)mec(l - cos9)
Where h is Planck’s constant, m« the rest mass of an electron, c the speed of 
light, and 0 the angle of scatter. This can be rearranged into the following form:
Where E is the energy of the scattered photon, when observed at a scattering 
angle 0, and Eo is the energy of the incident photon. It is therefore seen that the 
Compton effect is independent of atomic number (to a good approximation).
The directional distribution of photons removed from the incident beam, is 
described by the differential collision cross-section (da), evaluated as a 
probability per electron and expressed by the number of scattered photons 
found in an element of solid angle (dfl) at a mean scattering angle of 0.
For unpolarized incident photons:
E (2 .2 .2 )
1 + -5^= (1 - COS0)







ro is known as the ‘classical’ radius of the electron.
Equation 2.2.3 can also be written in the following form:
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A similar equation also exists for polarised photons:
da = I  ( | ) ( w + | - 2“ n W | 3 ) dn (2.2.7)
where p is the angle between the plane of polarisation of the incoming photons 
and the scattering plane. From this it can be seen that the flux of Compton 
scattered photons can be significantly reduced by using polarised photons such 
that sin20 cos2p is maximised, i.e. By setting 0=90°.
The directional distribution of unpolarized Compton scattered photons for
( T h o m s o n )
Direction
of incident 
pho ton sect ion
/ e l e c t r o n
130* 120* 110* 100* 9D#'*'.\80* 70* 60* 50*
Figure 2.2.1 - The number of photons scattered into unit solid angle d a /d ii at a  m ean scattering angle
of 0. (Evans. 1955)
various values of 0 is shown in figure 2.2.1. From the figure it is dear that, as 
photon energy rises the distribution becomes more peaked in the forward 
direction.
2.2.2 Photoelectric effect
In this process the intident photon energy is dissipated in ejecting a bound 
electron from an atom. The ejection of the electron will leave a vacancy to be 
filled by an electron from another shell.
For this process to occur the incoming photon must obviously have an energy 
greater than that of the bound electron. The bound electron is then ejected with 
a kinetic energy, Q, given by equation 2.2.8 where Eo is the energy of the 
incoming photon and Eb is the binding energy of the ejected electron.
Q = E^-Eg (2.2.8)
After the photo-electron has been ejected the atom is left in an extited state. 
The ground state energy is however quickly regained (within lfs) by one of two 
processes. Either the Auger process, where one or more outer shell electrons 
are ejected. (This is not of any interest to the project since these electrons are 
absorbed within a short distance in tissue.) The other possibility is by emission 
of an X-ray of characteristic energy (XRF).
This process results in a sharp increase in absorption cross-section just above 
the binding energies of the electrons for any given element. This is 
demonstrated in figure 2.2.2 (Hubbell, 1968).
It should be noted that photons of energy greater them but just above the L 
absorption edge have a much greater cross-section for photoelectric absorption 
than those just above the K absorption edge. It might therefore be thought that 
it would be better to use L X-rays when designing an XRF system. However L 
X-rays have a much greater linear attenuation coefficient, |i, in tissue than the 





















Figure 2.2.2 - Total X-ray cross-section for gold (Z=79)
reaching the skin surface, if they are emitted from the kidney which lies at a 
depth of greater than twenty-five millimetres.
I = (2.2.9)
Equation 2.2.9 gives the reduction in intensity of an X-ray beam, incident 
intensity Io, passing a distance x through a medium of linear attenuation 
coefficient p.. The linear attenuation coefficient, p, is a function of both energy 
of the incident photons and composition of the medium. Using a value of 
p = 0.1639mm'1 (Hubbell, 1982), and a value of x = 30mm (a typical kidney 
depth) gives a value of I/Io = 0.00073. Showing that almost complete absorption 
occurs for L X-rays.
Although the consideration of conservation of momentum means that a photon 




Figure 2.3.1 - Ideal Spectrum 
Compton process, this is not true of the photoelectric effect since the photon 
interacts with a bound electron and the whole atom can recoil.
2.3 The idea! spectrum
From the consideration of the basic physics, the ideal spectrum that would be 
obtained from an idealised experimental setup is shown in figure 2.3.1.
In this ideal situation the following assumptions are made:
• Both source and detector may be considered as points.
• Both source and detector are perfectly collimated. (Therefore only 
one sharp scattering angle is seen.)
In this spectrum the following features should be noted:
• K  - These sharp lines correspond to the Ko lines of gold. The Kp 
lines would also be present, but due to their reduced intensity 
they are not visible on this scale.
• C - Is the Compton peak, this corresponds to Compton scatter of 
one angle only. i.e. A scatterer that is infinitesimally small in 
size.
• E - These Eire peaks that are at the same energy as the source 
and are due to elastic scatter of the exciting photons.
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The non-ideality of these features is discussed in greater detail in the following 
sections.
2.4 Contributions of the detection system to non ideality
A small amount of non-ideality in the spectrum can be attributed to the
components of the detection system. However, with the exception of pulse 
shape timing, the effects are very small and are fixed for any given detection 
system.
2.4.1 Detector resolution
Detector resolution is that width which a peak recorded from a single energy 
photon will appear to have. Hyperpure germanium detectors of the type used in 
this project are usually supplied with a quoted resolution at photon energies of 
5.9keV (“ Fe), 122keV (67Co) and 662keV (137Cs). Better resolution is usually 
obtained with smaller diameter detectors.
The full width half maximum, Wt, of a typical peak in the spectrum can be 
modelled in the following way (Knoll, 1979):
= w ^ + w £  + w^ (2-4-1)
where the W values on the right-hand side are the peak widths that would be 
observed due only to effects of carrier statistics, charge carrier collection and 
electronic noise respectively.
Wd represents the inherent statistical fluctuation in the number of charge 
carriers created by the incident photon in the detector, and is given by
= (2.35)2FeE0 (2.4.2)
where F is the Fano factor, e is the energy required to generate one electron- 
hole pair, and Eo is the energy of the incoming photon. This statistical 
fluctuation is the primary contribution to the FWHM of the peak in small 
detectors. The values quoted for the detector used (10mm diameter, 7mm thick)
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were checked and found to be accurate.
The second term, W x, is due to incomplete charge collection in the detector. Its 
magnitude can be determined experimentally by carrying out a series of 
FWHM measurements at different applied bias voltages. It is usually assumed 
that if the bias could be made infinitely large then the contribution of 
incomplete charge collection would be negligible. A plot of FWHM of the 
122keV peak from a 57Co source against bias voltage, showed that at the 
recommended bias voltage (of -1000V) this effect was negligible for the detector 
used.
Another effect of incomplete charge collection is that a shelf is seen on the low 
energy side of peaks. This shelf corresponds to the photons being assigned a 
value that is too low in energy, because the charge was not completely 
collected. The presence of this shelf can be clearly seen in figure 2.4.1.





Energy /  keV
110
Figure 2.4.1 - 1 12keV emission peak from a 57Co source placed in front of the detector window. Neither 
the detector nor the source were collimated. There was no scattering medium present except the 
holder that the detector is mounted in. Note the expanded vertical scale necessary to show this shelf. 
The shelf height is approximately 1% of the peak height.
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components following the detector. Its magnitude may be measured by 
connecting the output of a precision pulser with highly stable amplitude to the 
preamplifier. A parallel test pulse input to the preamplifier is usually present 
for this purpose. It should be noted that the value of We is not entirely 
independent of the detector itself. Large detectors tend to have large 
capacitance and therefore larger electronic noise figures.
2.4.2 The 'Compton shoulder'
The ‘Compton Shoulder’ is a feature that can be seen in spectra of this type and 
is caused by the energy of the incoming photon not being completely absorbed,
i.e. The photon undergoes a number of interactions within the detector, but 
then escapes before its energy is completely absorbed. In normal 
circumstances, all scattering angles will occur in the detector. The energy, Ee, 
transferred to an electron in any one of these scattering events is given by
= E0 -E  (2.4.3)
where Eo is the energy of the incident photon and E is the energy of the 
scattered photon given by equation 2.2.2. Therefore by substituting equation
2.2.2 into equation 2.4.3 we obtain an expression for the energy, E«, transferred 
to an electron in any one interaction.
E
Ee =  -J   (2.4.4)
^  +1  
E\,(l- cos0)
where nuc2 is the rest mass energy of an electron, and Eo is the energy of the 
incident photon. If the photon escapes from the detector after only one 
interaction the detector registers a photon of energy E«. This energy has a 
maximum value corresponding to 0=180°. We therefore obtain an edge at this 
maximum energy, Ec, given by equation 2.4.5 and a continuum of energies 
below it; corresponding to the energies it is possible to transfer to an electron in 
a single interaction.
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Table 2.4.1 shows the position of the Compton shoulder for various isotopes. It 
can be seen that the Compton shoulder will be well below the gold fluorescence 
peaks for exciting sources near the K absorption edge of gold.
In fact experimentally the Compton edge could not be seen for either 241Am or
57Co and was only visible in the 137Cs spectrum (figure 2.4.2). This can be 
explained using equation 2.2.9. If a value of the linear attenuation for
germanium is used for a photon energy of lOOkeV, x = 7mm. We obtain the
result that I/Io = 0.12. However for a photon energy of 600keV we obtain
I/Io = 0.79 (Hubbell, 1982). Thus demonstrating that for a 67Co source we would
expect only 12% of the photons to be incompletely absorbed and for 137Cs about
79% of the photons to be incompletely absorbed. Therefore we would expect the
Compton shoulder for the 137Cs system to be about 7 times larger than for the
57Co system.
2.4.3 Pulse shape tinning
The pulse shape timing is a parameter of the electronic amplification system 
used. The term refers to the time constant in RC circuits used to change the 
shape of the incoming pulse. In general a shorter shaping time yields a higher 
achievable count rate, but the width of the X-ray peaks increases (the 
resolution of the detector decreases) and hence the signal to background ratio is 
reduced as the total number of counts in the peak remains constant. The pulse 
shape timing must be optimised for any given source.
Isotope Main Photon Ec




Table 2.4.1 - Energies of Compton ed g e  for various isotopes
Number of Counts
700
Energy /  keV
Figure 2.4.2 - Spectrum recorded when a ,37Cs source was placed in front of the detector window. The 
y-emission peak (G) and Compton ed g e  (C) are clearty visible
2.5 The Compton peak
It is clear that in practice it is impossible to collimate perfectly either the 
source or the detector. Otherwise the time taken to make a measurement 
would be prohibitively long. Therefore in a practical situation we expect the 
Compton peak to have a finite width, corresponding to a finite spread of 
scattering angles accepted by the detection system and the detector resolution 
effects discussed in section 2.4.1.
By considering the geometry of the experimental apparatus, the collimation of 
both source and detector, the finite size of both source and detector and amount 
and position of any scattering material present, it should be possible to predict 
both the shape and position of the Compton peak.
A series of four computer programs were written to model the response of the 
detector to Compton scattered photons in a typical experimental set up (figure 
2.5.3) with varying degrees of sophistication. In the first three models, each 
point in the scattering medium lying in the plane containing both the centre of 
the source and the centre of the detector was considered.
The first of these models simply considered the proportion of the source and 











Energy / keV Energy / keV
Figure 2.5.1 c  - Model 3 Including attenuation in Figure 2.5.1 d - Complete three dimensional
scattering model (Model 4)
Figure 2.5.1 - Models of Compton scattering with varying degrees of sophistication. Note small lump on 
high energy side of ail the fitted peaks, due to the fact that ^ Co is a  dual photon energy source 
(122keV (85%), 136keV (11%)). The Compton scatter of the 136keV peak therefore produces a 
subsidiary Compton peak on the high energy side of the main peak. Note also the number of points 
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Figure 2.5.2 - A more complete fit can be obtained with systems with less multiple scatter
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Figure 2.5.3 - Scale diagram of experimental apparatus used to obtain the results in figure 2.5.1. Both 
the S7Co source and the detector were in steel collimators. A small polythene bottle (47mm diameter) 
filled with a solution of chloroauric acid was used to represent the kidney. A glass beaker (90mm 
diameter) was used to represent the surrounding tissue.
[~j Area considered by modelling program
Source
itector
Figure 2.5.4 - Diagram illustrating the area considered by the Compton model program. The diagram 
also shows the parameters r, R, p & q used by the program.
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law. The second model included effects due to finite wall thickness in the 
collimators. The third model included an approximation for the attenuation of 
the primary and scattered photons when passing through the scattering 
medium. (It was assumed the linear attenuation coefficient varied linearly with 
photon energy over the energy range of interest (60-120keV).)
The fourth and most sophisticated model allowed a full three dimensional 
consideration of the scattering medium. The results of these four models fitted 
to a typical system are shown in figure 2.5.1. Note all the models ignore the 
Klein-Nishina formula (2.2.3) and assume equal probability for all scattering 
angles. This assumption is justified by the success of the models, although a 
careful examination of figure 2 .2.1 would not necessarily lead to this conclusion 
for photons of around lOOkeV (a * 0.2).
The modelling procedure in all cases involved considering a number of points in 
the area defined by the two collimators (figure 2.5.4). If the point was within 
the scattering medium and could be ‘seen’ by at least some of both source and 
detector, its contribution was added to the model spectrum. The contribution, 5, 
of any given point is given by equation 2.5.1.
8 = (2.5.1)
^  R
where g is the fraction of the source the point could ‘see’, G is the fraction of 
the detector the point could ‘see’, r is the distance from the point to the centre 
of the source, R is the distance from the point to the centre of the detector, p is 
the distance the unscattered photon travels through the scattering medium, q 
is the distance the scattered photon travels through the scattering medium and 
(i is the linear attenuation coefficient for a photon in the scattering medium 
and is a function of energy. From figure 2.5.1 it is clear that a fairly good fit of 
the centre section of the Compton peak can be obtained using this type of model 
especially using the full three dimensional model (model 4). It is also clear 
however that the models allowing for finite wall thickness in the collimator and
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attenuation in the water (models 2 and 3) are not significantly better than the 
crudest one. This indicates that these refinements are insignificant. Therefore 
it is sensible to use the (simple) three dimensional model (model 4) for future 
predictive work. It is also noted that the fit obtained from the models is very 
good on both the low energy side and the centre regions of the Compton peak. 
However the fit obtained on the high energy side is less good. It appears that 
there is more tailing in practice than would be expected, which may be 
explained by the presence of multiple scattering:
If a single scatter event through angle 0 is considered, then the energy of the 
scattered photon, E, is given by equation 2.2.2. Now considering a double 
scattering process through the same total angle: (i.e. A scattering event 
through an angle |3, followed by another scattering event through an angle 0-p.)
The energy of the incoming photon after the first scattering event is given by 
equation 2.5.2.
2.5.4. This expression can be simplified to have the form of equation 2.5.5.
1 + —V l  - C0SP>
(2.5.2)
Similarly the energy of the photon after the second scattering event is given by 
equation 2.5.3.
E"
1 + -^ 5  (1 - cos(6 - P)) 
n y r
(2.5.3)
Combining these equations 2.5.2 and 2.5.3 gives equation 2.5.4.
E" =
(2.5.4)
Now consider the difference between the denominators of equations 2.2.2 and
^2.2.2 ~ ^2.5.4 = (2.5.5)
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It is noted that from consideration of geometry the following conditions are 
imposed for most double scatter events:
-180° < 0 < 180° (2.5.6)
-180° < p < 180° (2.5.7)
If p>0 , 0>P Otherwise 0<P (2.5.8)
From these conditions it is seen that expression 2.5.5 is always positive if  0 and
p have the same sign. Which implies that E < E". (i.e. Less energy is lost in a 
double scatter event than a single scatter event for any given angle. (This is 
illustrated in table 2.5.1.) Therefore if double scattering occurs we would expect 
to see more high energy photons than would otherwise be expected. This would 
explain the high energy tailing on the Compton peak. The results in figure
2.6.2 are also consistent with this explanation, as when the amount of 
scattering medium is reduced, so is the degree of high energy tailing on the 
Compton peak.
2.6 The low energy ‘shelf below the Compton peak
Examining a typical spectrum (figure 2.5.1) we see a high level of residual 
background at energies lower than the Compton peak. As the source is 
monochromatic in energy and is therefore not directly responsible for these low 
energy photons. The most conceivable source of this residual background is 
from secondary (and higher order) scatter. It should be noted that this 
background is too large in magnitude to be attributed to incomplete charge 











1 90° 90° 98.6
2 45° 90° 107.0
3 30° 90° 111.3
4 22.5° 90° 113.7
Table 2.5.1 - Illustrating that a  122keV photon undergoing a  number of scattering events, but the same 
total scattering angle, loses less energy than a  122keV photon undergoing one single scattering event.
only 1% of peak height, whereas these background levels are up to at least 50% 
of peak height. If secondary scatter is responsible for this residual background 
then the height of the background should increase with amount of scattering 
medium present. A series of experiments was therefore performed to test this 
hypothesis. The detailed setup was similar to that described in section 2.5. 
Here, instead of a water bath containing a polythene bottle of gold solution, 
various sized perspex cylinders were centred in the source beam and the 
detection area as shown in figure 2.6.1. A selection of results is shown in figure 
2 .6 .2 .
The results show that as the amount of scattering medium is increased the 
residual background height increases. For the 6mm diameter container (figure 
2.6.2a) theoretically the chance of a primary scatter event is approximately 
10% (using 2.2.9 again). Therefore the probability of a secondary scatter event 
is small - of the order of 1%. However with the 90mm diameter container, for 
example, the chance of a primary scattering event is approximately 80% and 
therefore the chance of a secondary scattering event is greatly increased. This 
residual background is therefore consistent with secondary scattering events, 
and consequently an inherent feature of the spectrum.
Examining figure 2.6.2b (and most other spectra with secondary scattering 
present) we notice a shoulder, S. As this shoulder only seems to appear in 
spectra with multiple scattering it seems likely that the shoulder is 
attributable in some way to multiple scattering. One obvious possibility is that 
i t  corresponds to the maximum possible energy it is possible to lose in two 
scattering events. The maximum energy loss obtained from these two 
scattering events is when the denominator in equation 2.5.4 has its maximum 
value. Differentiation of this denominator with respect to both 0 and P leads to 
the conclusion for maximum energy loss:
P = -0  (2.6.1)
If values of 0 corresponding to the m in im u m  and maximum scattering angles
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NB: These spectra have 
had the 'background' 
recorded when no 
scattering medium was 
present subtracted.
Energy /  keV 
Figure 2.6.2c - 90mm diameter container
Figure 2.6.2 - Compton peaks for varying amounts of scattering medium. Note the decrease in the 
Compton height/residual background height ratio for increased amounts of scattering medium.
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the collimation system will accept are substituted into equation 2.5.4 using 
condition 2.6.1, it is found that the resulting range of energies corresponds to 
the range of energies over which the shoulder is seen. This shoulder is 
therefore attributed to the maximum energy it is possible to lose in two 
Compton scattering events. To confirm this a spectrum similar to that in figure 
2.6.2b was taken using a 153Gd source (97,103keV) instead of a 57Co source 
(122keV). The resulting spectrum had the shoulder in the position predicted by 
the theory outlined above. This type of argument is also supported by the 
results of extensive Monte Carlo calculations performed by Rosenthal and 
Henry (1990) for "Tcm sources and a sodium iodide detector for use in Nuclear 
Medicine and Laird et al (1982) for 57Co and a hyperpure germanium detector.
It would be useful to try and move this shoulder so that the gold peaks (figure 
2.5.1) do not sit on it, as the rapidly varying background makes the evaluation 
of the magnitude of the gold peaks difficult. The possible ways of doing this are 
either to use a source of different energy or to rearrange the geometry so that 
the average scattering angle accepted by the collimation system is changed.
2.7 Conclusions
By considering both the system geometry and the physical processes involved it 
is possible to understand the features on which the fluorescence peaks sit.
By consideration of just the geometry it is possible to predict the shape of the 
Compton peak. The exception to this is the tailing on the high energy side of 
the Compton peak. This tailing is consistent with secondary (and higher order) 
scatter events.
The rest of the spectrum can be understood qualitatively from the experimental 
results using scatterers of different diameter: The low energy ‘shelf’ is also 
consistent with secondary (and higher order) scatter.
It should now be possible to use this information to make a preliminary 





It is important to be aware of the detection limit (DL) of any system, i.e. The 
minimum concentration (of gold) that can be detected. The aim of the project is 
to achieve a detection limit of 40pg gold (g tissue)'1 at tissue depths of 30 - 
40mm. It is therefore important to understand the factors that affect the 
detection limit and to adopt the experimental arrangement that will achieve 
the lowest value. The parameters which may be varied are detector/source 
geometry, collimation, detector size, source to skin distance, detector to skin 
distance, source energy and phantom depth and each was investigated in turn. 
First however the meaning of detection limit is considered.
3.2 Detection limit definitions
There are various definitions of detection limit used in the literature. Most are 
based on the argument that follows (Bevington, 1969).
3.2.1 Standard definition of detection limit
The most common definition of the detection limit of an emission line relates 
the line intensity to the background count level. The observed number of 
counts, N o, is composed of two components: the number of counts in the peak, 
Np, and the number of counts in the background, N b , as illustrated in figure
Figure 3.2.1 - Illustration of NP/ Nb, and N0 (= NP + Nb)
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3.2.1. Poisson statistics are assumed due to the statistical counting process 
involved. Therefore the total number of counts and related uncertainty (1 
standard deviation) is given by equation 3.2.1.
N0 = (Np + NB) ± ^ N p +Ng (3.2.1)
In order to calculate Np, the background either side of the peak of interest is 
fitted and interpolated under the peak. The number of counts in the peak, Np, 
and related uncertainty is then calculated by subtraction using 3.2.2.
Np = (N0 ± - ( n b  * V N b )  (3.2.2)
= (n0 - n b) ± V 2 n b + n p
Usually Nb »  Np and therefore equation 3.2.2 approximates to equation 3.2.3 
to first order:
Np = (N„- Nb) ± ^/2Ng (3.2.3)
The precise definition for detection limit varies from group to group. Typically 
the detection limit is defined to be when the number of counts in the 
fluorescence peak, Np, is greater than twice (95% certain peak exists) or three 
times (99.7% certain peak exists) the uncertainty in peak area given by 
equation 3.2.3. The conditions for a peak to be detectable which are given in 
3.2.4 are therefore typical.
^ p,dl = 2Nb at 2 SD level (3.2.4)
= 3^2N B at 3 SD level
By assuming that the number of counts in the peak, Np, is proportional to the 
concentration, C, of gold in the phantom equation 3.2.5 is obtained.
NP = k c (3.2.5)
The constant of proportionality, k, can be determined experimentally (either
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from a single result, where k is obtained from the ratio of counts in the peak to 
the concentration of phantom used (Np,x/Cx), or from the least squares fit for a 
number of results using different concentrations). Combining equation 3.2.5 
with condition 3.2.4, the expression (at the 2 standard deviation level) which is 
given in equation 3.2.6 can be derived.
n p ,dl = (3-2 -6)
where Np,x and Nb are the number of counts in the peak and background 
obtained from an experiment and Cx is the concentration of gold solution in the 
phantom used in that experiment. This can now be rearranged to give the 
expressions for detection limit given in equation 3.2.7.
CDL "  N
2'v/2 N b Cx ^  2 /2  Cy (3.2.7)
p,x
where r is the ratio of counts in the peak to counts in the background (N p/N b). 
From equation 3.2.7 it is seen, that using this definition of detection limit, the 
detection limit decreases with increase in the square root of dose, as N b is 
approximately proportional to dose for a given experimental setup, the 
contribution from the fluorescence lines being small. Consequently if the 
photon flux (dose rate) is kept constant, detection limit decreases with increase 
in the square root of time. Similarly if exposure time is kept constant, detection 
limit decreases with increase in the square root of dose rate.
3.2.2 Other definitions of detection limit
The other definition of detection limit that is commonly used is that a peak is 
below the detection limit if  the peak area returned by the peak fitting program 
(section 3.8) is less than twice (2 standard deviations) the uncertainty in the 
peak area returned by the fitting program. This uncertainty in the peak area is 
derived from how well the model fits the raw data. However it is not so easy to
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extrapolate the detection limit from high concentrations using this definition. 
It is thought that strictly this is a more correct definition and should be used in 
a clinical system as the uncertainty in the peak fitting program is derived from 
the data set being used. (Conclusion of panel at International Symposium on in 
vivo body composition studies, Toronto 20-23 June, 1989)
3.2.3 Experimental verification that peak size is proportional to gold 
concentration, and  of predicted detection limit
Although obviously it is possible to predict detection limits using phantoms of 
high gold concentration and equation 3.2.7, it is unclear how accurate these 
predictions are. Therefore an experimental investigation was undertaken to 
establish the validity of this calculation, by firstly verifying that the number of 
counts in the fluorescence peak were proportional to the gold concentration in a 
phantom. Secondly by looking for which concentration could not be measured 
or no longer fell on the line of proportionality.
Two series of experiments were performed in which the concentration of gold in 
the kidney phantom was varied. In one series a 57Co source was used in a 90° 
geometry with an experimental arrangement identical to that described in 
section 3.4.1 and illustrated in figure 3.4.1, and in the other a 133Xe was used in 
a backscatter arrangement identical to that shown in figure 3.3.1.
In both cases the number of counts in the Kai gold fluorescence peak (obtained 
by using the fitting program described in section 3.8) was plotted against the 
concentration of gold in the phantom. The results are illustrated in figure 3.2.2 
and given in table 3.2.1. The predicted detection limits using the 500 g-i 
phantom result and equation 3.2.7 are 120 and 77 jig g 1 for 133Xe and 57Co 
respectively.
From these results it is clear that the number of counts in the fluorescence 
peaks is proportional to the concentration of gold in the kidney phantom. It is 
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Figure 3.2.2 - Plot of kidney phantom gold concentration against number of counts In the K«i 
fluorescence peak. (NB: The error bars on the figure represent the standard error in the number of 
counts In the Koi peak as returned by the fitting program.)
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Table 3.2.1 - Table of experimental results. The uncertainties In peak area are the standard error In the 
peak area returned by the peak fitting program
proportionality goes through the predicted detection limit without 
extrapolation.
3.3 Detector/source geometry
The detector/source geometry refers to the angle between the axis of the 
detector and the source beam axis. Of the possible geometries the backscatter 
geometry and 90° geometry have been evaluated by this and other groups 
although other arrangements are of course available. The angle referred to in
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this convention is approximately the average angle of scatter for singly 
scattered Compton photons, that is accepted by the detector.
3.3.1 90° Geometry
This geometry is used with the 67Co source already described so that the gold 
fluorescence peaks are not at the same energy as the Compton scattering peak. 
The inherent advantages of this geometry are that primary Compton scattering 
is at a minimum at 90° (Evans, 1955) and that it is easy to arrange the 
collimators for a well defined field of view. Another factor that should be noted 
is that arrangements with average scattering angles of less than about 135° are 
the only really practical geometries if  an X-ray tube is used as an exciting 
source as the X-ray tube is too large to accommodate a detector in the 
backscatter arrangement. The Swansea In Vivo Analysis Research Group 
(SIVARG) have found that the use of two separate collimators makes it much 
more difficult to keep the organ in the field of view of the well collimated source 
and is generally much more awkward to align to a patient.
3.3.2 Backscatter geometry.
A second detector/source geometry that has been investigated is one in which 
the scattered and fluorescence photons are detected at the maximum possible 
angle from the source beam (ideally 180°).
In this geometry the source is an annular source placed around the detector 
although shielded from it. A typical arrangement is shown in figure 3.3.1. From 
the figure it is clear that the average scattering angle is between 150° and 
160°. Since with this type of setup the source, source collimator and detector 
collimator are in the same unit, positioning of the apparatus / patient becomes 
much easier as only one collimator has to be located.
This type of system has been adopted by the Swansea group using "Tcm as a 
source for detecting platinum in neck tumours after cis-platin therapy. The 







Figure 3.3.1 - Typical experimental arrangement for backscatter geometry
detector/source head is easy to position in the relatively confined space in the 
neck area (Al-Sadhan et al, 1989) secondly "Tcm is a cheap and readily 
available source as it is used routinely in nuclear medicine studies.
The initial reason for adoption of the backscatter geometry was that if a source 
of energy just above the K absorption edge of the metal of interest is used, the 
fluorescence peaks lie above the Compton scattering peak as the Compton 
scattering energy loss is greatest at large scattering angles. Examining figure 
2.5.1 it is seen that if the fluorescence peaks he above the Compton peak in 
energy they sit on a much lower background. Applying equation 3.2.7 the 
detection limit should therefore be much lower. It turns out from equation 3.3.1 
that, in order for the fluorescence peaks to lie above the Compton peak, the 
source must have a energy as close as possible to the K absorption edge of the 
metal of interest. The exciting source being close in energy to the absorption 
edge metal also maximises the probability of the photoelectric effect and
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therefore the intensity of the fluorescence signal.
E (3.3.1)
1 +  s (1 - COS0)
mecr
Much work has been done by Somervaille et al (1985) on this type of system for 
bone lead. For bone lead work a 109Cd source (88.0keV) is used to excite lead 
(K abs=  88.0keV) in tibia. For tibia there is very little overlying tissue and 
multiple scatter caused by overlying tissue is minimal. Quoted detection limit 
is 10|ig (g wet bone)'1 at an absorbed dose of 100|iGy to 1.5kg of non­
radiosensitive tissue (Chettle et al, 1989). A similar type of system is possible 
for detection of gold (K ab s=  80.7keV) using a 133Xe (81.0keV) source, although 
xenon, being gaseous, is in an inconvenient physical form and therefore 
difficult to obtain high activities. A diagram of the collimators used for the 
evaluation of this system is shown in figure 3.3.2.
The disadvantage of this type of system is that the sensitivity falls off rapidly 
with tissue depth as reported by the Swansea group (Dutton et al, 1985) and 
supported by our own results. This phenomenon is discussed further in section
3.7.
I— 110 nun
Mark I Mark II (Better 
collimation)
Mark IB Isotope in solution | |^  Nylon mounting bracket
Ietector distance) Lead shield/ 
Collimator |  Perspex
Figure 3.3.2 - Different versions of the backscatter collimator
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3.4 Collimation
When making a comparison of results it is also important to be aware of the 
effect of the position of the kidney phantom in relation to the field of view of the 
collimators. If the whole of the phantom is within the field of view of both 
collimators then the detector effectively measures total gold content rather 
than gold concentration. However if  only a section of the phantom is within the 
field of view of the collimators then the system effectively measures gold 
concentration in the field of view of both collimators. This however is only an 
approximation which ignores the effect of attenuation of both the exciting 
source and fluorescence emission.
An experimental investigation into the effect of source collimation was 
undertaken. In this investigation the depth of the 57Co source in a cylindrical 
collimator was varied to produce different fields of view. The source to skin 
distance was kept constant throughout in order to deliver constant skin and 
kidney doses. The detector collimation was also kept constant. The source was 
used to irradiate a kidney phantom (containing 500jig gold (g water)'1) in a 
rectangular tank of water. The depth of the phantom measured along the 
source axis was 50mm and along the detector axis was 30mm, these being 
typical kidney depths in the human body. The detector collimator was placed as 
close as possible to the tank wall. A diagram of the apparatus is shown in 
figure 3.4.1. The full angular width, 0, of the source beam was varied. A 







N p/N b DL
/ bg g'1
10±0.3 690± 80 5912 0.114 158±18
20±0.8 2066±153 21579 0.095 111± 8
30±2 2757±204 38891 0.070 101± 7
40±3 3442±231 49892 0.069 92± 6
50±3 4354±273 70613 0.062 86± 5
60±4 4573±261 70832 0.064 82± 5
90±6 4652±285 76269 0.061 84± 5
180 4597±314 93909 0.049 94± 6







Figure 3.4.1 - Experimental arrangement for source collimation study
The position of the primary Compton scatter peak in the detected photon 
spectra moves to a higher energy as the angular width of the collimated beam 
increases, indicating a reduction in the average scattering angle of detected 
photons. This is illustrated in figure 3.4.2 which shows the spectra for beam 
angles of 10° and 90°. It is also noted that the proportion of secondary scatter 
relative to primary scatter increases markedly with decrease in collimation.
Consideration of the results in table 3.4.1 leads to the following conclusions: 
Firstly the number of counts in the gold Kai peak increases with volume of 






Figure 3,4,2 - Spectra obtained using 10° (Right) and 90° (Left) full beam angles
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peak rises with volume of scattering medium seen by the collimators. The 
background under the fluorescence peaks arises mostly from photons which 
have been scattered at least twice in the tissue volume before reaching the 
detector. Figure 3.4.3 illustrates how the peak (Np) and background (Nb) 
components increase, as expected, as the volume irradiated increases, but not 
directly in proportion.
Since the obtaining of the optimum detection limit is the primary aim, it is 
interesting to note that for a fixed dose the optimum detection limit is not 
obtained with the same degree of collimation as is the highest peak to 
background area ratio, r. The reasons for this are found by looking at equation
3.2.7. It can be seen that as the angular width of the collimated beam is varied 
the detection limit decreases as the denominator of this equation, W (N b), 
increases. Therefore in designing a system for optimum detection limit there is 
a trade off between peak to background area ratio, r, and count rate (increasing 
the beam angle increases the count rate and therefore VN b). From equation 
3.2.7 it can also be seen that detection limit is proportional to V (N b) /N p, this
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Figure 3.4.3 - Summary of colimation results
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allows the variation of detection limit with beam angle to be derived from the 
measured values of Np and Nb in the way illustrated in figure 3.4.3. The 
variation of Np and Nb are determined experimentally (figures 3.4.3a and 
3.4.3b respectively). The variation of VNb with beam angle can then be 
calculated directly (figure 3.4.3c), this can then be combined with the variation 
of Np with beam angle to give variation of detection limit with beam angle 
(figure 3.4.3d). The reason for the less rapid increase in detection limit than
i
might be expected for irradiating larger volumes than necessary to just cover 
the kidney phantom is partly attributable to the fact that detection limit only 
increases with the square root of counts in the background, whereas detection 
limit decreases linearly with number of counts in the peak. Empirically our 
results (both those presented in table 3.4.1 and other results for alternative 
phantom depths) indicate that the optimum detection limit is obtained when 
the whole phantom is just irradiated by the whole source (i.e. approximately 
50° in the case of the data in table 3.4.1). From figure 3.4.3d it can be concluded 
that it is better to irradiate a slightly greater volume rather than a slightly 
smaller volume due to the rapid deterioration of the detection limit with 
increased collimation (i.e. smaller angular widths of the irradiating beam).
On the assumption that the effect of varying detector collimation will be 
broadly similar to that of varying source collimation (i.e. the optimum detection 
limit will be achieved when the whole phantom diameter is just seen by the 
whole detector) the detector collimator was opened out, such that the whole 
detector would just see the full diameter of the phantom at a depth of 30mm 
(figure 3.4.4). A summary of results comparing the new and old collimators is 











Old 55 4552 68924 81
Old 10 690 5912 158
New 55 10379 153795 53
New 10 1530 16890 120
Table 3.4.2 - Detector collimation results. Phantom gold concentration was 500ng g '1
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11 Section removed to form new collimatori
11 Detector Head
I I Old collimator ,
7mm I 7mm
I |10frn |----- 1
20 mm
Figure 3.4.4 - Illustration of section removed from old detector collimator to form new detector
colfimator
described for the source collimation work (figure 3.4.1). The irradiation time 
and source to skin distance was identical for all the experiments.
From these results it can be seen that (for similar irradiation times) the 
number of counts in the peak, Np, for the new detector colfimator increases by 
the same proportion independent of source collimation. This is as expected, due 
to the fact that the peak size is proportional to the amount of gold seen and the 
extra volume of gold containing material seen increases by the same proportion 
in each case. However the number of counts in the background, N b, increases 
by a larger proportion for the highly collimated source than for the less well 
collimated source. This is due to the larger relative increase in 
secondary/multiple scatter accepted by the detector colfimator for the well 
collimated source than for the less well collimated source. (This is an observed 
experimental fact.) Combining these results for the peak counts, Np, and 
background counts, N b , leads to the conclusion that the highly collimated 
source will have a proportionally smaller decrease in detection limit than the
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less well collimated source. This is indeed found to be the case. However in 
both cases a significant reduction in detection limit has been obtained by 
opening out the detector collimator. It is therefore concluded that varying the 
collimation of the detector has broadly the same effect as varying the 
collimation of the source (although two different collimations is a very limited 
data set) and the new detector collimator gives a significant improvement in 
detection limit compared with the old one.
It is noted that the detection limits would be completely different if normalised 
to total absorbed energy rather than an organ dose. This is because with a well 
collimated beam less energy would be absorbed than with a poorly collimated 
beam, whereas the collimation of the source beam does not markedly affect 
skin dose. Therefore a well collimated beam would give a high peak to 
background area ratio with low absorbed energy and would be the optimum 
arrangement if total absorbed energy was the limiting factor. However when 
working to WHO guidelines it is not total absorbed energy but effective dose 
that defines the limits to permissible irradiation.
3.5 Detector Size
A larger detector should give a reduced detection limit as more photons would 
be detected in a given irradiation time. The count rate increases proportionally 
with detector area and therefore the detection limit decreases with increase in 
square root of the detector area or with increase in detector diameter. This is 
only an approximation which ignores the effect of poorer collimation and 
problems caused by higher count rates if high photon flux sources are used, 
which may reduce the expected improvement to detection limit if  a larger 
detector were used.
The resolution of larger volume detectors is usually poorer than small volume 
detectors, which can lead to the improvement in detection limit not being as 
great as predicted from the increase in area. This poorer resolution is primarily 
due to the lower electric field achievable in these detectors which leads to
greater incomplete charge collection (section 2.4; Knoll, 1979).
3.6 Source energy
It is obviously possible to use sources of different energies. The choice however 
is limited by the fact that we require a source with a simple spectrum with 
photon energies dose to but above the K absorption edge of gold; without 
additional higher energy components that cannot be filtered out; that can be 
obtained in relatively high activities and has a suitably long half life.
If sources lower in energy than the K absorption edge are used there is no cross 
section for K shell photoelectric absorption and consequently no detectable 
fluorescence. The maximum cross-section for absorption is obtained if the 
energy of the source is just above the K absorption edge of gold and as the 
energy of the source is increased above the K absorption edge the probability of 
photoelectric absorption decreases. Low activity sources require small skin to 
source distances to give a sufficient photon count in a limited irradiation time, 
this leads to large skin doses. A source with a short half life would require 
repladng regularly and would therefore have high overhead costs.
Table 3.6.1 shows the position of the Compton peak for various available 
sources, which have suitably simple emission spectra of energy dose to the K 
absorption edge of gold, in the two investigated geometries. It is noted that 
using 153Gd in a backscatter geometry or 133Xe in a 90° geometry means that the 
fluorescence lines (67-68keV) are coinddent with the Compton peak. If the 
fluorescence lines are coinddent with the Compton peak the detection limit will








Table 3.6.1 - Compton peak energies
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be increased unacceptably as the number of counts in the background, Nb, will 
be increased (equation 3.2.7).
It is concluded therefore that 57Co, "Tcm and 133Gd might be suitable sources for 
use in a 90° geometry and 133Xe, 57Co and "Tcm might be suitable sources for 
use in a backscatter geometry.
Preliminary experimental work comparing 153Gd (lOOkeV) and 57Co (122keV) in 
similar experimental setups has indicated that 153Gd is a better source than 
57Co because it is closer in energy to the K absorption edge of gold giving a 
higher cross section for K shell photoelectric absorption. The experimental 
results are presented in table 3.6.2. The theoretically predicted ratio of peak 
sizes could be determined from the ratio of cross-sections for absorption by gold 
(1.3 Gd:Co) and the ratio of photon fluxes reaching the kidney phantom from 
equation 3.6.1 (0.90 Gd:Co; 45mm water (to centre of phantom)). Therefore the 
predicted ratio of peak sizes is 1.2 Gd:Co. The ratio of peak sizes obtained 
experimentally (1.28 ± 0.13) is therefore explained.
I = (3.6.1)
153Gd is also available in higher activities (up to 37GBq) than 57Co (up to 2GBq) 
thus allowing larger source to skin distances to be used for a fixed irradiation 
time. It is not possible to use a source lower in energy than 153Gd in a 90° 
geometry as the gold fluorescence peaks become coincident with the primary 
Compton scattering peak.
It is therefore concluded that the effects of source energy can be explained 
using photoelectric absorption cross-sections and differential absorption of
Source Phantom SSD Kai Peak
Depth /mm /mm / Counts
hlCo 22.5 25 369±11
l53Gd 22.5 25 475±29
Table 3.6.2 - Comparison of ,53Gd and ^Co as sources In a  90° geometry. The skin dose for the results Is 
5mGy. The concentration of gold In the kidney phantom was 500}ig g*'.
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different photon energies by overlying tissue.
3.7 Kidney phantom depth
The effect of kidney phantom depth is not a simple problem as the magnitude 
of the effect is not independent of source energy or detector/source geometry. 
The effect of phantom depth has been investigated with two systems: 133Xe in a 
backscatter arrangement and 67Co in a 90° geometry.
3.7.1 ,33Xe backscatter system
In the experimental arrangement used the mark I collimator, shown in figure 
3.3.2, was mounted on the front of the detector and positioned as dose as 
possible to a beaker of water (115mm in diameter). The kidney phantom was 
then positioned at different positions within the beaker (figure 3.7.1). 
Effectively all that is happening in this series of experiments is that the depth, 
d, of the gold containing kidney phantom is being altered. The amount of water 
that is in the field of view remained constant as the beaker size remained 
constant. The results for various kidney phantom depth are presented in table
3.7.1.
The results may be understood partly by considering the effect of attenuation of 
photons due to overlying tissue and the inverse square law losses. However this 
simple model ignores any photons which are Compton scattered but still have 
enough energy to extite fluorescence. Firstly the attenuation of the 
fluorescence signal and extiting photons due to overlying tissue will be a 
relatively small factor (I/Io = 0.83 for 10mm at 80keV). Secondly the application 
of expression 3.7.1, which gives the form of the inverse square law for a
Phantom SSD Peak Area




Table 3.7.1 - Results from the mXe backscatter system with different phantom depths. The skin dose for 
all the results was 6.5mGy and the peak areas are for the Kat peak only. The concentration of gold in




Isotope in solution 
H ill Lead shield /  Collimator 
Nylon mounting bracket 
[SB Perspex
Area seen by collimation system
lcm
Figure 3.7.1 - Diagram o f  experimental arrangement for ,33Xe work
distance r along the axis from a ring source radius, R, leads to the conclusion
that for the dose received by the near side of the kidney phantom when 30mm
deep is only 0.49 of that received when 10mm deep.
1
1-2 + R2 (3.7.1)
The XRF signal received by the detector will also be reduced by the inverse 
square law. Applying both the attenuation and inverse square law factors, it 
would be expected that the fluorescence signal from the front surface of the 
kidney would be reduced by a factor of 11 when the depth is increased to 
30mm from 10mm. However taking the front of the kidney is by far the worst 
case for the inverse square law and performing a similar calculation for the 
centre of the kidney phantom (47mm diameter) yields a reduction by a factor 5. 
This is somewhat larger than the observed reduction of 3.9 and may be 
explained by considering the geometry of figure 3.7.1: When the phantom is 
30mm deep more phantom is seen by both collimators than when the phantom 







Figure 3.7.2 - Diagram of experimental arrangement for wCo work
the signal with depth of kidney phantom thus can be explained, at least partly, 
by a simple consideration of the basic underlying physical processes.
3.7.2 67Co in a 90° geometry
A similar set of experiments were performed using a 67Co source in a 90° 
geometry, however there are now two depths that can be varied, i.e. the depth 
with respect to the detector, di, and the depth with respect to the source, d2. 
The effect of varying both of these was investigated. A diagram of the 
experimental arrangement is shown in figure 3.7.2 and a summary of results is 
given in table 3.7.2.
Phantom Depth / mm SSD Peak Area
di d2 /m m / Counts
2 0  2 0 2 0 1099±84
30 30 2 0 739±70
Table 3.7.2 - Results from the 57Co 90° system geometry with different phantom depths. The skin dose for 
all the results is 5mGy and the peak areas are for the Koi peak only. The concentration of gold in the
kidney phantom was 600(ig g'1
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It is clear from these results that the sensitivity of the 67Co system falls off less 
rapidly with depth than the 133Xe system described above. This is partly 
attributable to the fact that the 122keV 67Co photons are more penetrating 
than the 81keV 133Xe photons. It is also partly attributable to the fact that 67Co 
photons that have undergone low angle Compton scatter will still have enough 
energy to cause a photoelectric transition in gold whereas Compton scattered
133Xe photons will in general not. However it is not possible to quantify the 
magnitude of the latter effect without a Monte Carlo type calculation, similar
to that described in chapter 5.
3.7.3 Conclusions
It is concluded that the peak area falls off less quickly for the 90° type systems 
with higher energy sources such as the 67Co results presented above. This 
phenomenon is attributed to two factors: Firstly the higher energy photons of 
the 57Co source are more penetrating so more unscattered exciting photons 
reach the kidney phantom, and secondly that more of the higher energy 67Co 
photons that have undergone Compton scattering will still be able to cause 
photoelectric transitions in gold. However it is not possible to predict the rate of 
decrease in sensitivity with increase in phantom depth for different energy 
sources.
3.8 Peak fitting program
The peak fitting program (given in Appendix A) was used to fit the region of the 
spectrum containing the gold fluorescence peaks. It was used to evaluate the 
area under the peaks (and hence for a calibrated system the concentration of 
gold could be deduced).
The program used a fitting function (described below) to fit both the 
background around the peaks (so that the background under the peaks could be 
interpolated) and the peaks themselves. The algorithm employed by the 
program was the non-linear least squares fit proposed by Levenberg and
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Marquadt. (Press et al, 1988; Marquadt, 1963)
The function used to fit the peaks is given in equation 3.8.1. The general cubic 
part was used to fit the background as no analytical expression exists for the 
background due to multiple scattering. The two gaussian parts were used to 
represent the Kai and Ko2 peaks of gold with small underlying shelf due to 
incomplete charge collection represented by the complementary error functions 
(Vamell and Trishcuk, 1969).
/ - ( x - a / \  ^  / X ' * 2 \  / - ( x - ^ + a s ) ) 2\
* = ) +a“erfc \7W )^ + a^ esp(  iif )
/ x - ( a ^ + a ^ \
+ i^erfc —  J + a 7 + a 8x + a9r - + a 10z3
(3.8.1)
where erfic represents the complementary error function given by equation
3.8.2 and ai-an are the parameters adjusted by the fitting program.
erfc(z) = 1 - —  [  e'z2dz (3-8,2)
J~n L
The parameters ai-an have the physical interpretations given in table 3.8.1 and 
illustrated in figure 3.8.1.
Parameter Interpretation
ai Height of Ko2 peak / Counts
su Height of Kai peak /  Height of Ko2 peak
a2 Position of Ko2 peak /  keV
as Difference in energy between Kai and Ka2 peaks / keV
a3 VSWHM of K02 peak /  keV
as VSWHM of Kai peak /  keV
an Height of shelf under peaks relative to their height
a7-aio Coefficients of polynomial used to fit background under 
the peaks







Figure 3.8.1 - Illustration of fitting parameters
In a typical fit parameters as, a3, ae, a4 and an were fixed to the values 
predicted theoretically; as is the theoretical separation of the two peaks, a3 and 
a6 are the detector resolution for the appropriate amplifier parameters 
(determined experimentally), a4 is the relative heights of the Kai and Ko2 peaks 
and was set to the relative transition probability, and an is the experimentally 
determined height of the shelf for an 241Am photon (59.5keV). (The method for 
the experimental determination is identical to that described in the caption to 
figure 2.4.1 except that an 241Am source was used instead of a 57Co source.) The 
other parameters were all allowed to vary freely. Initially a2 was set to the 
expected position of the Ko2 peak; a7-aio were set such that the background was 
the cubic determined using the method described by Jonson et al (1988); and 
finally ai was estimated from the raw data using the estimated background.
3.9 Inter-laboratory comparisons
A study of published work suggests there are three other groups other than 
ourselves actively involved in using XRF for determination of trace levels of 
heavy metals in the kidney in vivo although none are investigating gold in vivo. 
These groups are based in Swansea, Birmingham and Goteburg (Sweden). The
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following section compares the published results from these groups with our 
own preliminary work.
As detection limit is related to dose/time, a convenient measure of the potential 
sensitivity when comparing similar systems is to look at the peak area to 
background area ratio. This ratio should be independent of time, detector size 
and dose. The larger this ratio is the more potential the system has. However 
for a practical system the dose must not be ignored and an upper limit to the 
permissible dose is set depending on the diagnostic value of the investigation 
for the patient (WHO, 1977). It may be possible to have a system with a high 
peak to background area ratio and poor detection limit because of the high 
effective dose required to produce an acceptable photon count. This will be 
particularly true of highly collimated systems. Therefore it is also of interest to 
compare detection limits at similar skin doses, which are easy to measure and 
related to effective dose (Preface).
In order to compare different detection limits, with different quoted/measured 
skin doses, all results in the following discussion have been normalised to a 
skin dose of 4mGy. The detection limits were calculated assuming that 
detection limit decreases with increase in the square root of dose. It should also 
be noted that all detection limits quoted in this section are calculated from 
measurements obtained at higher concentrations using equation 3.2.7.
Examining table 3.9.1, which compares similar geometries with a 57Co source 
from our own laboratory and Swansea (Dutton et a ly 1985), it is noted that the 
systems appear to have different peak to background area ratios. This is








Peak Area1 DL8 
Back. Area / p g g '1
Swansea Pt 100 60 20 40 0.17 34
Bath Au 78 60 20 40 0.10 76
* See figure 3.7.2 ’ Areas under K«i only
* Normalised to absorbed skin dose of 4mGy
Table 3.9.1 - Comparison of results from Swansea and  our own work using a  ^Co source in a  90° 
geometry. The concentration of metal in the kidney phantom was 500jig g*1
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explained by the fact that although in both cases the arrangement was such 
that the volume seen by both collimators was nearly identical, in the case of the 
Swansea group the kidney phantom was larger in one dimension by a factor of 
approximately 1.6, the amount of metal in the phantom increasing in 
proportion. Thus although the normalised detection limit for the platinum 
system appears to be far superior, a number of factors contribute to this. 
Firstly the detector used in the platinum system was larger, this gives a 
detection limit reduction of 1.2 (calculated from the square root of the ratio of 
detector areas). Secondly the dose for the gold system is calculated rather than 
measured, a similar calculation for the platinum system yields a dose of 
2.5mGy rather than the 1.8mGy quoted; this gives another factor of 1.2. As 
already mentioned the platinum system has an increased signal to background 
ratio due to the increased size of the phantom, this gives a further factor of 1.3. 
Overall these three factors will reduce the detection limit by a factor of 1.9 
which would reduce the normalised detection limit for the gold system from 76 
to 40fig g 1, which is close to the 36|ig g'1 quoted detection limit for the platinum 
system.
The Birmingham group have opted for a "Tcm source in a backscatter 
arrangement for determination of platinum in the kidney (Todd, 1989). This 
type of system has also been adopted by the Swansea group for assessment of 
platinum in neck tumours although no detailed results have been published. A 
comparison of results from our own work (using the mark I xenon collimator) 
and the results from Birmingham is presented in table 3.9.2. No detection limit 
comparison is made because it is unclear how the TLD chips were positioned in
Group Metal Detector Phantom SSD Peak Area1
Area /mm2 Depth/mm /mm Back. Area
Birmingham Pt 256 20 30 0.08
Bath Au 78 20 30 0.09
1 Areas under Kai only
Table 3.9.2 - Comparison of results from Birmingham and  our own work using a  wTcm source in a  
backscatter geometry. The concentration of metal in the kidney phantom was 500^g g*'
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the Birmingham dose determination.
Although it would have been preferable to have a comparison of detection 
limits between the two systems, especially as the quoted detection limit by the 
Birmingham group is 56(ig g'1, it is clear from the peak to background area 
ratios that the results are very similar. It should be noted that both ourselves 
and the Birmingham group used similar sized kidney phantoms and therefore 
it is valid to compare the peak to background area results directly.
The group working in GOteburg have been using an X-ray tube as an exciting 
source with both polarized and unpolarized photons. The use of an X-ray tube 
has allowed large source to skin distances and therefore has reduced the 
necessary dose. The disadvantages of using an X-ray tube are that some of the 
radiation incident on the patient can not excite fluorescence as it is too low in 
energy but it contributes to the overall dose. Also, if polarized X-ray photons 
are to be used then a very high photon flux is required before the polarizer and 
therefore a large amount of shielding is needed to protect the patient (and the 
detector) from stray radiation. This group has not published any raw data 
which allows a direct comparison to be made between their work and our own.
In conclusion, our results are similar to those obtained by other groups using 
similar techniques to investigate low levels of platinum in the kidney. However 
the amount of data that is available to make these comparisons is extremely 
limited.
3.10 Conclusions
In designing a system with optimum detection limit for typical kidney depths 
there are several parameters which may be varied. These are skin to source 
distance, detector to skin distance, degree of collimation, detector size, source 
energy and geometry. The effect of varying these parameters has been 
investigated in this chapter with the following conclusions:
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3.10.1 Detector/source geometry
There are two types of geometry which have been commonly used: backscatter, 
where the source is mounted in a collimator which fits onto the front of the 
detector head, and other systems where independent collimation has been used 
for both source and detector. In the latter systems the angle between the source 
and detector axes is less than approximately 160° to accommodate both 
collimators. Angles less than 90° are excluded because of the rapid increase in 
the amount of tissue between the skin surface and the kidney at smaller angles 
(figure 3.10.1), and the 90° case has been investigated as an example of such a 
geometry. The inherent advantage of a backscatter system for gold detection is 
that a 133Xe type system can be used where the fluorescence peaks are above 
the primary Compton scattering peak in energy. The large angle of scatter is 
needed to place the Compton scattered photons below the energy of the 
fluorescence photons. The inherent disadvantage is that it  is difficult to well 
define the field of view of both collimators even when using a collimated point 
source rather than an almost uncollimated ring source. (Compare figures 3.4.1 
and 3.10.2) The only inherent advantage of the 90° type system is tha t it is




Field of View of Collimators
Figure 3.10.2 - Possible apparatus for backscatter geometry with a point source
relatively easy to well define the field of view of both collimators. Therefore no 
fluorescence radiation is detected from any other gold containing organ such as 
the skin or liver (Gottlieb et al, 1972; Based et al, 1988; Vernon-Roberts et al, 
1976).
3.10.2 Collimation
The effects of source collimation discussed in section 3.4 lead to the conclusion 
that the highest peak to background area ratios are obtainable with very fine 
collimation. However the best peak to background area ratios do not 
necessarily lead to the lowest detection limits due to low count rate per unit 
skin dose and it  appears that the optimum detection limits are achievable 
when the source just irradiates the kidney volume, thus obtaining the 
maximum number of counts in the fluorescence peaks. The detection limit 
proves to be not very sensitive to slightly poorer collimation due to the fact that 
it only increases with the square root of counts in the background and that the 
number of counts in the background increases less rapidly than the increase in
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the total volume of scattering medium seen by both collimators. The effect of 
varying detector collimation has not been studied extensively. The limited 
amount of experimental work that has been carried out indicates that the 
effects and conclusions would be broadly similar to those for source collimation. 
(i.e. An optimum system will be achieved when the collimation is such that the 
detector just sees the kidney volume).
3.10.3 Detector size
Although for economic reasons the effect of varying detector size has not been 
investigated, it is anticipated that generally an increased detector size will lead 
to a reduced detection limit due to an increased count rate per unit skin dose. 
The only exception to this may be in a backscatter system with source very 
close in energy to the K absorption edge (133Xe for gold or 109Cd for lead) where 
the larger range of scattering angles accepted and consequent increase in width 
of the Compton peak and background below the fluorescence peaks may lead to 
an increased detection limit.
3.10.4 Source to skin distance
If the skin to source distance is made large with respect to kidney size and 
depth then the kidney receives a more uniform dose distribution and variation 
in sensitivity across the kidney is reduced. Large skin to source distances 
would however require a source with very high photon flux to maintain a 
reasonable count rate. However it should be noted that with large skin to 
source distances a much smaller error in angular alignment will cause the 
irradiating beam of photons to miss the kidney completely.
3.10.5 Detector to skin distance
The effects of varying detector to skin distance can be explained using the 
inverse square law. This leads to the conclusion that the detector should be 
placed as close as possible to the skin surface in order to maximise count rate.
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3.10.6 Source energy
Varying the source energy has two effects: Firstly to change the cross section 
for absorption for the exciting photon by the gold and secondly the attenuation 
coefficient for the photon in tissue is different. Combining these two factors 
gives an indication as to whether the alternative source will improve or 
degrade system performance. It is not possible to use all source energies in all 
geometries due to the relative positions of the primary Compton scattering 
peak and the fluorescence peaks.
3.10.7 Kidney phantom depth
The effects of varying the kidney phantom depth can be explained to a great 
extent using both the inverse square law and simple attenuation of both 
fluorescence and incident photons in the overlying water. However as the 
linear attenuation coefficient is not independent of energy the effect of kidney 
phantom depth is not independent of source energy. The rate of increase in 
volume of scattering medium seen by the collimators with phantom depth is 
dependent on detector/source geometry and collimation. Thus the magnitude of 
the increase in detection limit with increase in phantom depth is not 
independent of collimation or detector/source geometry.
3.11 Design parameters for a  clinical system
From the above discussion one may conclude that to produce an optimum 
system it is necessary to maximise skin to source distance while maintaining 
high photon flux; minimise detector to skin distance; maximise detector size 
(unless a 133Xe type system is used); collimate such that the source and detector 
just see the kidney volume; and use a source of energy close to the absorption 
edge of gold (while bearing in mind that the primary Compton scattering peak 
should not be coincident with the fluorescence peaks).
The problem with a backscatter system is that increasing source to skin 
distance also increases detector to skin distance. Also if a 133Xe type system is
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used with the source surrounding the detector, increasing the detector size 
increases the count rate but also increases the relative height of the 
background underneath the fluorescence peak. Therefore an optimum 
backscatter system will be a compromise between competing requirements. 
However using an alternative geometry separates the source from the detector 
and allows the factors affecting detection limit to be optimised separately. 
Thus it is concluded that, although it is probably possible to achieve the desired 
detection limit of 40jxg g*1 with any of the arrangements investigated with the 
target organ close to the skin surface, it is best to proceed with the 90° 
geometry as the target organ lies at a depth of 25mm or more. Another 
advantage of a 90° type system is that it is easy to tailor the collimation such 
that the fluorescence signal comes from the kidney and no other organ. It is 
therefore concluded that the best system to proceed with is a 90° geometry
153Gd system as the field of view of the collimators can be well defined to cover 
only the kidney and no other gold containing organ. 153Gd has a better cross 
section for absorption by the gold than 67Co and is available in higher activities 
and therefore the source can be positioned some distance from the skin while 





In the conclusions to the last chapter a set of design parameters were proposed 
for a clinical system. The following work describes an evaluation of a prototype 
system based on these parameters.
4.2 The source
It was proposed in the last chapter th a t153Gd would prove to be a better source 
than 57Co for studies using a 90° geometry. 153Gd appears to give better 
detection limits than 67Co, has a similar half life, lower cost per unit specific 
activity, and is available in higher activities. Unfortunately 153Gd has strong 
emission of europium K X-rays (41-48keV, 110%) as well as emission lines at 
97keV (30%) and 103keV (20%). These europium K X-rays would give an 
absorbed radiation dose to the patient without inducing any fluorescence of the 
K lines of gold, and would also cause unnecessary dead-time in the detector by 
causing extra counts. It is however possible to filter the beam emerging from 
the source capsule to very significantly reduce the intensity of these very low 
energy photons. In order that only 10% of the incident photons have no chance 
of exciting fluorescence, the intensity of the photons with energy around 
lOOkeV should be approximately ten times the intensity of europium K X-ray 
photons (44keV). The appropriate attenuation coefficients of three possible 
filtration materials with widely varying atomic number are given in table 4.2.1 
(Hubbell, 1982). The ratio of intensities, T|, from a filtered source is given by 
equation 4.2.1
- u  X
r n  100
-n = 2 21 ____  (4.2.1)
I HI X
110 e 60
where x is the thickness of the filter and jiioo and fiso are the linear attenuation 
coefficients for the material at lOOkeV and 50keV respectively.
58
Material p/p at 50keV p/p at lOOkeV p
/m2 kg'1 / m2 kg______/k g in '3
Al 3.66x1 O'2 1.70xl0'2 2700
Fe 1.94xlOl 3.70xl0‘2 7860
U 1.12X101 1.95X101 18950
Table 4.2.1 - Mass attenuation coefficients (|i/p) and density (p)
Therefore the thickness of the filter that is required to give ri=10 can be 
calculated from equation 4.2.2
These thicknesses Eire given in table 4.2.2, for the possible filter materials 
given in table 4.2.1, together with the proportion of photons with energy of 
97keV or 103keV transmitted. Thus it can be concluded that a 2.4mm iron 
filter would be suitable, uranium gives a slightly higher flux of unattenuated 
97 or 103keV photons for a filter thickness such that r|=10 than iron due to its 
high atomic number. However, the advantage of uranium over iron is 
insignificant and not worth the extra expense that would be incurred and 
inconvenience of using an alpha particle emitter. The emission spectra of a 
153Gd both pre and post filtration with a 2.4mm iron filter can be seen in figure 
4.2.1. These experimental results agree well with the photon intensities 
predicted by equation 4.2.1.
4.3 Collimation
The conclusions from the previous chapter were that the optimum collimation 
system was when both the source and detector could just ‘see’ the kidney. A 
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Table 4.2.2 - Thickness of filter required foni=10
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Number of Counts Number of Counts
Pm iftI
35 110 35
Energy /  keV
Figure 4.2.1 -Spectra from ,53Gd source both before (left) and after (right) filtration with 2.4mm of steel
110
Energy /  keV
(as described in the previous chapter). A collimator along similar lines was 
built for the 153Gd source with an active diameter of 3mm in a XI041 capsule, 
as supplied by Amersham International, and is illustrated in figure 4.3.1. The 
design allowed for two alternative source to kidney centre distances: these were 
95mm and 130mm, the larger distance required additional collimation and 
therefore the addition of the extra collimating plate illustrated in figure 4.3.1. 
These distances were chosen such that two alternative source to skin distances 
could be evaluated, which were 20mm and 45mm, with a typical kidney depth, 
that would be found using this geometry, of 50mm. An additional blanking 
plate was also made for the collimator, so that source could be stored without 
removing it from the collimator.
■  Gd Source Capsule H  Removable Filter (2.4mm Steel Plate)
g§ Removable Steel Component g |  Steel Block
 ^ 2Qmm ^
WMMi • • • I f l l '  
• • • • . : .
: : • 
i s>" ’ ••• .
Rgure 4.3.1 - Scale diagram of l53Gd collimator
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Collimator JKai Peak JL)L
/ Counts / p g g '1
New 1886±145 102
Old 1587±165 142
Table 4.3.1 - Summary of results comparing old and  new source collimators with wCo source since163Gd 
source would not fit into the old source collimator
A comparison of the results obtained using this source collimator was made 
with those obtained with the old source collimator in similar experimental 
arrangements. A summary of the experimental results is given in table 4.3.1. 
From these results it can be clearly seen that the new collimator is superior in 
performance to the old source collimator, since improved detection levels are 
achieved with the same absorbed dose at the skin.
4.4 Dosimetry
There are three measures of radiation dose: absorbed dose which is simply the 
energy absorbed per unit mass (SI unit - Gray); equivalent dose which takes 
into account the biological effect of the type of radiation being used (SI unit -
Sievert); and effective dose which is calculated by summing the products of the
equivalent dose contributions and their respective weighting factors for 
different organs (SI unit - Sievert (as well!)). Equivalent dose, H t ,  is the 
product of absorbed dose, D, and the radiation weighting factor, w r , for the 
type of radiation being used (shown in table 4.4.1), as given by equation 4.4.1. 
It is these dose equivalents, that are used to calculate the effective dose, H e , 
using equation 4.4.2, together with the tissue weighting factors, w t , given in 
table 4.4.2. Dose limitations are usually defined in terms of the effective dose, 
however it is the absorbed dose of a particular organ that is usually measured 
or calculated.
H r  =  W jjD  ( 4 . 4 .  D
H e  =  Z  W T ;H t , ( 4 . 4 . 2 )i
When calculating effective dose, using the tissue weighting factors given in 
table 4.4.2, it should be noted that the tissue weighting factor for “other”
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Radiation Type WR Organ WT
a 20 Gonads 0.20
p, Electron 1 Red bone marrow, Colon,
y 1 Lungs, & Stomach 0.12 each
X-ray 1 Bladder, Breast, Liver,
Muon 1 Oesophagus, & Thyroid 0.05 each
Proton (>2MeV) 5 Bone Surfaces, & Skin 0.01 each
Neutron 5-20 Other 0.05
Table 4.4.1 - Radiation weighting factors for Table 4.4.2 - Tissue weighting factors for different
different radiation types organs
organs is composed of the adrenals, the brain, the small intestine, the kidneys, 
muscle, the pancreas, the spleen, the thymus and the uterus. The 
recommendations, given in ICRP report 60 (ICRP, 1990) also state “In those 
exceptional cases in which a single one of the other organs receives an equivalent 
dose in excess of the highest dose in any of the twelve tissues or organs for which 
an (individual) weighting factor is specified, a weighting factor of 0.025 should 
he applied to that tissue or organ and a weighting factor o f0.025 to the average 
dose in the rest of the other organs as defined above .”
With regard to skin dose the recommendations state that provided the 
maximum skin equivalent dose does not exceed that required to cause 
deterministic effects (0.5Sv y*1), the skin dose may be averaged over the whole 
skin surface. This, coupled with the relatively small weighting factor for the 
skin (0.01), makes the contribution of skin dose to the equivalent dose for an X- 
ray fluorescence investigation small. Nevertheless the maximum skin dose is a 
useful quantity since it can be measured directly or calculated using the dose 
rate constant. An approximate value for the kidney dose can be calculated 
allowing both for the attenuation effects of the overlying tissue, and of the 
inverse square law (since the kidney is further from the source than the skin).
It is possible to calculate the skin dose received from an isotope source at any 
distance from the source using the dose rate constant, T. This is defined in 
ICRU report 33 and has dimensions of Sv m2 h*1 Bq'1. The equivalent dose, H t , 
received from a source of activity A, at distance x, over a period of T hours is
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given by equation 4.4.3.
H p  =  ^  ( 4 . 4 . 3 )
The value of the dose rate constant, T, is “a characteristic of a radio-nuclide 
(and) is defined for an ideal point source. In a source of finite size, attenuation 
and scattering occur and annihilation radiation and external bremsstrahlung 
may be produced. In some cases these processes necessitate significant 
corrections * (ICRU 33, 1980). Therefore it is clear that any calculation made 
using a published value of the dose rate constant, T, will contain a degree of 
uncertainty since the sources used are not perfect point sources and are 
contained in a metallic capsules which will cause a degree of attenuation.
4.4.1 Thermoluminescence Dosimetry
Since dose rate constants are not available for all radio-isotopes and none that 
have been filtered such as the 163Gd described above, it is necessary to have a 
method of measuring dose experimentally. The method usually employed is 
thermoluminescence dosimetry (TLD). A large number of materials exhibit 
radio-thermoluminescence. In this process light is emitted from a previously 
irradiated material when it is heated, by the release of electrons from traps in 
the lattice. The intensity of the emitted light is related to the dose of radiation 
absorbed by the material and this property is utilised to measure absorbed 
radiation doses.
The technique is relatively simple requiring a suitable dosimeter material, a 
controllable heating mechanism, and a light collection and recording system. 
Photomultiplier tubes with a low response to infrared radiation are used to 
detect the low levels of light emitted by the thermoluminescence detectors. The 
plot of emitted light intensity as a function of temperature or time is called the 
glow curve. The glow curves of radio-thermoluminescent materials contain 
many glow peaks, corresponding to different traps depths each occurring at a 
different temperature. The glow peak temperature depends on several factors,
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for example it increases with heating rate. For ease of measurement and 
simple thermal treatment, a single well-resolved and stable peak is generally 
required. With low temperature peaks the thermoluminescence signal may 
reduce or fade during storage or use of the material and with high temperature 
peaks non-radiation induced signals may increase the background or zero dose 
response of the dosimeter material. Therefore a glow peak in the temperature 
range 190°C to 240°C is usually used.
Of the thousands of materials which exhibit thermoluminescence, only four 
with low effective atomic, Z, similar to that of tissue are commonly used in 
applied radiation dosimetry. These are lithium fluoride (LiF), lithium borate 
(Ii2B407), beryllium oxide (BeO) and magnesium borate (M gB ^). These 
materials are doped with various activators which characterise the 
thermoluminescence properties of each material. For example L 1 2 B 4 O 7  doped 
with copper gives a blue luminescence and high sensitivity, but when doped 
with manganese gives an orange luminescence and consequently a low 
sensitivity, due to the low sensitivity of the photomultiplier tubes at the red 
end of the spectrum.
Impurities and intrinsic defects such as vacant atomic sites are crucial to the 
thermoluminescence process. The impurity additions to the host material 
therefore need to be controlled to give optimum performance. The phenomenon 
of radio-thermoluminescence is basically a three stage process. In the first 
stage free electrons and holes are produced by irradiation. In the second stage 
some of these free carriers become trapped in the field potential of certain 
defects. The more tightly bound carriers require more energy (higher 
temperatures) to release them. In the third stage some of the electrons released 
from the traps recombine with the holes releasing the excess energy in the form 
of light. The plot of light intensity against absorbed dose gives the dose 
response curve of the irradiated material, generally the shape of this curve is 
linear up to about 5Gy. Weakly bound charge carriers are released easily from
64
Material Sensitivity Dose Threshold Fading Factor
O / kg'1 Do / uGy T /%
BeO 0.2-1 <100 5 (in 1 to 5m)*
Li2B407:Cu 2 10 <5 (in lOd) *
Li2B407:Mn 0.2 50-100 <5 (in lm)
LiF(TLD100) 1 50 5 (in ly)
LiF:Mg,Cu,P 20 ■ - 5 (in 2m)
MgBaOiDy 5-10 20-50 <5 (in lm ) *
4* fading In the dark per year (y), month (m) or day (d)
* Light sensitive 
O for ,37Cs, relative to TLD100 
Table 4.4.3 - Properties of some commercially available TLDs
trapping centres and therefore lead to low temperature glow peaks which fade 
relatively quickly at room temperature. These weakly bound charge carriers 
are therefore deliberately released in a preliminary low temperature (120°C) 
part of the heating cycle before counting of the luminescent photons begins. 
The properties of some commercially available TLD chips are given in table 
4.4.3.
4.4.2 Calibration of TLD Chips
When using TLD chips it is necessary to calibrate one set by irradiating them 
with a known dose of radiation of equivalent energy to the source under test. 
This can be a problem if no calibrated source exists. However it is usually 
possible to use a source with a different energy profile to the one under test 
because most chips have a reasonably flat energy response. A typical energy 
response curve for TLD chips is shown in figure 4.4.1.
The sources used for calibration were X-ray therapy units, which had been 
calibrated using an NPL secondary standard ionisation chamber. These are 
inherently broadband sources which have a spectral output of similar shape to 
that shown in figure 4.4.2. In order to determine a calibration for TLD chips 
when using a single energy photon source such as the filtered 153Gd described 
above, the logical approach is to use an X-ray source from which the peak 
photon count is of similar energy to the energy required. An inspection of X-ray 
spectra such as the one illustrated in figure 4.4.2, leads to the conclusion that
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Figure 4.4.1 - Plot of sensitivity against energy for Vinten LiF TLD chips
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Figure 4.4.2 - Typical spectral output from an X-ray source
the peak photon count (in the bremsstrahlung) occurs at approximately one 
third the peak energy. The calibrated sources that were available locally had 
peak energies of 120keV, 250keV and 6 MeV. Therefore the most appropriate 
was the 250kV source, however all three were used to give some idea of the 
possible error introduced into the calibration from the variation in sensitivity of
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the TLD chips with energy. Figure 4.4.1 would indicate that the TLD chips 
would be more sensitive at the lower X-ray energies than at 6MeV. This was 
confirmed in the experimental work described below.
4.4.3 TLD Experimental Work
In order to estimate the absorbed doses at different tissue sites with 
alternative experimental arrangements, it is useful to know the value of the 
dose rate constant for the source and capsule being used. This value will allow 
for the factors mentioned in section 4.4, such as the fact that the source is not a 
point, but distributed within a metallic capsule. Therefore the effective dose 
rate constants for both our 57Co and the filtered 153Gd were determined 
experimentally using LiF TLD chips supplied by Vinten. These chips were 
annealed at 300°C for 1 hour and then 80°C for 16 hours (Harshaw TLD100 
[used later in the project] - 400°C for 1 hour followed by 80°C for 16 hours), put 
in small sachets (three chips in each). Calibration of the TLD chips was 
performed using the Varian Clinac 6MeV linear accelerator, the Philips RT250 
250kV ortho-voltage therapy X-ray set, and the Therapax Series 3 superficial 
treatment X-ray set at the Royal United Hospital in Bath, whose outputs had 
been calibrated using an NPL secondary standard dosimeter. Two sachets were 
exposed on each machine. Three sachets were also left unirradiated as a 
determination of the background. In order to experimentally determine the 
dose rate constants for both 57Co and filtered 153Gd, two sets of two sachets were 
affixed to a small water bath (180 x 110mm) to represent the phantom 
arrangement used in previous experimental arrangements to represent the 
human body. These sets of two sachets were then irradiated for 92 hours, one 
using the 35MBq 57Co source used in earlier work and the other using a 63MBq 
153Gd filtered with 2.4mm of steel. The sources were positioned at a distance of 
50mm from the water bath.
The results read out from the TLD reader (Vinten Toledo 654) are given in 
tables 4.4.4 (calibration) and 4.4.5 (isotope source results). The calibration
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Radiation Average C.V.* Dose Calib. Factor
Source Counts /% /mGy / Counts mGy'1
Clinac 48639 2.4 (n=6) 40.3 1206
RT250 59983 1.9 (n=5) 42.3 1418
Therapax 65292 2.1 (n=6) 41.0 1592
Background 559 19.6 (n=9) - -
*C.V. - Coefficient of variation over n results 
Table 4.4.4 - Calibration results from TLD experimental work
Radiation Average C.V.* Skin Dose
Source Counts 1% Drt25o /  mGy
57Co 33678 2.1 (n=6) 24.0
.15?Gd(Fel.... 18874 4 .3  (n=4) 13 1
*C.V. - Coefficient of Variation over n resuits 
Table 4.4.5 - Results from TLD work with ^ Co and  163Gd
factors given in table 4.4.4 have a coefficient of variation of only 10% about 
their mean (1405 counts mGy'1). Therefore if the RT250 calibration factor is 
used to determine the doses for the isotope sources, which is the most 
appropriate for the reasons discussed in section 4.4.2, the error in the doses 
deduced in table 4.4.5 is unlikely to exceed 5%. The analysis of these results 
gives a value of the dose rate constant, T, for 67Co r=18±l|iSv m2 h*1 GBq*1, 
using the RT250 calibration. It should be noted that the absorbed dose, D, has 
been converted to equivalent dose, H t ,  using the unity radiation weighting 
factor, w r , for 7-radiation in equation 4.4.1. This value of the dose rate constant 
lies between the published values for S7q0 0f  p=15pSv m2 h'1 GBq'1 
(Siemens, 1991) and r=22jiSv m2 h 1 GBq'1 (Padikal and Fivozinksy, 1982). 
There are three factors which may lead to the experimentally determined 
values of the dose rate constant disagreeing with the calculated published 
values. Firstly the calculated value does not allow for the absorption of photons 
backscattered from the water bath, which will increase the dose absorbed by 
the TLD chips. Secondly the calculated value does not allow for the fact that 
the source is contained in a metallic capsule which will attenuate the photon 
flux by around 5%, and thirdly the source is not a perfect point source. The fact 
that the source is not a perfect point source will only be a small effect since the 
active area of the source is small (2mm diameter) and very thin (less than
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100|im). Therefore there is an insignificant amount (estimated as less than 2%) 
of self attenuation of the source in the forward direction due to the finite 
thickness of the source.
The values of the dose rate constant for the filtered 153Gd source that was 
calculated from the experimental results above is r=5.7±0.3|iSv m2 h'1 GBq*1. 
For future work on filtered 163Gd systems this value of the dose rate constant 
based on the RT250 calibration will be used to calculate skin doses, for the 
reasons discussed in section 4.4.1 and supported by the work for the 57Co result 
described above.
It also possible to calculate a value of the dose rate constant, T, in air using the 
following method. It is known that the rate of energy loss with distance, x, to a 
medium of energy absorption coefficient, |x e , is given by equation 4.4.4; where E 
is the energy of the photons.
Therefore the rate of energy loss, with distance, to a medium from a point 
source of activity, A, over a period of time, T, is given by equation 4.4.5; where 
m is the number of photons of energy, E,-, per disintegration and |X& is the 
energy absorption coefficient at that energy.
As the source is a point source, this energy is being lost to a spherical shell of 
radius, x, and mass, dm, given by equation 4.4.6; where p is the density of the 
medium.
Therefore the rate of energy loss per unit mass, which is equivalent dose, Ht, 
for y-rays, is given by equation 4.4.7.
(4.4.4)
(4.4.5)
dm = 47ipx3dx (4.4.6)
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(4.4.7)
Using equation 4.4.3 an expression for the dose rate constant, r, can now be 
obtained, and is given by equation 4.4.8.
A more useful form of equation 4.4.8 is given by equation 4.4.9; where e is the 
elementary charge; the photon energy, Ei, is in keV; and the dose rate constant, 
T, is in jxSv m2 GBq'1 h'1.
Using equation 4.4.9 a value of the dose rate constant for 67Co in air of 
T = 19pSv m2 GBq'1 h*1 is obtained, which is in agreement with both the 
tabulated and measured values.
4.5 Evaluation of a 1MGd system
Now that an effective dose rate constant for the 153Gd source had been 
determined, an evaluation, including the resultant dose consequences, of an 
X-ray fluorescence system based on a 153Gd could be undertaken. The optimum 
design parameters for such a system were discussed and demonstrated to be 
correct in chapter 3 and sections 4.2 & 4.3. The experimental arrangement 
shown in figure 4.5.1 was adopted. The kidney was represented by a small 
(150ml) polythene bottle which was 47mm diameter and filled with chloroauric 
add such that the concentration of gold was 500jxg g'1. This kidney phantom 
was placed in a water bath that was 210mm x 150mm to represent the 
surrounding tissue. The source and detector were collimated such that they 




maximise the count rate, the detector collimator was placed against the water 
bath. So that the kidney phantom just filled the field of view, the source 
collimator was placed such that source was 20mm from the surface of the water 
bath (75mm from the kidney surface). The 153Gd source, which had been 
removed from a Novo bone densitometer based at the RNHRD (Bath), had an 
activity of 1.6GBq. The dose rate at the skin surface from this source was 
therefore 22mGy h l. In a further experiment the source collimator was moved 
a further 20mm away from the water bath, to reduce the skin dose compared to 
the kidney dose, such that the source to kidney surface distance was 95mm. 
The additional collimatdon plate was added to the front of the collimator for 
this experiment so that the kidney phantom, again, just filled the field of view 
of the source collimator. The dose rate at the skin was consequently reduced to 
4.4mGy h 1. A summary of the results from this preliminary work is given in 
table 4.5.1. All the results in the table were for a skin dose of 8mGy assuming 
the dose rate constants given at the end of section 4.4 are correct.
I ]  Kidney phantom M Steel collimator □  Water
H  1{^ Gd Source H HP Ge detector 20 mm
50mm
30mm
Figure 4.5.1 - Scale diagram of apparatus for evaluation o f 163Gd based system
SSD Irradiation Kai Peak DL
/mm Tim e/s /Counts / l ^gg1
45 6000 2718±165 76
20 1200 1476±120 103
Table 4.5.1 - Summary of results of preliminary evaluation of ,53Gd based system
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Examination of these results leads to the conclusion that even if  the source is 
positioned at a distance from the skin, the required detection level can not be 
achieved with the current detector and source, in an acceptably short 
irradiation time. However for the desired detection level to be achieved a larger 
detector could be used, thus increasing the count rate per unit dose. The 
forecast improvements for larger source and detector are discussed in section 
4.7.
4.6 Alignment Uncertainties
It is obviously important to be aware of any variation that could be introduced 
into the results by misaligning both source and detector collimators. Potentially 
the errors involved are likely to be significant because of the relatively small 
detector to kidney and source to kidney distances. Therefore a study was 
undertaken in order to assess the reproducibility of the results from slight 
differences in alignment. In order to assess the system component(s) that led to 
the largest errors, a four stage study was undertaken. In the first stage (stage 
I) only the source collimator was repositioned between spectra. In the second 
stage (stage II) the source collimator and the phantoms were repositioned 
between measurements and in the third stage (stage III) all the system 
components were repositioned between measurements. In the fourth stage 
(stage IV) no system components were repositioned in order to find the 
statistical variation in the results. It was found that this variation was of the 
order of 1/VNp which is the variation that would be predicted theoretically for 
the number of counts in the peak, Np. The variation found in stage IV indicated 
that the fitting program was not introducing a significant amount of 
uncertainty into the size of the peaks. In each stage of the study three separate
Stage Coefficient of 
Variation / %






Table 4.6.1 - Summary of results from first reproducibility study
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beneath Kai / Counts
C.V.*
/%
I 20680 2.4 206387 1.8
II 21351 8.0 211539 1.4
III 21627 8.1 204745 1.2
IV 20755 1.2 205537 1.6
* C.V. - Coefficient of Variation 
Table 4.6.2 - Summary of results from second reproducibility study
spectra were token and the coefficient of variation due to the system 
component in question was calculated. A summary of the results from these 
experiments is given in table 4.6.1. These results show that alignment 
problems are leading to poor reproducibility. To try and improve the 
reproducibility in the laboratory apparatus the whole apparatus was positioned 
on a piece of graph paper glued to a wooden base, and pieces of acetate sheet 
showing the direction of the field of view were attached to the bottom of the 
collimators. The results after this improvement are shown in table 4.6.2. It can 
be seen that these improvements generally led to significant improvements in 
reproducibility and emphasised the need for both accurate positioning in a 
clinical system and accurate kidney depth determination. The latter point 
being made by the large increase in coefficient of variation of peak counts 
between stages I and II, without an increase in coefficient of variation of the 
number of counts beneath the peak; thus indicating the variation came from 
the relative position of the kidney phantom in the water bath, rather than the 
absolute position of the water bath.
In a further experiment the effect of misalignment was assessed. The source 
collimator was deliberately positioned so that the centre of the irradiating 
beam was not coincident with the centre of the kidney phantom by a known 
distance. The experimental arrangement is illustrated in figure 4.5.1. This was 
repeated for each distance three times and a summary of results is given in 
table 4.6.3. From these results it can be seen there was a marked decrease in 
sensitivity when the part of the kidney phantom nearest the detector was not 
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* The source collimator was moved parallel to the detector axis. A negative number Indicates that the
source was moved towards the detector.
Tabie 4.6.3 - Summary of misalignment study results
attenuation considerations as discussed briefly in the previous chapter. (A 
more thorough theoretical consideration of sensitivity variation with different 
parameters will be given in chapter 5.) Therefore in any clinical system, 
assuming that the gold is uniformly distributed in the kidney, it will be 
important to make sure the part of the kidney nearest the detector is 
irradiated, so as to maximise the fluorescence signal detected and also to give 
reproducible results.
4.7 Clinical system performance: predictions
From the preliminary experimental results above it is possible to make some 
predictions about the performance of a prototype clinical system. These 
predictions will allow the performance of this system to be compared with other 
systems described in later chapters. For simplicity these predictions will be 
made for a single kidney depth which is 50mm of overlying tissue between the 
source and the kidney surface and 30mm of overlying tissue between the 
detector and the kidney surface. In the introduction it was stated that for the 
system to be clinically useful the detection limit must be below 40|igg'1. 
Therefore in order to make a comparison with other systems, the absorbed dose 
that would be required to give this detection limit will be estimated. Another 
limitation of an isotope based system is the activity of the isotope that would be 
required to give the required detection limit in 30 minutes, since this is the 
maximum acceptable time for patient studies. Therefore the activity required 
will also be estimated.
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SSD Skin Absorbed Minimum Source
/mm Dose / mGy Activity / GBq
20 9 1.2
45 3 2.0
Table 4.7.1 - Anticipated skin doses required with 32mm diameter detector to obtain detection limit of
40jig g '1
It was anticipated that before a clinical system was constructed a larger 
detector (32mm diameter) would be purchased. This would give a higher count 
rate per unit time and therefore a reduced detection limit. It was anticipated 
that this would reduce the detection limits by approximately a factor of three, 
since due to the Poisson nature of the counting process involved the detection 
limit decreases with the square root of the number of counts collected, and the 
number of counts collected per unit time increases approximately with detector 
area. Table 4.7.1 therefore contains the prediction of system performance (i.e. 
absorbed skin and kidney doses required to obtain a detection limit of 40|ig g'1) 
using a 32mm diameter detector for both of the different source to skin/kidney 
distances used in the experimental apparatus described in section 4.4.3. It also 
gives the minimum activity o f163Gd that would be required in each case for an 
irradiation time not exceeding 30 minutes.
Examining the results in table 4.7.1 it is clear that the required detection levels 
can be achieved at .skin doses of a few milligray. This skin dose is well within 
those used in normal diagnostic investigations. The activity of source required 
is also well within that available; a 153Gd source for a bone densitometer when 
new is typically 37GBq. Therefore it was anticipated that a system based on 






Ahlgren and Mattsson (1981) reported a marked variation in sensitivity with 
depth with their cadmium X-ray fluorescence system, using a 241Am source 
(59keV). This would be significant from a calibration point of view for any 
X-ray fluorescence. Therefore both an experimental study and computer 
modelling were carried out in order to confirm the magnitude of these effects 
with our higher energy system, and predict variation in sensitivity for different 
kidney positions.
The processes that are involved and need to be considered for any computer 
model are the inverse square reduction in photon intensity with distance, or 
appropriate form for a non-point source, and photon attenuation due to 
overlying tissue.
5.2 Sensitivity variation in air
In the first instance a computer model was written with no attenuation due to 
overlying tissue. The predictions from this model could then be compared with 
the results obtained from measuring the fluorescence signal from a small gold- 
plated ball at various positions, in the plane containing the centre of the 
detector and the source, in air.
In air, it is assumed that there will be insignificant scatter of the lOOkeV 
exciting photons. This is reasonable since using the absorption coefficient 
(|X=1.54xlO'2m2 k g 1, Hubbell (1982)) in equation 5.2.1, it can be seen that less 
than 0.2% of the photons undergo an interaction in a distance of 100mm in diy 
air. Since the scatter of photons is insignificant, all photons reaching the gold- 
plated ball will have similar energy and thus similar cross-section for 
absorption. Therefore the only factor that needs to be considered in the 
computer model is the inverse square reduction in intensity.
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I  =  I / 1'  ( 5 . 2 . 1 )
Also included in the model must be geometrical factors from the experimental 
arrangement. These factors include relative positions and collimation of the 
source and detector. The 163Gd source is physically small and can therefore on 
the scale of this experiment be considered as a point source. Therefore the 
sensitivity fall off from the source should be modelled by the inverse square 
relation. Since the detector is extended in size there will be a large penumbra 
effect that will also need to be included in the model.
5.2.1 Computer model
A diagram of the arrangement modelled, together with some of the distances 
used in the model is given in figure 5.2.1. The sensitivity is assumed to vary 
with the inverse square of the distance from the source to the gold-plated ball 
(r) and with the inverse square of the distance from the ball to the detector (R ). 
Any point that could not be seen by either the detector or the source due to 
collimation was ignored. Each point was assumed to have a sensitivity in 




Figure 5.2.1 - Illustration of parameters used in model of sensitivity variation In air
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thus allowing for the penumbra effect of collimation.
The factors discussed above were used to calculate a sensitivity for pixels in the 
field of view of the the detector and a source, using equation 5.2.2, where, s, is 
sensitivity at a point with parameters as illustrated by figure 5.2.1, and k  is the 
product of the proportion of the detector and the proportion of the source that 
can be seen by the point. The results of this model are illustrated in figure 
5.2.2.
s = A  (5-2-2)
The value of k  is therefore between zero and unity, only being unity when the 
whole of the detector and the source can be seen by the point. For this to occur 
the conditions given in both 5.2.3 and 5.2.4 must be fulfilled.
p  - (s + x) tanG < y  < p  + q + (s + x)tanG (5.2.3)
P - (S + Y)tan<J) < x < P  + Q + (S + Y)tan<|> (5.2.4)
However k  will be zero if  the point can not be seen by either the source or the 
detector, this will be true if the conditions in either 5.2.5 or 5.2.6 are fulfilled, 
assuming the collimators are made of perfectly absorbing material. (The effect 
of collimators which are not perfectly absorbing has already been shown to be 
small by ourselves (chapter 2) and by Laird et al  (1982)).
p  - (a tanG + q ) < y < p  + q + (a tanG + q) (5.2.5)
P - -  * ^  (A tan<J> + Q ) < x < P  + Q + ^ * -  (A tan<|> + Q) (5.2.6)
5.2.2 Experimental results
The experimental arrangement was identical to that modelled and described 
above. The gold-plated ball was moved around a 10mm grid and a spectrum 
recorded at a number of positions for 30 minutes. Table 5.2.1 gives the recorded 
number of counts in the Kai peak in each position. The value calculated for 
each point by the model is also given in italics in table 5.2.1. Figure 5.2.2 gives
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Figure 5.2.2 - Diagrammatic representation of both experimental and model results for sensitivity
variation in air
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z/mm 5 15 25
z/mm
35 45 55 65 75
5 0 0 0 0 0 0 1021±85 1185±84
0 0 0 0 0 231 1975 2029
15 0 0 0 0 0 1004±83 1375±90 1378±89
0 0 0 0 0 1485 1928 1868
25 0 0 0 0 0 1639±90 1739±93 1827±93
0 0 0 0 0 1926 1887 1751
35 0 0 0 0 124±73 1974±95 2181±95 1984±95
0 0 0 0 0 1995 1851 1659
45 0 0 0 0 668±86 2080±100 2120±97 2016±94
0 0 0 0 612 2039 1812 1580
55 0 0 0 0 1650±90 2186 1815±93 1554±93
0 0 0 0 1579 2056 1766 1504
65 0 0 0 0 2003±93 1823±95 1643±91 1441±92
0 0 0 0 2268 1909 1589 1324
75 0 0 0 149±75 2130±95 1724±93 1410±90 1342±88
0 0 0 2 2040 1666 1374 1140
85 0 0 0 746±81 1814±92 1342±90 1207±90 982±89
0 0 0 722 1776 1440 1183 979
95 0 0 122±72 853±83 1624±90 1312±89 1106±87 885±85
0 0 0 1143 1516 1229 1010 838
Table 5.2.1 - Experimental and  model results for sensitivity variation In air (.Model results In Italics)
a diagrammatic representation of both the model and experimental results, 
using a contour plot of number of counts at a given point. Normalisation of the 
model was achieved by weighting the model such that the total number of 
counts, at the points where experimental data was available, was the same as 
the total number of counts in the experimental data.
5.2.3 Conclusions from work in air
A comparison of the modelled response with the experimentally determined 
response reveals a good correlation. Thus it is concluded that the fall off in 
photon intensity is well understood, and can be explained by use of the 
appropriate form of the inverse square law. The apparent slight deviations 
observed between the experimental data and the computer model in figure
5.2.2 can be explained by the fact that the experimental data contains a degree 
of error, due both to counting statistics and uncertainty in the position of the
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gold-plated ball and collimators.
5.3 Sensitivity variation in water
The introduction of a scattering medium such as water complicates the 
modelling problem considerably. As already mentioned the exciting photons 
will be attenuated by the scattering medium, as will the fluorescence photons. 
It would be easy to allow for this using an appropriate absorption coefficient in 
equation 5.2.1. The appropriate form of equation 5.2.2 would then become that 
given in equation 5.3.1.
_ K / •  ■¥» (5.3.1)
However this is an over-simplification of the problem, since exciting photons 
that are scattered by the water, may still have enough energy to excite 
fluorescence in the gold. Indeed these scattered photons which still have 
enough energy to excite fluorescence will have an energy closer to the K 
absorption edge and therefore an increased cross-section for absorption. It can 
be deduced from the Klein-Nishina formula that a good proportion of photons 
are scattered in the forward direction (section 2.2; a=0.2). Therefore to model 
this situation with accuracy would require a Monte Carlo, photon tracking, 
type of calculation.
5.3.1 Monte Carlo Model
Since the only method of accurately modelling the sensitivity variation in water 
would be a Monte Carlo type model, such a model was written. The detailed 
code is given in Appendix B, however an outline of the model, followed by some 
of the specific details are given below.
In order to calculate the relative sensitivity to gold at each point in the 
scattering medium, the model tracked the ‘life history’ of a large number of 
photons. In outline the program generates a photon from the source and follows
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it until it ‘dies' (see below). The photon initially has a random trajectory within 
the constraints imposed by the source collimator. The energy of the photon is 
randomly determined: In the case of the filtered 153Gd source used in previous 
experiments, there is a probability of 0.60 of the photon energy being 97keV 
and 0.40 of being 103keV. From the photon energy an appropriately weighted 
random path length can then be determined (further details are given below). 
At the end of this path the photon undergoes some interaction, in the case of 
photons of initial energy around one hundred keV, there are three possibilities: 
Compton scattering, elastic scattering or a photoelectric interaction. The 
probability, pi, of an interaction type i is given by equation 5.3.2, where \u is the 
component of the absorption coefficient due to interaction type i and jitot is the 
total absorption coefficient given by equation 5.3.3.
H.<E)
p iE) = - ± 7=  (5.3.2)
*itot(E) = E  ^ E) (5.3.3)
i
Once the type of interaction has been determined the effect on the photon can 
be calculated. For a scattering interaction a new trajectory for the photon can 
be found in a random fashion, and hence for a Compton scattering the new 
energy of the photon. The process described above is then repeated. For a 
photoelectric transition it is assumed that the energy of the photon is 
completely absorbed at the interaction site. If the interaction is with a gold 
atom then there will be a resulting fluorescence signal which is of interest. The 
proportion of this fluorescence signal entering the detector is then calculated 
using equation 5.3.4, where r is the distance between the interaction point and 
the point where the photon leaves the scattering medium in the direction of the 
centre of the detector; jiphoto and iiphoto^ u are the the components of the 
absorption coefficient due to the photoelectric effect, and the photoelectric effect 
due to gold alone respectively; and Q is the solid angle subtended by the
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detector at the interaction point.
s = M'photo’Au R  (5.3.4)
V>to 4k
Obviously a photoelectric transition leads to the ‘death’ of a photon, as far as 
tracking its life history is concerned. However there are also other ways in 
which the photon can ‘die’. Firstly it can leave the scattering medium: The 
situation represented by the program given in appendix B is that the scattering 
medium is a semi-infinite cuboid with bounding planes z -  SSD, and x = 
-X_SKIN, where SSD is the source to skin distance and X_SKIN is the distance 
between the source and the skin in the direction of the detector. The source is 
a t the position x = y  = z -  0, and the centres of both the detector and the source 
He in the y -  0 plane. This is iUustrated in figure 5.3.1. If the photon left the 
scattering medium and entered the detector the energy of the photon was 
recorded. This was used to build up a profile of the background spectrum that 










Figure 5.3.1 - Illustration of Monte Carlo model parameters
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experimented results. Secondly the photon can also ‘die* by losing so much 
energy by Compton interactions it is no longer of any interest. This occurs 
when the photon can no longer excite a photoelectric transition in gold. The 
program was therefore written such that it would stop tracking a photon once 
its energy was less than the K absorption edge of gold (~80keV).
The details of how the program modelled a number of situations are described 
in the following paragraphs, beginning with path length. In order to determine 
an average path length in a scattering medium, it is necessary to know the 
number of photons, n, in a beam at a distance, r, through the medium. This is 
given for a medium with attenuation coefficient, |i, by equation 5.3.5, where no 
is the initial number of photons in the beam.
n = ng (5.3.5)
Therefore the probability, p(r) that the first interaction occurs between r and 
r+dr in such a medium is given by equation 5.3.6 and equation 5.3.7 gives the 
corresponding distribution function, P(r), for a first collision at distance less 
than or equal to r.
p(r)dr = [e^r] pdr (5.3.6)
P(r) = j  p(r) dr = 1 - e (5.3.7)
It follows that the Monte Carlo determination of path length, r, from an 
arbitrary point of departure to first collision, assuming the medium is 
homogeneous and infinite, is found by setting the distribution, P(r), equal to a 
random number, £, with a value between zero and unity. This can be 
rearranged so that the path length, r, is given by equation 5.3.8.
,  -  ^  ' ,5.3.8,
Since (1 - Q is equidistributed o n O ^ £ < l i f £ i s ,  equation 5.3.9 may be used in
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the program to determine the path length, r, in the scattering medium.
(5.3.9)
It is clear that for many of the situations modelled by the program, a value of 
an attenuation or scattering coefficient is needed. These coefficients are a 
function of energy, and are therefore not constant within the history of a 
photon. Data was therefore taken over an appropriate energy range from 
Hubbell (1969 & 1982) and a log-log linear regression of coefficient against 
energy was then performed, (for gold separate regressions were performed 
above and below the K absorption edge). In all cases the modulus of the 
correlation coefficient exceeded 0.98, and therefore these models were used to 
calculate the appropriate coefficients by the program.
Once the path length has been determined, the effect of the interaction at the 
end of that path needs to be found. The photoelectric interaction has already 
been discussed which leaves two scattering interactions to consider. When a 
photon is Compton scattered, the scattering angle can be between 0 and 180°. 
However each angle does not have an equal probability, and, as already 
discussed in chapter 2, the scattering distribution is approximately given by 
the Klein-Nishina equation which is given by equation 5.3.10 for unpolarized 
photons, where ro is the classical radius of an electron; Eo and E are the 
energies of the photon before and after scattering respectively and 0 is the 
scattering angle.
There also exists a unique relationship between the scattering angle, 0, and 
final energy of the photon, E, which is given by equation 5.3.11a, which can be 






Since it is true in general that,
dll = - 271 d(co50) (5.3.12)
The differential scattering cross-section can be written entirely in terms of 
energy and is given by equation 5.3.13 where a and oco are the final and 
incident energies of the photon as a proportion of the rest mass energy of an 
electron, and are given by equations 5.3.14 and 5.3.15 respectively.
Von Neumann’s device (Cashwell and Everett, 1959) can now be used to sample 
this distribution to give the energy of the scattered photon, with correctly 
weighted probabilities.
The treatment of elastic scattering is more difficult, and this has therefore been 
ignored by most authors of photon tracking Monte Carlo models. This is not a 
bad approximation since the probability of elastic scattering is relatively small 
compared to the probability of Compton scattering at energies around 
80-100keV. The angular distribution for elastic scattering is given by equation
5.3.16, where F(x,Z) is the atomic form factor for the atom by which the photon 






*2 - 9 (5.3.16)dagl = (1 + cos2©) [F(x , Z )f d£l
_ E0 sm9 _ sin9 (5.3.17)
he X
The method adopted by ourselves was that proposed by Persliden (1983), and is 
now described. From equation 5.3.16 the probability, p(0), of a photon being 
elastically scattered by an angle 0 can be derived and is given in equation 
5.3.18.
da .(E , 0 , Z) d0
p(9)d6 = el - f r   (5.3.18)
eP *
This probability is then rewritten in terms of x2, where x is given by equation
5.3.17, and is given by equation 5.3.19
p ( x W  = (1 + cos%) (PCx , Z)f dx2 (5.3.19)
ae,(E , Z)
since it is true that
ptx2) dx2 = jp(0)d0 (5.3.20)
The two functions
X2




ACj^ . Z )  = f  [F(x, Z)f dx2 (5.3.22)
0
where
^max = |  (at 0 = 7C) (5.3.23)
are now introduced. The expression for p(x2)dx2 given in equation 5.3.19 may
now be rewritten as follows:
87
pix2)dx2 = rjj k 4X
or as
^(x2)dx2 = C(E , Z) x ^(0) x /(x2 , Z) (5.3.25)
Now, /(x2, Z) is a frequency function, #(0) is bounded O^g(0)^l and C(E, Z) can 
be considered as constant for a given material and photon energy. In order to 
determine the scattering angle, a value of x is determined randomly using the 
inverse of /(x2, Z), and then Von Neumann’s device (Cashwell and Everett, 
1959) is used with g(0) to decide whether this angle was rejected or accepted. If 
the angle was rejected the whole procedure was repeated.
The first stage of this process, that is finding the value of x from the initial 
random number, £, is non-trivial and is described in the following paragraph, 
which may be omitted on a first reading. To determine a value of x (given by 
equation 5.3.17) from a random number, £, it is clear, that the equation that 
needs to be solved for x in terms of £ is given by 5.3.26.
The solution of this is obviously non-trivial. The method that was used by 
ourselves was the value of A(x2, Z) was found by numerical integration (using 
the trapezium method with tabulated values of F(x, Z)), both for gold and water 
using the alternative expression for A(x2, Z) given by 5.3.27. The inverse 
distribution was then approximated by a fifth-order polynomial expression 
using a Marquadt-type fit. These polynomials were then used in the Monte 
Carlo program code (Appendix B).






The method of operation of the Monte Carlo model has now been discussed in 
detail. Each section of the model was tested individually, for example the 
Compton scattering section was tested to check that distribution of scattered 
photons was that predicted by Klein-Nishina formula, to within a 1% level of 
significance using the %2 test. The model was then run tracking lxlO6 photons, 
with parameters of X_SKIN=55mm, SSD=45mm and DETECT_X,Y,Z = 90, 0, 
130mm respectively. The results of this test run are presented in the following 
sections.
5.3.2 Model Results
The output from the model was a series of numbers representing the predicted 
sensitivities over a 10mm grid within the scattering medium. A plane section 
through this grid was taken containing the centre of both the source and the 
detector. A contour plot was then made of sensitivity. The contours represent 
80%, 60%, 40% and 20% of the maximum sensitivity predicted. These contours 
could then be compared with a similar plot for the experimental results 















Figure 5.3.2 - Scatter spectrum predicted by Monte Carlo model, compared with experimentally 
determined spectrum. Note: The experimental data has been deconvolved with the detector 
response function as described and for the reasons detailed In Chapter 7
89
The other output of the model, as already mentioned, was a prediction of the 
shape of the Compton spectrum underlying the fluorescence peaks. A typical 
output is shown in figure 5.3.2 where this output is compared with an 
experimentally recorded spectrum. From this diagram it can be seen that the 
fit over the fairly limited energy region sampled is good, and therefore this a 
good indication that the model is working correctly. In fact the model was also 
run without any elastic scattering events, and the output was statistically 
insignificantly different from that with elastic scatter events. This 
demonstrates that the effect of elastic scatter is small, and is therefore 
justifiably omitted by most authors.
5.3.3 Experimental Results
As with all Monte Carlo models, it was important to test the model as 
thoroughly as possible, as erroneous results are easily obtained with this sort of 
model unless it is compared with experiment.
The experimental arrangement modelled, shown in figure 5.3.1, was set up so 
that the variation of sensitivity with position for one position of the source and 
detector could be evaluated, and is now described in more detail. Two small 
gold chain links were then moved over a 10mm grid in the plane containing 
both the centre of the source and the centre of the detector. Spectra were 
recorded over a period of 30 minutes for each grid position and the fluorescence 
peaks fitted using the program already described and given in Appendix A. The 
areas of the peaks were then used to draw a sensitivity contour plot in a 
similar way to that described in the preceding section. This contour plot was 
then compared with the one derived from the model results and this is shown 
in figure 5.3.3. The diagram also shows the primary beam of the source and the 
beam of acceptance of the detector. These beams being defined by the source 
and detector collimators. The significant penumbra on the detector beam of 
acceptance is also shown, as this was also allowed for within the model.
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Figure 5.3.3 - Sensitivity variation In water predicted by the Monte Carlo model compared with that
determined experimentally
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z/mm -40 -30 -20
i/mm
-10 0 10 20
70 0 777±346 314±336 0 364±339 1115±355 878±324
0±0 3±1 35i4 225±11 415±16 372±14 167±8
80 0 1106±341 0 620±340 952±342 1463±334 1564±340
14±5 m 107±12 233i21 544i24 418±19 198±11
90 300±346 802±340 4151±344 5230±348 3739±347 3822±348 2027±330
57±18 99±18 213±23 473m 538±28 387i20 203±12
100 2239±336 7501±346 5995±349 6291±351 4680±350 3601±335 2489±343
131±37 127M 274±32 530±36 472m 322±19 185±12
110 4803+342 5506±344 6695±350 5403±350 3545±348 2651±349 2088±329
206±50 136±31 345±34 513+37 385±26 254±18 m i l
120 4312 ±3 43 4975±346 3922±347 3648±349 3765±351 2278±333 1647±342
m 2 158±32 258±33 273±32 27M2 194±16 U5±10
130 546±351 2543±328 3714±348 2718±328 1959±344 190S±327 898±325
34±28 m o 180±31 187±27 138±19 8ltl3 59±9
Table 5.3.1 - Experimental and model results for sensitivity variation In water (Monte Carlo model results
In Italics)
5.3.4 Discussion and  Conclusions
It is clear from figure 5.3.3 that the model fits the recorded experimental data 
fairly well, although not perfectly. The reasons for this discrepancy need to be 
considered carefully. It should be pointed out first that the experimental data 
is quite noisy which is difficult to show diagrammatically.
As already mentioned, one possible reason for the discrepancies between the 
contours predicted by the model and those derived from the experimental data 
is that both the model and experimental data contain uncertainties, which in 
some cases are a significant proportion of the determined value. This is easily 
seen upon examination of table 5.3.1 which shows the raw experimental data 
and the data output from running the model. The uncertainties associated with 
the experimental data are 1 standard deviation as returned by the fitting 
program. However there will also be some uncertainty associated with the 
positioning of the gold chain links (approximately ±2mm in all three 
dimensions). During the experimental procedure there would also have been 
some uncertainty in the alignment of the source/detector collimators, and also 
in the position of the scattering medium. The reason for this is that the tank in
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which the water was contained had polythene sides which tended to bow when 
it was full. This meant that the tank sides were not perfectly vertical (as 
modelled) and therefore it was not possible to push them hard up against the 
collimators.
5.4 Monte Carlo Model In Use
The fact that both models discussed in the preceding sections predict the 
experimentally determined sensitivities with a good degree of accuracy shows 
that all the significant physical processes are well understood.
5.4.1 Sensitivity variation with different kidney position
Now that the Monte Carlo model has been shown to work, it is clear that it can 
be used to make some predictions. For example the model can be used to 
predict how the sensitivity to gold in the kidney would vary with position. This 
could be easily achieved by summing the sensitivities returned by Monte Carlo 
model over the volume of a kidney. This process could then be repeated with 
the source and detector collimators modelled in different positions such as 
might be used with different kidney positions in a clinical situation. And thus 
the relative sensitivities to gold with the kidney in various positions could be 
predicted. The results of using the model in this way for a number of different 
kidney positions are given in table 5.4.1. The volume summed over was a 
cuboid with a 60 x 60mm base in the x-z plane, which was 100mm high and 
centred on the intersection of the source and detector axes. These results show 
that there will be a strong fall off in sensitivity with depth, and therefore an 
accurate depth determination will be important.
Kidney Phantom Monte Carlo Photoelectric











Figure 5.4.1 - Sensitivity contours predicted by Monte Carlo model for different kidney positions. The
black circle shows the kidney volume
The model can also be used to predict how the sensitivity will vary over the
kidney volume for different kidney positions. This type of prediction of how the
sensitivity varies over the kidney volume is illustrated in figure 5.4.1. The
figure shows how the sensitivity varies over a 60mm square centred on the
kidney for three different kidney positions. These positions are 30mm, 40mm &
50mm between the kidney surface and skin surface in the direction of the
detector and 50mm, 60mm & 70mm respectively between the kidney surface
and the skin surface in the direction of the source. In this diagram the
contours are normalised to the maximum sensitivity found for the 60/40mm
kidney position. It is clear from these results that most of the gold fluorescence
signal comes from the side of the kidney nearest the source. This is an
important fact that will have to be borne in mind when interpreting any
clinical results.
5.4.2 Effect of increased source to skin distance
Another use that can be made by the Monte Carlo model is to predict how the 
sensitivity will vary with an increased source to skin distance. An increased 
source to skin distance would need to be used if a more active source were used, 
since otherwise the detection system would saturate with the increased count 
rate. In order to evaluate the effect of increased source to skin distance the
9 4
SSD X_SKIN Z_MIN DETECTJZ SOURCE ANG
/ m / m / m r
0.045 0.055 4 (SSD+0.075) 12.0
0.125 0.055 12 (SSD+0.075) 6.4
Table 5.4.2 - Different parameter settings in the Monte Carlo model to assess the effect of increasing
the source to skin distance
model was run twice with parameters set as shown in table 5.4.2. The 
difference between the two runs was an increase in source to skin distance 
from 45mm to 125mm. However in order that only the kidney volume was 
‘irradiated’ the collimation angle of the source collimator also needed to be 
reduced from 12.0° to 6.4°. The sensitivity variation with position, within a 
60mm square centred on the centre of the kidney volume is shown as a contour 
plot in figure 5.4.2. The contours shown are normalised to 100% on the 
maximum sensitivity (in counts) for the 45mm source to skin distance.
An examination of figure 5.4.2 leads to the conclusion that the difference in 
sensitivity variation across the kidney between these two different source to 
skin distances is small. From inverse square fall off alone it would be expected 
that the fall off in sensitivity across the kidney would be less rapid with an 
increased source to skin distance. However most of the photons reaching the
10mm
SSD = 45 mm 
SSD = 125mm
Figure 5.4.2 - The effect of increasing source to skin distance on the sensitivity contours within the kidney
volume
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kidney (around 70% for a depth of 50mm) will have undergone some interaction 
and therefore the observed effects will not necessarily be intuitive. As already 
mentioned, those photons undergoing a Compton scattering interaction have a 
large probability of being scattered in the forward direction when they have an 
energy of XOOkeV (section 2.2). Obviously sensitivities for the various kidney 
positions actually found in practice would need to calculated as described in 
section 5.4.1, however this does show that a relatively large error in 
determining source to skin distance would lead to a small error in determined 
gold concentration.
5.5 Conclusions
It is clear, from the work described above, that the Monte Carlo model works 
well and can be used in a predictive way to find the relative sensitivities at 
various kidney positions. This will obviously be very useful when it comes to 
undertaking clinical work. Using the model it will now be possible to tabulate 
the relative sensitivities for different kidney positions that might be found in 
practice. However if an atypical kidney position were found in a clinical 
situation it would be possible to run the model on a personal computer to find 
the relative sensitivity for that position.
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Chapter 6 
In situ radiation source
6.1 Introduction
In the work discussed in earlier chapters the radiation source used to excite the 
fluorescence was external to the body. There is however another possibility 
which is to use a source of radiation that is in the kidney. The method of 
getting this radiation source to the kidney is to use a radio-labelled drug, that 
when injected intravenously into the body, will end up in the kidney. This 
technique will have two advantages over the method using 153Gd described in 
chapter 4. Firstly the source will be in the kidney and therefore will be 
unattenuated by overlying tissue. Secondly there will be greater uniformity of 
the radiation dose over the kidney volume, thus overcoming some of the large 
sensitivity variation discussed in chapter 5. A number of suitable drugs already 
exist and are used for studies in nuclear medicine departments. The two drugs 
that are in use regularly locally are diethylenetriamine penta-acetic acid 
(DTPA) and dimercapto succinic add (DMSA). The former is used for dynamic 
(renogram) studies and the latter for imaging studies. DMSA is therefore 
designed to remain in the kidney for a longer period of time, and consequently 
gives a higher absorbed dose to the kidney than DTP A. The possibility of using 
either of these drugs as a radiation source in the kidney in situ in the kidney is 
discussed in this chapter. The questions that are addressed are whether 
suffltient activity of "Tcm is found in the kidney for a suffident period of time 
to give the required detection limit of 40jig gold (g tissue)1.
6.2 Activity of "Tcm actually found in the kidney
In order to establish the activity of "Tcm during a typical nuclear medidne 
study, the scans of patients stored on the computer at Royal United Hospital, 
Bath were re-examined. A phantom study was also undertaken, so that the 
count rate from a known activity of "Tcm could be assessed for differing kidney 
depths.
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Patient Right Kidney Left Kidney
Number 5mins* 40mins* 5 mins* 40mins*
1 450 220 500 240
2 810 200 570 150
3 1070 250 990 250
Average 780 220 690 210
* Time after injectton 
Table 6.2.1 - Count rates (s'1) from patients undergoing renogram (DTPA) studies
6.2.1 Re-examination of patient scans
The count rate variation over the region of interest of one kidney could be 
extracted from all renogram (DTPA) and some DMSA studies performed 
locally. It should be noted that in all these studies, the gamma camera was set 
to count over an energy window with a mean energy of 140keV ("Tcm emission 
line) and (full) width of 28keV. This relatively large window width was 
required so that all the unattenuated 140keV photons would be detected due to 
the poor resolution of sodium iodide detectors.
In the case of renogram studies, there existed a well defined analysis protocol 
on the computer attached to the gamma cameras. Firstly the counts in several 
frames were summed so that the kidney could be easily identified. Secondly a 
region of interest was drawn around both left and right kidneys by hand using 
the joystick on the computer terminal. A background region of interest that 
was approximately kidney sized was also constructed. The computer then 
counted the number of counts in each of these regions on every frame. A graph 
of count rate against time was then presented. Figure 6.2.1 is a diagram taken 
from a typical display. Count rates at two different times after injection from a 
number of reportedly normal patients are given in table 6.2.1. The injected 
activity for all these studies was 185MBq.
A similar procedure was adopted for DMSA scans. However in this case, the 
count rate was calculated from a single frame. DMSA studies were imaging 
studies and therefore contained pictures taken from different positions around 
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Figure 6.2.1 - Diagram taken from a  typical display from the nuclear medicine computer showing 
count rate from the kidneys as a  function of time
interest was drawn around both kidneys. The computer then summed the 
number of counts in each of these regions separately. The toted number of 
counts in each region of interest was then divided by the time of exposure to 
give the count rate from each of the kidneys. Count rates deduced in this way 
from apparently normal patients are given in table 6.2.2. It should be noted 
that the pictures from which these count rates were derived were taken 
approximately three hours after the injection of the DMSA, and therefore the
"Tcm had decayed by half a half-life. The injected activity for all these results 
was 185MBq; this is the same as for the DTPA scans.
In order to relate the count rates reported above to activities in the kidney a 





















Table 6.2.3 - Summary of results from gamma camera phantom study
with a solution containing 20MBq of "Tcm. This phantom was a 150ml, 47mm 
diameter polythene bottle, similar to those filled with chloroauric add and used 
in the experiments described in previous chapters. The kidney phantom was 
then placed at various depths in a water bath. Pictures were taken with the 
gamma camera in a position similar to that used for renal studies. The count 
rate over the region of interest of the bottle was calculated in a similar manner 
to that described for the DMSA studies above. The results for various depths, 
representing the range of kidney depths that would be found in practice, are 
given in table 6.2.3 and a diagram of the experimental arrangement is shown 
in figure 6.2.2.
From these results it was concluded that the count rate recorded by the gamma 
camera is not very sensitive to kidney depth. This is important since kidney
@Kidney phantomgi Gamma camera □  Water
9.0mm
Figure 6.2.2 - Diagram showing experimental arrangement for phantom study with gamma camera
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depth was not recorded in the patient records, and therefore an average kidney 
depth would have to be assumed in order to estimate the activity in the kidney. 
From the phantom data it was concluded that the uncertainty in this activity 
was not likely to exceed ±10% from the mean, as the count rate only fell from 
2100CS'1 at a phantom depth of 30mm to a rate of 1750CS'1 at a depth of 60mm. 
This represents a fall in count of only 17%. An average count rate of 1925cScf 
from the phantom was assumed, this corresponds to 96cs* MBq*1.
Averaging the data in table 6.2.1 over reportedly healthy kidneys of patients 
undergoing renogram studies gives a count rate of 740±240cs'1 5 minutes after 
injection falling to a rate of 220±35cs1 40 minutes after injection. Thus the 
activities that are to be found in the kidney, allowing for both the range of 
recorded count rates and uncertainty in kidney depth, are 7.7±2.6MBq 5 
minutes after injection and 2.3±0.8MBq 40 minutes after injection. Most of the 
uncertainty in these estimated activities is due to the physiological variation 
from patient to patient rather than the uncertainty due to an average kidney 
depth being assumed.
Averaging the-data in table 6.2.2 over apparently healthy kidneys of patients 
undergoing DMSA scans gives a count rate of 1490±80cs'1 approximately three 
hours after injection. The biological half-life of DMSA is much longer than the 
physical half-life (Maisey, 1980) and therefore the count rate variation with 
time is small. Using the phantom calibration described above, this count rate, 
of 1490±80cs1 corresponds to an activity of "Tcm in the kidney of 15.5±1.8MBq, 
again allowing both for the spread in count rates recorded and uncertainty in 
kidney depth. In this case the uncertainty due to the assumed average kidney 
depth is more significant due to the small variation in count rate over the three 
patients in table 6.2.2. This is probably due to the physiological variation in the 
uptake of DMSA being less than for DTPA, which is consistent with the 
different uses of the two drugs: DTPA is used when a severe renal failure is 
suspected, and DMSA is used when the suspected pathology is impaired renal
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function from small isolated parts of the kidney. It is therefore expected that 
with DMSA studies the variation in uptake of the drug would be smaller them 
with DTPA.
The conclusion from the above study is that for the same injected activity (in 
this case 185MBq) a higher activity is found in the kidney with DMSA than 
with DTPA over the time period available for the patient measurement. 
Additionally for the same injected activity the estimated effective dose is 
approximately the same for both pharmaceuticals.
When examining the pictures of both phantom and patient studies, there was a 
region of lower intensity surrounding the kidneys/phantom. In a patient this 
could be due to uptake of the radio-pharmaceutical in the surrounding tissue, 
low angle Compton scatter in the tissue of the 140keV photons, or penetration 
of the gamma camera collimator by photons. If this phenomenon was due to 
uptake of the radio-pharmaceutical by the surrounding tissue the magnitude of 
this effect would vary between the phantom and patient studies. A region of 
interest dose to, but not overlapping, the kidney/phantom from a number of 
scans was analysed for count rate using a similar method to that described for 
DMSA scans above. This area was rectangular and was approximately one 
quarter of the area of the region of interest covering the kidney/phantom. The 
results are summarised in table 6.2.4. From these results it can be clearly seen 
that the intensity of the background in both cases is similar and is therefore 
due primarily to collimator penetration or low angle Compton scatter in the 
tissue. The gamma camera is an array of hexagonal holes in a 41mm thick 
sheet of lead with septal thickness of 0.3mm and hole diameter (side to side) of 
2.5mm. A simple calculation based on equation 6.2.1 indicates that septal
Study Kidney (Nk) Background(NB) Nk/Nb
/ Cts Pixel*1 / Cts Pixel*1 /%
Patient 64 4 6
Phantom 332 21 6
Table 6.2.4 - Background count In patient and phantom studies
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penetration is going to be a very small effect, contributing a background of 
much less than 1% of the image intensity. Therefore this background was 
attributed to low angle scatter.
I = (6.2.1)
6.2.2 Phantom study using HPGe detector
A study was also undertaken using the hyperpure germanium detector to 
establish the activity of "Tcm that would be required in the kidney to obtain the 
required detection levels. The experimental arrangement for this study is 
shown in figure 6.2.3. The detector collimator is the one that has already been 
described (section 3.4). Therefore it is clear that collimation was only optimum 
for a kidney depth of 30mm, however this was considered not to be important 
since the study was only to assess the feasibility of the technique, and detection 
levels would vary little due to under collimation as long as the whole kidney is 
seen by the detector (section 3.4). The kidney was represented as in previous 
experiments by 150ml, 47mm diameter, polythene bottle containing chloroauric 
acid with a concentration of gold of 500pg (g solution)'1. The uptake of the 
radio-pharmaceutical was represented by a small (4.5ml) polythene tube, 
containing approximately 20MBq of "Tc”, placed down the centre of the bottle.
[H Kidney phantom ^  Steel collimator □  Water 
99 m
11 Tc solution HI HP Ge detector 20mm
Figure 6.2.3 - Diagram of apparatus for phantom study with HPGe detector
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This kidney phantom was placed in a water bath at a range of depths which
may be found in practice. The wall of the water bath was positioned against the 
surface of the detector collimator. For an initial activity of 20MBq the resultant 
spectra were recorded over a period of 30 minutes, this represents the 
maximum acceptable time for patient studies. In practice the actual irradiation 
times were adjusted to compensate if the initial activity was different from 
20MBq, using the following method. It is the total number of decays, P, that 
should remain constant between experiments. If the initial activity of the 99rpcm 
is Ao and the decay constant is A, the total number of decays in a time period T 
is given by equation 6.2.2.
T
This equation can then be rearranged to give the time, T, required for a given 
number of decays, P. This is given by equation 6.2.3.
The number of decays, P, from an initial activity of 20MBq of "Tcm over a 
period of 30 minutes is easily calculated from equation 6.2.2, given that the 
decay constant, A, for "Tcm is 0.1151T1. This value (of P=9.71xl06) can then be
activities, Ao. This was the method used to calculate the scan time required for 
alternative kidney depths, so that all scans were equivalent to an initial 
activity of 20MBq scanned for 30 minutes.
A summary of the results from the scans at different depths is given in table 
6.2.5. These results look very promising, with detection levels fairly close to the 
required 40|igg'1, for kidney depths of less than 30mm. These results do 
however require that 20MBq of "Tcm is taken up in the kidney. This is clearly 








With this sort of experimental arrangement, the measurement of dose is 
considerably more difficult. It would be possible to measure the skin dose of a 
patient/phantom by attaching TLX) chips to the skin surface. However since the 
radiation source is within the body, the skin absorbed dose will be small 
compared with the absorbed dose received by the kidneys. There are published 
figures for absorbed dose to different organs from standard injections used in 
nuclear medicine (ICRP, 1988). These values, for the kidney, for an injected 
activity of 185MBq of both DMSA and DTPA are given in table 6.3.1, together 
with the effective doses calculated using the weighting factors given in ICRP 
publication 60 (ICRP, 1990). With DTPA the absorbed dose to the kidney is 
much smaller than with DMSA. The reason for this is that with DTPA the 
bladder wall receives a considerable dose, contributing around 62% of the 
effective dose (ICRP, 1988).
The absorbed doses may also be calculated, if the activity in the kidney and 
other organs is known as a function of time (Snyder et a l, 1975). Such a 
calculation is outlined below for DMSA which has the major uptake of 99rpcm 
into the kidney.
Scan Activity Phantom Kai Peak DL
Time /s / MBq Depth /mm /Counts / n g g '1
2280 15.9 20 3860±212 55
1800 20.0 30 3305±201 61
2028 17.8 40 2481±182 73
2979 12.3 60 1516±153 100
Table 6.2.5 - Summary of results from HPGe detector phantom study
Drug Kidney Dose Effective Dose
Dose /mGy / mSv
DMSA 31 1.1
DTPA 0.9 0.8
Table 6.3.1 - Doses from 185MBq injected activity of DMSA and DTPA
105
In a calculation of this nature, the accumulated activity of the isotope under 
consideration in each organ in the body must be known. The absorbed dose to 
the target organ is then given by equation 6.3.1:
D = E  SA  (6-3-1)
j
where A, is the accumulated activity of the isotope in organ j ,  and S/ is the 
weighting from the organ j  to the target organ. These ‘S’ values are given in 
MIRD pamphlet NQ11 for a number of commonly used isotopes. For the 
calculation of kidney dose from intravenously injected DMSA, the only ‘S’ value 
other than kidneys to kidneys that is significant is spleen to kidneys. However 
the amount of DMSA taken up in the spleen is small (ICRP,1988) and therefore 
the only significant contribution to absorbed dose in the kidney is from 99rpcm 
taken up in the kidneys themselves. It has already been found that 24% of the 
injected activity is taken up in the kidneys and stated that it stays there 
indefinitely. Therefore the effective decay constant, A, of "Tcm in the kidneys is 
the physical decay constant of "Tcm, that is 0.1 ISh*1. The accumulated activity 
is given by equation 6.3.2. (This expression can be derived from equation 6.2.2 
by setting T= ©o, and A is the effective decay constant.)
A = V *  = \  (6 3 2)
m2 A
where Ao is the initial activity in the kidney. The appropriate kidneys to 
kidneys ‘S’ value is 5.1xlO'2mGy MBq'1 h'1. Therefore the absorbed dose for the 
kidneys for an injected activity of 185MBq is 19mGy.
6.4 Clinical system performance: predictions
As has already been mentioned, the results from the phantom study looked 
very promising, particularly at shallow kidney depths. These results did 
however rely on there being 20MBq of "Tcm in the kidney, which clearly is not 
the case from the results in section 6.2.1, where a maximum activity of about 
15MBq was detected. However if the detector size was increased to a diameter 












Table 6.4.1 - Predicted performance of cilnlcal system
reduced by approximately a factor of three (as discussed in section 3.5), thus 
bringing the sensitivity well within the useful range even for kidney depths of 
60mm. It is clear from the results in section 6.2.1 that DMSA will be the 
optimum drug for this type of study, since for similar injected activities and 
effective doses a higher activity remains in the kidney for a longer period of 
time. Assuming that the detection limit will increase with decrease in square 
root of activity of "Tcm in the kidney, and that the detection limit decreases 
with increase in detector diameter, for the same reasons as discussed in section 
4.6, the anticipated activities that would be required (AAR) in each kidney to 
give a detection limit of 40|ig g*1 are given in table 6.4.1. The absorbed dose to 
the kidney for the activity required in the kidney is also given (these were 
calculated using the MIRD ‘S’ value calculation outlined in section 6.3 and 
equation 6.4.1).
H = WrD (6.4.1)
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Chapter 7 
X-rays as an  excitation source
7.1 Introduction
In the previous chapter a proposal of using intravenously injected radio­
labelled pharmaceuticals was discussed. The reason for this proposal was to 
give better uniformity of irradiation of the kidney than when using external 
radio-isotope sources. Another way of giving better uniformity of irradiation of 
the kidney might be to place the radiation further from the skin, thus reducing 
the effect of the inverse square law. However when using a radio-isotope 
source, there is a point where it impossible to obtain a source of sufficient 
activity to maintain the photon flux to keep the measurement time within 
acceptable limits. If an X-ray machine source could be used then, providing the 
tube rating is sufficient, much higher photon fluxes can be obtained. However 
an X-ray source is far from ideal in terms of its photon energy spectrum, as it 
contains large numbers of photons with insufficient energy to excite 
fluorescence in the gold. These low energy photons will give an absorbed 
radiation dose with no benefit. In fact the X-rays with energy just below the K 
absorption edge of gold will lead to an increased scatter background beneath 
the fluorescence peaks in the detected spectrum, with no benefit in terms of 
fluorescence yield.
An X-ray spectrum consists of two components, the bremsstrahlung and the 
lines characteristic of the target. If these characteristic lines are to be utilised, 
then they must have greater energy than the K absorption edge of gold 
(80keV). For the Ka radiation to have an energy greater than 80keV, a target 
with an atomic number, Z, greater than 86 (radon) is required. The only 
elements which fulfil this requirement and Eire stable are thorium (Z=90) and 
uranium (Z=92). There are no commercially available X-ray generators that 
have a target with such a high atomic number, and therefore the 
bremsstrahlung radiation must be utilised to cause fluorescence. It is, however,
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possible to filter the beam of X-rays to increase the proportion of high energy 
X-rays. This is discussed further in section 7.2.
It has been demonstrated by Jonson et al (1988) that improved detection limits 
can be achieved by the use of partially polarized X-rays. The reasons for this 
are that if a 90° geometry is used the number of incoherently scattered photons 
entering the detector can be reduced by a suitable choice of axes, since plane- 
polarized X-rays will not scatter at 90° in the plane of polarization. However 
since the published results from this group in Goteburg indicate that 
polarization only leads to an improvement in detection limit by a factor of less 
than two, initial experiments were carried out using unpolarized X-ray source, 
using an old lOOkV screening X-ray machine with a tungsten target. This 
machine had all filtration removed and had an unsmoothed half wave rectified 
power supply. The inherent filtration on the tube was 0.7mm aluminium.
7.2 Spectral measurements
As already mentioned in order to reduce any unnecessary absorbed dose to the 
patient due to low energy photons, it is necessary to filter the X-ray beam. It is 
obviously possible to calculate the effect of any filtration using tables of linear 
attenuation coefficient (for example Hubbell, 1982). However in order to do this 
it is necessary to know the spectrum of the unfiltered beam. A number of these 
spectra have been tabulated by Birch et al (1979). Therefore firstly an 
experiment was undertaken to check that the spectrum from our X-ray 
machine corresponded well to the appropriate one of these tabulated spectra.
In principle, the output spectrum of the X-ray machine could be measured by 
simply irradiating the hyperpure germanium detector with the X-ray 
generator, and comparing the recorded spectrum with the tabulated one. 
However in practice it was necessary to filter the X-ray beam emerging from 
the generator with an extra 1.7mm of aluminium so that it could be compared 
directly with the 2.5mm aluminium lOOkVp tungsten target spectrum given by 
Birch et al (1979). It was also necessary to take precautions so that any X-rays
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scattered from the head of the X-ray generator did not enter the detector and 
distort the recorded spectrum. The proportion of scatter entering the detector 
could be reduced by placing the X-ray generator at a large distance from the 
detector or by arranging collimation of source and detector so that only photons 
emerging from the tube entered the detector. Therefore three experiments 
were carried out. In the first the output from the X-ray generator was highly 
collimated as was the input to the detector. These were then aligned using a 
small HeNe laser. In the second experiment the X-ray generator was placed at 
a large distance from the detector (~3m) and in the third experiment both 
collimation and a large distance were employed. The results from these 
experiments are given in figure 7.2.1.
An examination of figure 7.2.1 leads to the conclusions that all three methods 
give similar spectral shape, and that there is considerable mismatch between 
the recorded and tabulated spectra at the low energy end. One possibility is 
that the low energy distortion is a side effect of incomplete charge collection in 
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Figure 7.2.1 - Results of experiments to record X-ray spectra with reduced scatter effects
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each, photon energy that is detected, there will be a small number that will be 
assigned an energy below their real energy due to incomplete collection of the 
charge generated. A shelf is therefore seen on the low energy side of a 
monochromatic peak, of approximately 1% of the peak height. The 
accumulation of this effect over all the photons above 40keV, say, could well 
lead to the sort of distortion that is seen in these spectra. It is dear that at 
energies greater than 40-50keV a relatively good fit can be obtained.
In order to ascertain whether incomplete charge collection was responsible for 
the distortion of spectra at the low energy end of the spectrum, it would be 
necessary to deconvolve the recorded spectrum with the response function of 
the detector, which indudes any incomplete charge collection effects. The 
recorded spectrum, h(E), is the convolution of the real spectrum, /(E), with 
detector response function, g’CE). and is therefore given by equation 7.2.1.
hiE) = /(E) * ^(E) (7.2.1)
Taking the Fourier transform of equation 7.2.1, equation 7.2.2, is obtained by 
the convolution theorem; where H(t) is the Fourier transform of A(E).
Hit) = Fit) x Git) (7.2.2)
Therefore the real spectrum may be obtained by dividing the Fourier transform 
of the recorded spectrum by the Fourier transform of the detector response 
function and taking the inverse transform. Unfortunately the response function 
of this type of detector is not independent of energy. However the response 
function of the detector varies relatively slowly and smoothly with energy, it 
was therefore detided to attempt to deconvolve a real spectrum with the 
detector response function at an average energy. The energy chosen was that of 
the 241Am photo-peak at 59keV since the response function of the detector could 
easily be measured at this energy, due to the very simple emission spectrum of
241Am. The result of this deconvolution is shown in figure 7.2.2, together with
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Figure 7.2.2 - Effect of deconvolution
Birch et al (1979). The deconvolution was performed using the a computer 
program based around the routine given by Press et al (1988). From this figure 
it can be clearly seen that this deconvolution process removes the low energy 
shelf from recorded spectra, and therefore it is incomplete charge collection 
that is the cause of the low energy shelf.
The next stage was to ascertain whether the effect that filters had on the 
output could be predicted by using the linear attenuation coefficients such as 
those tabulated by Hubbell (1982) together with the unattenuated spectrum. In 
order to do this the output of the X-ray generator was filtered with 6mm of iron 
and the pulse height spectrum was recorded and corrected using the 
deconvolution method described above. This spectrum was then compared with 
those predicted theoretically, using the data tabulated by Birch et al (1979) and 
Hubbell (1982) in equation 7.2.3. The result, shown in figure 7.2.3, clearly 
indicates that the effect of filtration can be predicted from available data on 
linear attenuation coefficients.
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Figure 7.2.3 - Comparison of measured and calculated filtration effects
7.3 Unpolarized X-ray system
7.3.1 Incident spectrum
In the work described in the previous section a method of measuring spectra 
from X-ray sources was devised and demonstrated to be valid. It was also 
demonstrated that the effect of filtration with different filters of differing 
elements could be successfully calculated. For an X-ray fluorescence system 
with optimum fluorescence yield per unit absorbed dose it is obviously 
important to have a spectrum with a large proportion of photons with energy 
above the K absorption edge of gold incident on the patient. This leads to the 
conclusion that the beam should be heavily filtered. However if the beam is too 
heavily filtered then there will be insufficient photon flux to give the required 
detection levels due to the tube current limitations of the X-ray generator being 
used. The predicted result of filtering an unsmoothed lOOkV spectrum from a 
tungsten target (characteristic lines omitted) with various filters is given in 
figure 7.3.1. From this figure it can be seen that the effect of filtering with 
0.35mm of uranium (as used by Jonson et al (1988)) is similar to that of 
filtering with 5mm of iron. Since an appropriate thickness of uranium filter 










Figure 7.3.1 - Spectral output of X-ray generator with different filters
Filter Proportion of photons able to excite fluorescence / % 
lOOkV Spectrum HOkV Spectrum
8mm Steel 55 84
6mm Steel 41 71
5mm Steel 37 67
4mm Steel 30 56
3.3mm Steel 25 52
0.35mm U 39 68
Table 7.3.1 - Proportion of spectral output able to excrte fluorescence in gold
easier to handle, the other spectra are for various thicknesses of iron filter. The 
proportion of radiation with energy above the K absorption edge of gold (81keV) 
(i.e. the useful radiation for X-ray fluorescence production) is tabulated in table 
7.3.1. As expected the proportion above the K edge falls with decrease in 
thickness of filter for a given element.
7.3.2 Phantom study
In order to assess the detection levels that might be achieved with this type of 
filtered X-ray system a phantom study was undertaken. A diagram of the 
experimental arrangement is given in figure 7.3.2. The head of the X-ray 
generator was covered with 2mm lead sheeting to help prevent any leakage. 
Collimation, so that the kidney phantom was just irradiated, was achieved
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Detector and Collimator 
Figure 7.3.2 - Diagram of experimental ap>paratus for unpolartzed X-ray system
using a small block of lead, 10mm thick, with a 10mm diameter hole drilled 
through it. In order that a good photon flux could be maintained with the 
limited tube current available on the X-ray equipment a 3.3mm steel filter was 
employed. An experiment was also undertaken using a 6mm steel filter to 
assess the improvement that could be achieved with a beam with a higher 
proportion of photons that could cause fluorescence. The filter was placed 
between the X-ray source and the collimator, so that scatter from the filter was 
largely eliminated. The detector collimator, kidney and body phantoms were 
those identical to those used to evaluate the 153Gd system (chapter 4). Correct 
alignment of the phantoms was achieved using the image intensifier on the 
C-arm of the X-ray machine: thin strips of lead were temporarily placed down 
the side of the kidney phantom so that it could be distinguished from the water 
bath on the image intensifier display.
So that comparison could be made with the systems described in previous 
chapters, a similar kidney phantom position was adopted, that is 50mm lateral 
depth and 30mm posterior depth. Two tube potentials were used, the lOOkV as 
already mentioned and one of approximately HOkV. This latter potential was 
achieved by adjusting the control on the X-ray generator that allowed 
adjustment for slight variation in mains supply voltage so that the maximum 
possible tube potential was achieved. A summary of the results collected from 
these phantom studies is given in table 7.3.2. These results clearly indicate 
that an X-ray source could be used as a source for X-ray fluorescence, but in
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Tube Filter Tube Irradiation Kai Peak DL
Potential /kV Current / mA Time / min /Counts /Pgg']
100 3.3mm Steel 45 60 936±198 281
110 3.3mm Steel 30 60 1454±203 184
110 6.0mm Steel 125 60 2179±210 127
Table 7.3.2 - Summary of results from X-ray system phantom experiments
order to compare these results with earlier systems some dosimetric 
information must first be obtained.
7.3.3 Dosimetry
In order to compare the results obtained above with other systems, such as the 
one based on 153Gd it is obviously necessary to know the absorbed dose that is 
being received by the various organs. A dose determination was therefore 
carried out using TLD chips (section 4.4), for different degrees of filtration. The 
experimental arrangement consisted of a 180x140mm water bath, the surface 
of which was placed 300mm from the focal spot of the X-ray generator. Sachets 
containing three TLD chips were then stuck to the surface of this water bath. 
Calibration of the TLD chips in this case was carried out using the 250kV 
X-ray generator described in chapter 4 which had been calibrated from an NPL 
secondary standard dosimeter. The uncertainty in the resulting absorbed doses 
is expected to be less than 5%. A summary of the results is given in table 7.3.3. 
From these results it is possible to calculate the absorbed dose to the skin for 
other focal spot to skin surface distances using the inverse square law, and for 
alternative tube currents by linear scaling. However absorbed doses due to 
alternative filtration schemes and/or tube voltage need to measured directly.
Tube Filter Tube Irradiation Skin Dose
Potential /kV Current /mA Time / min / mGy
100 3.3mm Steel 0.5 30 27
110 3.3mm Steel 0.5 30 42
110 6.0mm Steel 0.5 30 13
Table 7.3.3 - Summary of Dosimetry results for X-ray system
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7.3.4 Beam Uniformity
To test the uniformity of the irradiation a piece of film was attached to the 
front face of the image intensifier. This was then exposed and developed. This 
was repeated for two different exposure times, with fixed tube current. When 
both films were scanned using a densitometer, the variation in optical density 
was less them 1% across the field. One had an optical density of 0.80 (8.4mA s) 
and the other an optical density of 2.85 (30mA s). From this it was concluded 
that there was very good uniformity of exposure over the irradiated area.
7.3.5 Conclusions from unpolarized X-ray system
From the work described above it is clear that it would be possible to use a 
heavily filtered X-ray source for XRF studies. If the fluorescence yield per unit 
dose is similar or greater than for the other systems described in chapters 4 
and 6, then an X-ray system would be the system of choice, since the extra 
expense of replacing an isotope source at intervals would not be incurred. A 
summary of results allowing the X-ray systems described in this chapter to be 
compared with the isotope systems proposed in previous chapters is given in 
table 7.3.4. The results given in the table are a combination of those given in 
tables 7.3.2 and 7.3.3, and have been scaled in a similar way to those in 
previous chapters for a 32mm diameter detector and a source to skin distance 
of 500mm.
The results for the lOOkV and HOkV tube potentials with 3.3mm steel 
filtration compare as expected. Since an examination of table 7.3.1 leads to the 
conclusion that the HOkV spectrum will contain approximately twice as many 
useful photons as the filtered lOOkV. Therefore when using lOOkV, it would be
Tube
Potential /  kV
Filter Skin Dose for Tube Current 30min 
DL of 40|ig g'1 / mGy Irradiation Time / mA
100 3.3mm Steel 9.5 490
110 3.3mm Steel 4.2 125
110 6.0mm Steel 1.9 280
Table 7.3.4 - Prediction of clinical system performance
117
expected that just over twice the dose would be required to give a similar 
sensitivity (assuming dose is independent of photon energy over this relatively 
narrow energy range). This is indeed observed in table 7.3.4. Using a similar 
argument it would be expected that using 6mm rather than 3.3mm steel 
filtration would only reduce the required dose by a factor of 1.4, whereas a 
factor of 2.2 is observed. This can, at least in part, be explained by that with 
6mm steel filtration the average photon energy is greater. Therefore a greater 
proportion of the photons are still able to excite fluorescence after having been 
scattered through a small angle. Since such large improvement in terms of 
sensitivity per unit dose can be achieved by increasing from lOOkV to llOkV, it 
is obvious to consider whether a further improvement could be achieved using 
a 120kV X-ray generator. Using a similar argument based on the proportion of 
photons above the K absorption edge of gold in the incident spectrum, the 
conclusion is that there would be little anticipated improvement for 3.3mm 
steel filtration. As the proportion of useful photons would only increase from 
52% to 61% and as the peak energy moves away from the absorption edge the 
cross-section for absorption falls off.
From the results in table 7.3.4 it can be concluded that an unpolarized X-ray 
source would be a suitable source for the determination of gold in vivo. There is 
a clear advantage of increasing the tube potential to llOkV and increasing in 
terms of reduction of skin dose. The latter is limited by the rating of the tube 
with regard to sustainable tube current. Although there would probably be 
some improvement in increasing the tube potential still further (our tube was 
designed for lOOkV only) it is not anticipated that significant reductions in skin 
dose per unit sensitivity would be obtained.
7.4 Polarized X-ray source
As has already been mentioned, it has been reported that using a plane- 
polarized X-ray source reduces the background below the fluorescence peaks 
and therefore the detection limit is decreased. The background is decreased
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since polarized photons will not scatter through 90° in the plane of polarization. 
It was therefore decided to attempt to verify this effect experimentally. In our 
experimental arrangement, the method employed to plane-polarize the photons 
was to scatter them off an aluminium target. The target was 25mm in diameter 
and cut off at the end at an angle of 45° to the axis. Unfortunately an X-ray 
source of 155kVp, such as that used by the group in Goteburg, was not 
available to us. Therefore any polarized system that was evaluated was not 
actually going to be suitable for X-ray fluorescence studies of gold. However it 
would be possible to get an idea of the effect of polarization.
Therefore in the experimental arrangement, the scattering target was 
irradiated with a collimated beam of X-rays. The X-rays were collimated using 
a steel tube which had an internal diameter of 20mm and a wall thickness of 
3mm. The two ends of the tube were placed against the X-ray generator and 
the sharpened end of the scattering target respectively. The distance between 
the X-ray generator head and scattering target was 300mm. The partially 
polarized X-rays were then used to irradiate a 150 x 200mm polythene 
container filled with water. The scattered radiation was then detected using 
our new 32mm diameter germanium detector. The detector and the polythene 
container were surrounded by 2mm lead sheet except for a small area through 
which the container was irradiated. Completely surrounding the apparatus 
was found to be necessary in order to reduce the background scatter from the 
surroundings to acceptable levels. The experimental arrangement is illustrated 
in figure 7.4.1.
The resultant spectra were recorded with the X-ray generator and the 
scattering target in two different orientations. One so that the amount of 
scatter from the water bath was a theoretical m a xim um  and the other a 
minimum. Two spectra were also recorded without the aluminium scattering 
target present so that any part of the recorded spectrum that was due to 









along 20mm diameter 
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Figure 7.4.1 - Schematic diagram of experimental arrangement for polarized X-ray studies
Direction of Maximum Scatter 





Energy /  keV
Figure 7.4.2 - Compton background In directions of minimum and maximum scatter
the recorded spectrum. All recorded spectra had a constant current-time 
product, and were recorded at sufficiently low count rates such that system 
dead-time was insignificant. The results from these experiments are shown in 
figure 7.4.2. From this figure it is clear that partial plane polarization does 
reduce the detection rate of Compton scattered photons. However the 
"background’ that had to be subtracted from the spectra shown in figure 7.4.2 
was of similar magnitude to the spectra themselves. Because of this large 
"background’ and the fact that the experiments were carried out at lower 
energy than would be required in a clinical situation, it is impossible to
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quantitatively predict the effect of polarization. However it is possible to 
confirm that it is a real effect. It is also dear from these experiments that if 
such a partially polarized X-rays were to be used in a dinical environment 
shielding of unwanted scattered background’ radiation would be a problem, 
probably requiring a customised X-ray generating system surrounded by 
shielding, the rating of the tube would also have to be similar to those used in 
radiotherapy machines. Therefore setting up such a system would be a 
(prohibitively) costly procedure and may not give significantly improved 
detection limits, as compared to a radio-isotope system due to the background’ 
scatter.
7.5 Conclusions
It is clear from the results using the unpolarized system that X-ray sources are 
a possible source of radiation for X-ray fluorescence studies of gold in vivo. It is 
also clear that a carefully constructed partially polarized system would give 
improved detection limits. However, X-ray systems are not without 
disadvantages. The main problems are that the large source to skin distances 
used lead to alignment problems and that a significant amount of scattered 
radiation from the intense primary beam can enter the detector if suitable 
precautions are not taken. In the phantom studies described above, thin strips 
of lead on the kidney phantom and the image intensifier on the C-arm of the 
X-ray generator were used to aid alignment. In an in vivo this would obviously 
not be possible, and an alternative alignment system would need to be sought. 
The scatter problems could easily be overcome with a purpose built system 
with shielding in suitable places, this would require a dedicated X-ray 





Now that all the various excitation possibilities have been evaluated (chapters 
4, 6 and 7) and an understanding of the effect of other parameters has also 
been gained (chapter 3), it is possible to design a clinical system. The main 
design criteria are that the system should deliver the smallest possible 
radiation dose to the patient with the shortest possible irradiation time to 
achieve a detection limit of 40jig g'1. The system must also not saturate any of 
the detection system components: the detector, pulse-shaping amplifier or the 
multi-channel analyser (MCA).
8.2 Optimum design parameters
8.2.1 New detector and  Electronics considerations
In order that a larger number of counts could be collected per unit time/dose, a 
larger hyper-pure germanium detector was purchased. This detector was 
32mm in diameter and 10mm thick with a resolution of 740eV (FWHM) at the
57Co 122keV emission line. The new detector therefore had an area ten times 
greater than the old one, and thus would yield ten times the count rate for a
given experimental arrangement. The new detector was designed to handle an
energy throughput of 5000MeV s'1, that is around 70 OOOcs'1 with an average
photon energy of 70keV. This had throughput implications for the electronics
following the detector preamplifier.
In the experiments described in previous chapters a shaping time of 6 jis  had 
been used on the pulse-shaping amplifier. If this practice were continued, the 
maximum frequency that could be handled by the pulse-shaping amplifier 
would be around 25 OOOcs1 (or more realistically 6000CS1 with a 25% dead­
time), since the pulse length is approximately 6.6 times the shaping time. 
However at this counting frequency a significant amount of information would
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be lost due to the irregular nature of the counting process involved. Therefore if 
significant losses of information were not to occur due to amplifier dead-time, a 
significantly shorter shaping time would be required. Thus a shaping time of 
lps was adopted for future work with the new detector, as recommended by 
EG&G Ortec (the suppliers of the detector). This gave a theoretical maximum 
count rate for the pulse shaping amplifier of around 160 OOOcs-i (40 OOOcs'1 
with a 25% dead-time).
The final component in the detection equipment was the MCA. This had a fixed 
dead-time of 25 jis per pulse. Therefore the theoretical maximum count rate was 
around 40 OOOcs'1 (10 OOOcs'1 with a 25% dead-time). This would seem to be the 
limiting factor, but the MCA had a low level discriminator (LLD) which could 
be varied between 0 and 50% of the full scale. Since in this type of X-ray 
fluorescence study, there is no reason for retaining the spectrum below the 
fluorescence peaks, much of the spectrum could be removed using the LLD. 
Thus the count rate that the MCA needed to handle could be greatly reduced 
by using the LLD such that only the portion of the spectrum above 60keV was 
collected by the MCA. This, for most excitation sources, effectively almost 
doubles the count rate that can be handled by the MCA to around 80 OOOcs-i 
(20 OOOcs'1 with a 25% dead time).
All the stated limitations on count rate above, assume that the incoming 
photons are, on average equally spaced. This is obviously true for a radio­
isotope source, however for an X-ray generator this is not always the case. If 
the X-ray generator does not have a constant potential power supply, photons 
of a given energy, E, can only be produced when the potential across the tube is 
greater than E/e, where e is the elementary charge. Therefore if the X-ray 
generator is unsmoothed such as the one used in the experiments described in 
chapter 7, the higher energy photons are produced in bursts. This is illustrated 
in figure 8.2.1 which shows the output of the pulse shaping amplifier recording 
a spectrum with the X-ray generator in an experimental arrangement similar
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Figure 8.2.1 - Output of pulse shaping amplifier while recording an X-ray spectrum (The oscilloscope
settings were 2V div' and 10ms div')
X-ray generator
Phantom
Detector and Collimator 
Figure 8.2.2 - Experimental arrangement for X-ray experiments
to that illustrated in figure 8.2.2 with 6mm steel filtration. From figure 8.2.1 it 
can be seen that the photons arrive at the detector in bursts, the frequency of 
these bursts being 50Hz. This is due to the fact that the X-ray generator used 
was only half-wave rectified and unsmoothed. Using this type of generator it 
would be the frequency of pulses within these bursts, rather than the frequency 
of the pulses averaged over 20ms, that would provide the count rate limitation. 
Therefore since the bursts of high energy pulses occupy less than one sixth of 
the total period of a 50Hz cycle, the total throughput of the system will be over
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six times less them might otherwise have been expected.
8.2.2 Optimum excitation source
In previous chapters, when using the smaller 10mm diameter detector, three 
excitation sources have been considered. These were 153Gd as the preferred 
external isotope source; "Tcm radio-labelled pharmaceuticals; and X-ray 
sources. As previously stated the best excitation source will give the required 
sensitivity with the minimum radiation dose to the patient with the minimum 
exposure time. A summary of the best results predicted for the 32mm diameter 
detector from the results of previous chapters is given in table 8.2.1. In the first 
five columns, this table shows the resulting absorbed doses and activity/current 
required for a 30 minute counting time to achieve a detection limit of 40jig g'1. 
The sixth column of the table gives the counting time that would be required to 
achieve a detection limit of 40pg g'1 with a count rate of 10 OOOcs*1 after the 
LLD on the MCA, which is the count rate that would give a dead-time of 25% 
with our MCA. The final column shows the corresponding required 
activity/tube current. Using the above criteria, it is clear that radio-labelled 
pharmaceuticals give larger doses of radiation to the kidney than external 
sources. Coupled with this the radio-pharmaceuticals give significant doses to 
other organs as well (ICRP, 1988), thus leading to an effective dose that is 
significantly greater than for the external sources. Therefore the optimum 
system is going to be based around an external source. Whether, for reasons
System Peak Skin Kidney ED+ Activity/Curr. Minimum Activity/Curr. for *
Dose/mGy Dose/mGy /jiSv /GBq or |iA Time*/min /GBq or pA
DMSA 0.0 6.2 160 0.06 25 0.12
153Gd# 3.1 0.4 11 2.2 12 8.1
X-rayl 4.2 3.1 80 120 62 95
X-ray2° 1.9 1.3 30 280 30 420
* ED - Effective Dose, due to skin and kidney doses only 
* Source to Skin Distance (SSD) = 45mm 
3.3mm steel filtration, SSD = 450mm. Tube potential = 1 lOkV 
a 6mm steel filtration, SSD = 450mm. Tube potential = 1 lOkV 
* Time required with count rate of 10 000 cs-' a t the MCA with LLD a t 60keV 
Table 8.2.1 - Predicted system performance with new 32mm diameter HPGe detector, all predictions
for DL of 40jig g '1 in 30 minutes
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£3 Kidney phanton® Steel collimatorQ Water
I C O
B  Gd Source M HP Ge detector 20mm
50mm
30mm
Figure 8.2.3 - Experimental arrangement for '“ Gd source
which will be discussed below, an X-ray source or a 153Gd. source is preferable as
an excitation source is less clear.
Since the results in table 8.2.1 involve a considerable amount of extrapolation, 
it was decided to verify them experimentally with the new detector. The 
experimental arrangements used were those illustrated in figures 8.2.2 and 
8.2.3, it should be noted that the 10mm diameter hyper-pure germanium 
detector has been replaced by one that is 32mm in diameter. Due to the 
increase in diameter of the detector a new detector collimator was required. 
This is illustrated in figure 8.2.4 and was designed such that the whole kidney 
phantom would just be seen at a depth of 
30mm. The results from this experimental 
evaluation are given in table 8.2.2.
As table 8.2.2 shows the predicted detection
limit of 40|ig g 1 was not achieved with the 36mm
20mm
32mm diameter detector with either the 
filtered I53Gd source or the X-ray sources. 22mm
The main reason for this is that the larger 20mm 
detector was used with a shorter shaping
Figure 8.2.4 - New detector collimator
time leading to a poorer resolution than the
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System Activity/Current Irradiation Time DL Dead Time
/|iA or GBq / min /|ig g*1 /%
153 Gd# 1.6 30 57 12
X-ray 1’ 20 120 68 5
X-ray 2° 65 80 64 6
4' ° See caption for table 8.2.1 
Table 8.2.2 - Experimental results with the 32mm diameter detector
smaller diameter detector with a longer shaping time: 550eV at the 60keV 
241Am emission line (compared with 380eV for the smaller detector). This leads 
to a predicted 20% increase in detection limit (from the square root of the ratio 
of resolutions). The system dead-times also were not allowed for in the 
extrapolations. The results for the filtered 153Gd source were obtained with a 
slightly more active source (1.6GBq) than the source activity predicted 
(1.4GBq) to achieve 40pgg'1. This leads to an expected 6% decrease in the 
detection limit over that predicted (from the square root of the ratio of 
activities). When the above factors are considered the measured performance of 
the 32mm diameter detector system agrees well with the performance 
predicted from the results obtained with the smaller detector.
It is clear from table 8.2.2, that of the three experimental systems examined, 
the 163Gd system will give potentially the lowest detection limit, as it requires 
the lowest count rate to achieve 40jxg g*1. However, as already mentioned, the 
X-ray sources used were not ideal. It is possible to make some predictions, from 
the results of table 8.2.1, concerning the minimum detection limits that could 
be achieved with our current detection system and other X-ray sources. Table
8.2.3 gives the result of these predictions for all source types for a count rate of 
10 OOOcs1 at the MCA, corresponding to an MCA dead-time of 25%.
For the X-ray sources the result of using a constant potential generator is 
predicted, assuming a six-fold increase in the number of counts collected in 30 
minutes, for the reasons already mentioned. A further improvement has been 
reported by Jonson et al (1988) using a partially polarized X-ray source. For 
their partially polarized X-ray system (155kVp, 0.35mm uranium) with a
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System Detection Limit in 30 minutes ED
at 10 OOOcs'1 /|ig g'1 /uSv
DMSA 36 270
Half-wave rectified X-ray/110kV/6mm steel 65 12
Const Potential X-ray/110kV/6mm steel 26 75
Polarized X-ray/155kV/6mm steel* 15 75
Filtered 153Gd 25 27
• Assuming a  1.75 fold decrease In DL, due to the partial polarization of the X-ray source 
Table 8.2.3 - Predicted detection limits achievable with our current detection system
kidney depth of 40mm to the kidney centre, they reported a factor of 1.75 
improvement in detection limit over a lOOkVp unpolarized system. This 
improvement factor has been assumed for the comparison in table 8.2.3. Some 
of this improvement, however, may have been due to an increase in average 
energy of the incident photons as it has already been found by ourselves that 
an increase from lOOkVp to HOkVp gives a dramatic improvement in detection 
limit using our half-wave rectified generator.
The predictions in table 8.2.3 would indicate that the highest sensitivity would 
be achieved using a partially polarized X-ray source. The filtered 153Gd source 
produces a slightly poorer sensitivity for a similar effective dose. The 
advantage of an administered radio-pharmaceutical as an exciting source is its 
cheapness, but it does result in a higher effective dose for a poorer sensitivity 
than achievable with the other sources.
In conclusion it appears that a partially polarized X-ray system would give the 
best detection limits. However, for a partially polarized X-ray system, high tube 
potentials and currents must be used, which calls for a more heavily shielded 
room than for a 153Gd source, also a suitable X-ray generator is required. Since 
we do not have access to a suitable X-ray generator or heavily shielded room, a 
system based around 163Gd is best suited to our local circumstances and is 
proposed for clinical studies.
128
8.3 The prototype clinical system
8.3.1 Clinical system with old MCA
Having decided that a 153Gd source was the optimum source, a more active 
(37GBq) source was purchased. This source was then incorporated into a 
prototype clinical setup which is shown in figure 8.3.1. This system was on a 
table that could be adjusted in height. On the table were arrangements to keep 
the axis of the source and the detector perpendicular. These arrangements 
allowed the source to be moved both perpendicular and parallel to its axis. The 
detector also could be moved on rails perpendicular to its axis. The position of 
the detector was arranged such that the front surface of the collimator was 
flush with the table. A chair with a modified back position was also made, in 
order to allow a patient to be seated with back support during a measurement.
In order that a significantly more active 153Gd source would not saturate the 
detection electronics it would need to be moved away from the body (phantom). 
With the collimation used in previous experiments this would mean that an 
area greater than necessary would be irradiated. The work described earlier 
(section 3.4) indicated that if too great an area were irradiated the detection 
limit would be reduced. Therefore extra collimation plates were made that
50mm approx I—I
Variable Height Platform
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Figure 8.3.1 - Schematic diagram o f  the prototype clinical system
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could be bolted on to the front of 
the source collimator in order to 
reduce the beam angle. These 
extra collimation plates are 
illustrated in figure 8.3.2.
These collimation plates gave a 
discrete number of source to 
kidney distances for which the 
whole kidney volume would just 








Figure 8.3.2 - Illustration of extra collimating plates
extra flexibility an extra collimating ‘leaf was attached to the collimating plate, 
on the detector side of the source beam. This ‘leaf (which was mounted on a 
0.5mm/tum screw thread) could then be moved parallel with the detector axis, 
so that no tissue between the kidney and skin surface closest to the detector 
would be irradiated. The extra collimation that the ‘leaf afforded, reduced any 
unnecessary background under the fluorescence peaks.
The above prototype was then evaluated using a very large tank of water (570 
x 300 x 300mm), with the kidney phantom suspended in it, placed on a trolley 
in the position where the patient would sit. The kidney phantom was placed at 
the standard lateral depth of 50mm and posterior depth of 30mm used in 
previous evaluations. The detector with collimator was aligned with the kidney, 
and placed against the surface of the tank. The 6° extra collimating plate was 
attached to the front of the source collimator and the extra collimating leaf was 
moved in seven turns from the edge of the beam. The source to kidney surface 
distance (SKD) was 275mm.
With this experimental arrangement a detection limit of 40pg g'1 was achieved, 
as compared with 57|ig g'1 with the previous source at a source to skin distance 
of 45mm, with a measurement time of 30 minutes. By using the count rate at 
the MCA and the MCA dead-time, a calculation of the expected difference in
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the detection limit can be made. The count rate with the new source was 
25 000 cs'1 (at the amplifier) as opposed to 8000 cs*1 with the old source. The 
dead-time on the MCA had increased from around 10% to around 32%. 
Multiplying the MCA live-time by the count rate, leads to the conclusion that 
the expected number of total counts recorded in the spectrum would have 
increased by a factor of 2.25, for the new source as compared with the old 
source. Since the detection limit is approximately inversely proportional to the 
square root of the total number of counts (section 3.2), it would be expected 
that the detection limit would have decreased by a factor of 1.5, which would 
give an expected detection limit of 38pg g'1, which is dose to the observed value 
of 40pg g 1.
It was therefore concluded that the prototype system was performing as 
expected from previous results, and that measurements with a detection limit 
of around 40pg g'1 could commence on patients. With the source at such a large 
distance from the skin, sensitivity could be dramatically improved, probably by 
at least a factor of 2.5 to 16jig g*1 in 30 minutes by purchasing a new ADC with 
a reduced dead-time per pulse, such as the Canberra model 582 which has a 
fixed dead-time of 1.5ps per pulse (an improvement on the 25ps we are 
currently using). Alternatively the time required to achieve a detection limit of 
40)ig  g'1 would be reduced to around 5 minutes with this new ADC.
8.3.2 Clinical system with new ADC/MCA
Therefore a Canberra model 582 ADC was purchased together with an 
Accuspec B MCA to work in conjunction with the analogue to digital converter. 
The new detection system was tested for resolution at various count rates. The 
results are given in table 8.3.1. Examining the table leads to the conclusion 
that the detector resolution falls off quite quickly at high count rates. Therefore 
the detection limit does not fall as quickly as predicted above. However, the 
detection limit at high count rate is still below that at low count rate. If a 











Tab!© 8.3.1 - Resolutions of the new detection system at various count rates with a  shaping time of 1 us
on the pulse shaping amplifier
However since the dose using the old MCA was around 48|iSv, even a ten fold 
increase in dose would still put the dose within category I of the WHO 
guidelines, and within the range of doses given for a chest X-ray (10|iSv - 
1.3mSv, NRPB (1986)).
Due to the fact that the resolution of the detector decreases at high count rates 
it was necessary to rewrite the analysis program such that it could allow for 
different detector resolutions. (It is this version of the program that is given in 
appendix A.) At very high count rates a pulse-shaping time of l|is  would be too 
great, due to amplifier saturation and therefore the pulse -shaping time would 
need to be reduced; this would lead to further decreases in detector resolution, 
and consequently detection limit.
8.4 Sensitivity variation with position
It is clear that the sensitivity predicted for 50mm lateral depth and 30mm 
posterior depth will not be the same for all kidney positions. The lateral depth 
is the distance between the kidney surface and skin surface in the direction of 
the source, and the posterior depth is the distance between the kidney surface 
and skin surface in the direction of the detector. Therefore it was necessary to 
carry out an evaluation of sensitivity variation with phantom position. To 
obtain some indication of the sensitivity variation the experiment described 
below was carried out. However in the clinical situation the source would need 
to be brought closer as the source decayed. Therefore a calibration would need 
to be carried out for the collimating plate and skin to kidney distance being 
used.
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Lateral* Posterior* Depth / mm




50 26074 14751 8695
37 68 83
25074 15821 9634
70 16974 9362 6127
56 84 98
18189 11639 7052
* Posterior depth: Depth from skin surface to kidney surface In the direction of the detector.
* Lateral depth: Depth from skin surface to kidney surface in the direction of the source.
Table 8.4.1 - Sensitivity variation with kidney position using a  24GBq source with an  Irradiation time of 20 
minutes. In terms of experimental Kai peak counts, Monte Carlo Kai peak counts (shown condensed), and
detection Dm It (shown In Italics)
To evaluate the sensitivity variation with the prototype clinical system a 
kidney phantom containing 500pg g'1 of gold was placed in a very large tank of 
water (570 x 300 x 300mm) at the position where the patient would sit. The 8° 
collimating plate shown in figure 8.3.2 was always used with the le a f  11 turns 
in from the edge of the beam. A source to kidney surface distance (SKD) of 
200mm was used. However the source and detector positions were adjusted so 
that the field of view was aligned with the kidney phantom positioned at 
different depths. Spectra were recorded over a period of 20 minutes and the 
activity of the 153Gd source at the time of the experiment was 24GBq. The 
results given in terms of both Kai peak counts, and detection limit with this 
source are given in table 8.4.1. The table also shows the relative sensitivities 
predicted by the Monte Carlo model for the different kidney positions shown. 
These agree well with those obtained experimentally and so the model could be 
used for interpolation of different calibration factors in a clinical situation. (The 
Monte Carlo model results are normalised to the sensitivity recorded for the 
50mm lateral depth / 30mm posterior depth experimental result.)
The results also show that the detection limit increases with depth, and rapidly 
with posterior depth. Therefore accurate calibration and kidney position
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determination are important for measurements on patients.
8.5 Conclusions
A prototype clinical system has now been constructed that gives detection 
limits that will be clinically useful. A table of calibration data has also been 





Now that a clinical system, with a suitable detection limit had been 
constructed, a clinical evaluation could be initiated. Ethical committee 
approval was obtained for this study, and the work carried out is outlined 
below, together with a discussion of possible errors.
9.2 Clinical Studies
It was suggested that a number of clinical studies should be carried out, as 
they might provide useful information; these were:
• To compare the level of administered gold with the detected level to assess 
whether there is any correlation;
• To study the variation of kidney gold with time after cessation of 
chrysotherapy;
• To compare the detected level in the kidney on patients with proteinuria; and
• To compare levels in the kidney for orally and intravenously administered 
gold, to see whether there are significant differences.
These studies would obviously require the gold level in the kidney to be 
measured for a large number of patients with varying clinical histories.
The protocol that was adopted for patient measurements is now described 
briefly. Before any measurements were performed a consent form (Appendix E) 
was signed by the patient. The procedure for a gold determination was that the 
depth of the patient’s right kidney was first determined, in both a lateral and 
posterior direction, from an ultrasound scan with the patient in a seated 
position. The posterior position of the kidney was also marked on the skin of 
the patient at this stage. The patient was then seated in a high-backed chair 
and the source and detector adjusted such that their axes intersected at the
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centre of the patient’s kidney. The source to skin distance was always arranged 
such that the kidney diameter was just irradiated. A number of collimating 
plates were available, as described earlier, so that the source could be moved 
closer to the patient as it decayed in order to maintain the count rate. A 
spectrum was then recorded for 30 minutes on the multi-channel analyser. 
This spectrum was then analysed on a personal computer using the Marquadt 
non-linear least squares fitting algorithm to find the size of the fluorescence 
peaks in terms of counts (Appendix A). Measurements have now been 
completed on 12 patients, and the raw results are shown in table 9.2.1. The 
table gives the number of counts in the gold Kai peak found by the fitting 
program together with the uncertainty in this number of counts, an outline of 
the clinical history of the patient and the depth of the kidney. (The number of 
counts in the Ko2 peak would give no extra information, since the relative size 
of the Kai and Ka2 peaks was fixed in the fitting program.) It is clear that in 
order to convert number of counts in the fluorescence peak into a gold 
concentration in the kidney, a calibration factor is required. These calibration 
factors could be determined during phantom studies, with a kidney phantom 
placed at a similar position to that measured for the patient. However the 















1 2630 IV 36 36 2/92 859± 578
2 260 IV 31 40 9/80 NRF
3 6000 IV 47 32 8/90 1305± 891
4 6650 IV 71 64 - 2495±1335
5 1000 IV 20 21 10/90 NRF
6 4870 rv 62 60 - 559± 503
7 4500 IV 30 51 6/91 3941±1295
8 4290 IV 25 29 4/92 10326±1434
9 6320 rv 46 27 6/92 1955± 630
10 8000 IV 25 25 11/91 1381± 839
11 3750 IV 40 24 7/92 3336± 764
12 10480 IV 31 60 - 3158±1109
NRF - Peak fitting program unable to produce a  reliable fit 
Table 9.2.1 - Raw clinical results
136
number of experimentally determined sensitivities given in the last chapter.
Dining patient studies, it was noted that the count rate monitor attached to 
the pulse-shaping amplifier (part of the detection system electronics) 
sometimes recorded a higher count rate in the clinical measurement than 
during the equivalent phantom study. Experimental work was therefore 
carried out to establish whether this was due to the irregular shape of patients. 
In this experimented study, the large cuboidal body phantom (that had been 
used previously) was replaced by two different body phantoms in turn. The first 
was a large cylindrical tank of 300mm diameter and with vertical sides; the 
second was a bucket which had an upper diameter of 250mm and a lower 
diameter of 170mm, and height of 240mm. Therefore the bucket had sloping 
sides and it was not possible to push the detector collimator flush against the 
surface. The different body phantoms were placed in the middle of the clinical 
measurement system in the position where the patient would sit. A kidney 
phantom containing 500pg g'1 of gold was suspended in the body phantom, at a 
number of average depths. The 8° collimating plate was used with the le a f  in 
11 turns from the edge of the beam. A source to kidney phantom surface 
distance (SKD) of 200mm was always used. The source and detector positions 
were adjusted so that the field of view was aligned with the kidney phantom 
positions. Spectra were recorded over a period of 20 minutes.
The spectra recorded were then analysed using the peak fitting program 
(Appendix A) and the number of counts in the Kai peak together with the count 
rate measured at the pulse-shaping amplifier are given in table 9.2.2. Table 
9.2.2 also gives the results for a cuboidal body phantom (in a similar 
experimental arrangement to other body phantoms) taken from table 8.4.1. The 
results for the curved phantoms have been normalised to a source activity of 
24GBq to make them comparable with the results for the cuboidal phantom. 
The results clearly show that the number of counts in the Kai peak does not 
vaiy significantly between the studies, however the count rate recorded for the
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Lateral* Posterior* Depth / mm
Depth / mm 30 50 70
30 34652 (26) 15065 (19)
31724 (27) 16217(20)
35100 (31) 16200 (23)
50 26074 (22) 14751 (17) 8695 (11)
27145 (23) 13245 (17) 9130 (11)
27033 (27) 14194 (19) 8344(12)
70 16974 (17) 9362 (13) 6127 (8)
20470 (17) 10232 (12) 6041 (8)
21608 (22) 10030 (16) 6803 (9)
* Posterior depth: Depth from skin surface to kidney surface in the direction of the detector.
* Lateral depth: Depth from skin surface to kidney surface In the direction of the source.
Table 9.2.2 - Sensitivity variation with kidney position using a  24GBq source with an  Irradiation time of 20 
minutes. In terms of experimental K«i peak counts. Count rates In kilohertz for these experimental results 
are given in parentheses. (Cuboidal tank results are shown In plain text, cylindrical tank results are 
shown In italics, and bucket results are shown h condensed text)
bucket was usually higher than that recorded for the other phantoms.
The results of this study suggest that the higher count rate recorded in some of 
the patient measurements is due to the fact that the detector collimator was 
not pushed up right against the skin of the patient. The effects of a gap 
between the detector collimator and the patient's skin therefore need to be 
considered. This gap would cause the source to irradiate a small amount of 
tissue between the posterior kidney surface and the patient's skin. Thus an 
increased count rate would probably be observed. However it is unlikely that 
the gap would cause a reduction in the number of fluorescence counts recorded, 
since the whole kidney will still be irradiated, as illustrated in figure 9.2.1. 
Even if the side of the kidney furthest from the detector was not completely 
irradiated, it is unlikely to cause a large error in the number of fluorescence 
counts recorded due to the significant variation in sensitivity over the kidney 
volume found from the results of the Monte Carlo model (chapter 5).
It is concluded that the calibration factors derived from the table in the 
previous chapter are accurate, and for other kidney depths (found in practice) 
the Monte Carlo model can be used for interpolation. Therefore the
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Note: No air gap  here
(a)
(b)
Note: Air gap  here
Figure 9.2.1 - Illustration of that both (a) without an air gap  and (b) with a limited air gap  between the 
detector collimator and the patient the whole kidney is still irradiated due to the absence of the extra 








Cone. / pg g
1 24± 15 2 <42
3 31± 21 4 233±125
5 <15 6 60± 55
7 81± 26 8 119± 17
9 40± 13 10 17± 10
11 82± 19 12 84± 29
Table 9.2.3 - Gold concentrations in the right kidneys of chrysotherapy patients (Where no reliable fit 
could be made to the fluorescence peaks a  gold concentration less than the detection limit is
indicated)
concentration of gold remaining in the kidneys of the patients in table 9.2.1 are 
given in table 9.2.3. For the patients where no reliable fit (NRF) could be made 
by the fitting program, a value of gold concentration less than the detection 
limit of the measurement system is indicated in table 9.2.3. The calibration 
factors used were either obtained from a phantom study, or interpolated from 
existing phantom study results using the Monte Carlo program. The
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calibration factors were applied after the raw results had been corrected for the 
decay of the 153Gd source.
9.3 Uncertainties in Clinical Results
It is clear that the uncertainties returned by the peak fitting program are not 
the only source of uncertainty in a clinical measurement. Other sources of 
uncertainty will now be discussed in the following sections.
9.3.1 Uncertainties in kidney depth determination
The kidney depth determination is actually prone to some error. The depth 
required is from the kidney surface to the uncompressed skin. The problem is 
that in order to produce a scan, some pressure has to be applied to the 
ultrasound transducer. To try and minimise this error the pressure on the 
transducer was gradually released, until the picture on the scanner screen 
began to disappear, the picture was then captured and the ultrasound scanner 
software was used to make a depth determination. This problem of 
compressing the soft tissue between the kidney and the skin may lead to 
around 2mm error in the depth determination. The uncertainty that this error 
(in depth) will give in the gold concentration depends on the calibration factor, 
which in turn depends on the absolute position of the kidney. For a typical 
kidney depth of 50mm laterally and 30mm in the posterior direction, erroneous 
depth determinations of 48mm and 28mm respectively would give an error in 
the calibration factor of 6%. (A depth determination that is too small is most 
probable due to tissue compression.)
9.3.2 Uncertainties due to patient movement
Unlike an inanimate phantom, a patient is bound to move at least to some 
extent during a measurement. This movement is of two types, firstly the whole 
trunk of the patient can move and secondly the kidney of the patient will move 
due to respiration. The movement of the kidney due to respiration was limited 
(this could be seen on the ultrasound scan), and an average position was taken.
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Other movements of the patient had to be watched for, for example if the 
patient slouched, they were asked to sit up again. During the initial set up, 
care was taken to make sure that the detector collimator was pushed up 
against the patient's skin, the position of the patient could thus be easily 
checked from time to time during the measurement. Therefore the effects of 
patient movement were minimised, and it is thought that this type of error did 
not lead to significant errors in the final gold concentration.
9.3.3 Non-uniform distribution of gold in the kidney
It has been assumed all through the project that the distribution of gold in the 
kidney is uniform. However the results of Gottlieb et al (1972) suggest that 
higher concentrations of gold are to be found in the renal cortex (the outer layer 
of the kidney) than the medulla. It has already been shown by the Monte Carlo 
model, described in chapter 5, that the greatest proportion of the fluorescence 
signal comes from the part of the kidney nearest the surface. In fact, for a 
typical kidney, around 40% of the gold fluorescence comes from the 15mm 
closest to the detector. There is therefore a very significant contribution from 
other parts of the kidney, including the renal medulla. Hence the gold 
concentrations quoted in the results can only be seen as an average 
concentration, and as absolute values must be interpreted with some caution. 
However the values may be compared with each other, as relative values, with 
a good degree of confidence, as the proportion of signal from the cortex or 
medulla does not vary rapidly with kidney position.
9.4 Conclusions
The gold content of the kidney of a number of patients has now been 
determined successfully. The uncertainty in the concentration in the gold in the 
kidney is in most cases quite large, and the figure itself needs to be treated 
with some caution since a uniform gold distribution in the kidney is assumed. 
The range of gold concentrations found was also quite large, and perhaps 
reflects the wide range of clinical histories of the patients involved in the study.
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It is obvious that more data still needs to be collected before any clinical 
conclusions can be drawn, however it is possible to make a few observations on 
some apparent trends, which although are far from conclusive may be 
reinforced by further patient measurements.
In order to look for trends the gold concentration found in the clinical studies 
needs to be plotted against various parameters, such as total gold administered 
and time since cessation of gold therapy. The level of gold in the kidneys of 
patients just after the onset of proteinuria also needs to be compared. The plots 
of gold concentration in the kidney against total gold administered and time 
since cessation of therapy are shown in figures 9.4.1 and 9.4.2. We still have 
insufficient data on the level of gold in the kidney just after the onset of 
proteinuria to draw even a tentative conclusion, and still have not measured 
the gold concentration in any patients having oral gold therapy, so it is 
obviously impossible to make any observation concerning the differences 
between oral and intravenous therapy. Figure 9.4.1 shows that there appears 
to be no correlation between the total gold administered and the gold 

















Figure 9.4.1 - Plot of total gold administered against gold concentration found in the kidney
10000 12000
Total Gold Administered / mg
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Time since Therapy Ceased /  months
Figure 9.4.2 - Rot of time since cessation of therapy against gold concentration found in the kidney. 
(The figures next to the experimental points show the total amount of gold administered to the nearest
gram)
possible fall off in the amount of gold remaining in the kidney with time after 
therapy has ceased. The figure also shows the total gold administered (to the 
nearest gram) next to each experimental point.
In conclusion it is clear that a mobile measurement system that is capable of 
determining trace levels of gold in vivo has been constructed; and more clinical 
data needs to be collected before any definite conclusions can be drawn.
Chapter 10 
Conclusions and Further Work
O th er  uses for th e  gold measurement system
Now that the in vivo X-ray fluorescence system has been developed it could 
easily be adapted for the determination of other heavy metals in vivo. For 
metals of atomic number, Z, close to gold (Z=79), such as platinum (Z=78), 
mercury (Z=80) and lead (Z=82), it is likely that the system could be used with 
the same radiation source. However for lower atomic number metals, such as 
cadmium (Z=48), an alternative radiation source would have to be sought. It is 
possible that for cadmium determination 241Am could be used, since it is 
commercially available in high activities. However it may be that the lower 
energy fluorescence of cadmium (~23keV) may give the system insufficient 
sensitivity at large kidney depth. A feasibility study into an X-ray fluorescence 
system for cadmium using 241 Am as a radiation source could be carried out 
either experimentally or by adapting the Monte Carlo model.
P ossibilities for improving the  detection limit
The current lower detection limit of the X-ray fluorescence measurement 
system seems to governed by the count rate/energy throughput that can be 
handled by the germanium detector (chapter 8). However most of the radiation 
entering the detector is of no assistance to the X-ray fluorescence 
measurement. Therefore if this radiation could be prevented from entering the 
detector there would be no detriment to the measurement. In fact the removal 
of this radiation would increase the count rate of useful photons that could be 
handled by the detector, and may therefore improve the detection limit that 
can be achieved. It is possible that some of the surplus radiation could be 
prevented from entering the detector by placing a metal foil across the entrance 
to the detector. If a metal foil with a K edge of energy just above the 
fluorescence peaks of interest were used, it would act as a bandpass* filter, as 










Figure 10.1 - IBustration of Iridium K edge fitter for gold
iridium (Z=77). Iridium foil is very expensive (-£1000), and this experiment 
might not be affordable. An experiment that might be performed to evaluate 
the magnitude of the improvement in detection limit using this method is to 
look for iridium (Z=77) fluorescence from a phantom filled with iridium 
chloride, with and without a tungsten filter (Z=74), which is inexpensive. Using 
the method described above it is possible that an X-ray fluorescence system 
could be built which gives an improved detection limit.
Another method by which detection limits could be improved by up to around 
40% (section 8.2) is by the use of a partially polarized X-ray source (chapter 7). 
However the use of a partially polarized X-ray source would require a 150+kVp 
constant potential X-ray generator, and a dedicated room. The measurement 
system would then no longer be mobile. It is also unlikely that the extra 
expense incurred in building such a system could be justified.
C oncluding remarks
A mobile system that is capable of detecting trace levels of gold in vivo has 
been designed, constructed and evaluated. The construction of such a
145
measurement system was the primary aim of the project. The measurement 
system has been designed by consideration of the underlying physical 
principles involved. The success of the Monte Carlo model clearly demonstrates 
that all the relevant interactions of ionising radiation with matter have been 
understood. A number of different methods of excitation have been considered, 
including different radio-isotope sources, radio-pharmaceuticals (Shakeshaft et 
al, 1991), and X-ray sources. Of the possible radiation sources 153Gd was 
selected as the source best suited to local needs. The detection system has been 
optimised for the best detection limit with this radio-isotope source, by 
consideration of other parameters such as collimation. The early clinical results 
reported show that a wide range of gold concentrations can be found in the 
kidney following chrysotherapy. However more data still needs to be collected 
before any significant clinical conclusions can be drawn; although there are 
some indications that the amount of gold remaining in the kidney is not related 
to total dosage, and reduces with time.
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/ * Program for analysis of data from MCA
/ * Requires files in format the same as XXX.DAT files from Canberra
/* Packard Accuspec control software
/* Modified 22/10/90 Re-iterate on negative amplitude
/ * Modified 13/12/90 Guess from Alphal Height rather than Alpha 2
/* Modified 05/03/91 New resolution for new detector 
/* Re-Iterate on bad position for peaks
Major revision 04/03/92 Converted from EG&G file format to Canberra
format, and to Zortech C 
Modified 12/03/92 Read configuration from disk 
Modified 14/07/92 Improved date_decode routine 
Modified 15/07/92 Iteration of background first
This program must be linked with a double precision version of 
a library of the routines from Numerical Recipes in C - The art 
of scientific computing by Press WH et al (CUP)






^define TRUE -1 
^define FALSE 0
(/define FG_ALIGN_BL 0 
(/define FG_ALIGN_TL 1 
#define FG_ALIGN_BR 2 
//define FG_ALIGN_TR 3
//define CHANNELS 204 8 
//define MAX_CHN_FILE_LEN 9216 
//define N_PARMS 10 
//define N_BACK_FIT 35
//define SQRT_2PI 2.506628275 
//define TWICE_SQRT2 2.828427125 
//define SQRT2 1.414213562
i/include <math.h> /* ANSI standard */
i/include <stdio.h> /* ANSI standard * /
//include <stdlib.h> /* ANSI standard * /
(/include <disp.h> /* Header for display routines in Zortech c * /
j/include <fg.h> /* Header for graphics routines in Zortech c */
(/include <nr.h> /* Numerical recipes library header */
//include <nrutil.h> /* Numerical recipes utilities library header */
void lin__lin(double *, double * , double *, int, int, int);
int data_ fetch(char *,int *,double *,char *,char *,char *,char *, double
ouble *,double *,double *);
void double_peak(double,double *,double *,double *,int); 
float float_decode(char *);
Al
l o n g  i n t _ d e c o d e ( c h a r  * ) ;  
s h o r t  w o r d _ d e c o d e ( c h a r  * ) ;
v o i d  p a r m s _ d i s p l a y ( d o n b l e  * , d o u b l e  * * , i n t ) ;
v o i d  p e a k _ c o u n t ( i n t , i n t , d o u b l e  * , d o u b l e  * , d o u b l e  * , d o u b l e  * , d o u b l e  * ) ;  
v o i d  t e x t _ d i s p l a y ( c h a r  * , c h a r  * , c h a r  * , c h a r  * , c h a r  * , d o u b l e , d o u b l e , i n t ) ; 
v o i d  d a t e _ d e c o d e ( i n t ,  i n t  * ,  i n t  * ) ;
s t a t i c  d o u b l e  s q r a r g ;
/ *  I n c r e a s e  s t a c k  s i z e  f ro m  d e f a u l t  o f  2048 * /  
u n s i g n e d  _ s t a c k  = 32768;
v o i d  d a t e _ d e c o d e ( i n t  j u l i a n ,  i n t  *mm, i n t  * i d )
{
/ *  On e n t r y :  J u l i a n  c o n t a i n s  d a y  number 1 - 366 * /
/ *  On e x i t :  mm c o n t a i n s  t h e  m onth  * /
/ *  i d  c o n t a i n s  t h e  d a y  * /
s t a t i c  i n t  m o n th _ c u m l(13]  = { 0 ,  31 ,  6 0 ,  91 ,  121 ,  152 ,  18 2 ,  2 1 3 ,  2 4 4 ,  2 7 4 ,  305 ,  
3 3 5 ,  3 6 6 } ;  
i n t  i ;
i f  ( j u l i a n  > m o n th _ c u m l[ 1 2 ] )  n r e r r o r ( ' B a d  d a t e  i n  d a t e _ d e c o d e * ) ;  
i  = 0;
w h i l e  ( j u l i a n  > m o n t h _ c u m l [ i + l ] ) 
i+  + ;
* i d  = j u l i a n - m o n t h _ c u m l [ i } ;
*mm = i + 1 ;
}
v o i d  f g _ p u t s _ x ( f g _ c o l o r _ t  c o l o r ,  i n t  mode, i n t  m ask ,  i n t  r o t a t i o n ,  f g _ c o o r d _ t  x ,  f g  
c o o r d _ t  y ,  c h a r  * o u t _ s t r i n g ,  f g _ p b o x _ t  c l i p ,  i n t  a l i g n )
{
f g _ c o o r d _ t  s x ,  s y ,  n x ,  n y ;  
s x  = 0 ,  s y  s 0;
f g _ a d j u s t x y ( r o t a t i o n ,  s t r l e n ( o u t _ s t r i n g ) , &sx, &sy, f g _ c h a r b o x ) ; 
nx = x ,  ny  = y ;  
s w i t c h  ( a l i g n )  { 
c a s e  FG_ALIGN_BL: 
s w i t c h  ( r o t a t i o n )  { 
c a s e  FG_ROT90:
nx += f g _ c h a r b o x [ FG_X2] ;  
b r e a k ;  
c a s e  FG_ROT180: 
nx -= SX;
ny ♦= f g _ c h a r b o x [ F G _ Y 2 ] ; 
b r e a k ;  
c a s e  PG_ROT270: 
ny += s y ; 
b r e a k ;
}
b r e a k ;  
c a s e  FG_ALIGN_TL: 
s w i t c h  ( r o t a t i o n )  { 
c a s e  FG_ROT0:
n y  -= fg _ c h a rb o x [F G _ Y 2 ] ;  
b r e a k ;  
c a s e  FG_ROT90:
nx ♦= fg _ c h ax b o x [F G _ X 2 ] ;  
ny -= s y ;  
b r e a k ;  
c a s e  FG_ROT180: 
nx -= s x ;  
b r e a k ;
}
b r e a k ;  
c a s e  FG_ALIGN_BR: 
s w i t c h  ( r o t a t i o n )  { 
c a s e  FG ROTO:
A2
n x  - =  S X ;  
b r e a k ;  
c a s e  FG_ROT180:
ny ♦= f g _ c h a r b o x [ FG_Y2 J ; 
b r e a k ;  
c a s e  FG_ROT270:
nx -= f g _ c h a r b o x [ FG_X2] ;
ny += s y ;
b r e a k ;
}
b r e a k ;  
c a s e  FG_ALIGN_TR s 
s w i t c h  ( r o t a t i o n )  { 
c a s e  FG_ROTO: 
nx -= S X ;
ny -= f g _ c h a r b o x [ F G _ Y 2 ] ; 
b r e a k ;  
c a s e  FG_ROT90: 
ny - = s y ;  
b r e a k ;  
c a s e  FG_R0T270:
nx -= f g _ c h a r b o x [ F G _ X 2 ] ; 
b r e a k ;
}
b r e a k ;
}
f g _ p u t s ( c o l o r ,  mode, m ask ,  r o t a t i o n ,  n x ,  n y ,  o u t _ s t r i n g ,  c l i p ) ;
}
v o i d  l i n _ l i n ( d o u b l e  * x , d o u b l e  * y l ,  d o u b l e  * y 2 ,  i n t  n p t s ,  i n t  r o i l , i n t  r o i 2 )
{
d o u b l e  x _ s c a l e ,  y _ s c a l e ,  y_max, y_m in ;  
i n t  i ;
f g _ c o o r d _ t  x s ,  y s ,  x l l ,  y l l ;  
f g _ b o x _ t  b o x _ c o o r d ;  
f g _ l i n e _ t  l i n e _ c o o r d ;  
c h a r  t e m p _ c h ,  * t e m p b u f ;
/*  F r e e  s p a c e  f o r  t e m p o r a r y  s t r i n g  b u f f e r  * /  
t e m p b u f = ( c h a r  * ) m a l l o c ( 8 0 * s i z e o f ( c h a r ) ) ;
i f  ( I t e m p b u f )  n r e r r o r ( ' a l l o c a t i o n  f a i l u r e  i n  l i n _ l i n ( ) * ) ;
/ *  S e t  up v a r i a b l e s  * /
y _ m in = l . 0E38;
y _ m a x - - 1 . 0 E 38 ;
f o r  ( i = l ;  i < = n p t s ;  i t - - )  {
i f  ( y l [ i ] <y_min) y _ m i n = y l [ i ] ; 
i f  ( y 2 [ i ] <y_min) y _ m i n = y 2 [ i ] ;  
i f  ( y l [ i ] >y_max) y _ m a x = y l [ i ] ; 
i f  ( y 2 ( i ] >y_max) y_m ax=y2( i ] ;
}
/ *  S e l e c t  g r a p h i c s  mode * /  
f g _ i n i t ( ) ;
x s  = ( f g _ c o o r d _ t ) ( ( ( l o n g ) ( f g _ d i s p l a y b o x ( F G _ X 2 ] - f g _ d i s p l a y b o x ( F G _ X l ] ) * 8 0 L ) / 1 0 0 L ) ; 
y s  = ( f g _ c o o r d _ t ) ( ( ( l o n g ) ( f g _ d i s p l a y b o x [ F G _ Y 2 ] - f g _ d i s p l a y b o x ( FG_Y1] ) * 6 8 L ) / 1 0 0 L ) ; 
x _ s c a l e = ( d o u b l e ) ( x s ) / ( r o i 2 - r o i l ) ; 
y _ s c a l e = ( d o u b l e ) ( y s ) / ( y _ m a x -y _ m in ) ;
/ *  Axes l o w e r  l e f t  * /
x l l  = f g _ d i s p l a y b o x [ F G _ X l ] + ( 1 0 * ( f g _ d i s p l a y b o x [ F G _ X 2 ] - f g _ d i s p l a y b o x [ F G _ X l ) ) ) / 1 0 0 ;  
y l l  = f g _ d i s p l a y b o x [ F G _ Y l ] + ( 1 6 * ( f g _ d i s p l a y b o x [ F G _ Y 2 ] - f g _ d i s p l a y b o x [ F G _ Y 1 ] ) ) / 1 0 0 ;  
/ *  Now d raw  a x e s  * /  
s p r i n t f ( t e m p b u f , y _ m in ) ;
fg_puts_x(FG _W H ITE, FG_MODE_SET, *0, FG_ROTO, x l l - 1 ,  y l l ,  t e m p b u f ,  f g _ d i s p l a y b o x  
, FG_ALIGN_BR);
s p r i n t f ( t e m p b u f , * % . l f ' ,  y _ m ax ) ;
fg_puts_x(FG _W H ITE, FG_MODE_SET, ‘ 0 ,  FG_ROTO, x l l - 1 ,  y l l + y s ,  t e m p b u f ,  f g _ d i s p l a y  
b o x ,  FG_ALIGN_TR);
s p r i n t f ( t e m p b u f , * % . l f ' ,  x ( r o i l ] ) ;
fg_puts_x(FG _W H I TE, FG_MODE_SET, *0, FG_ROTO, x l l ,  y l l - 1 ,  t e m p b u f ,  f g _ d i s p l a y b o x  
, FG_ALIGN_TL);
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s p r i n t f ( t e m p b u f , ' % . l f ' ,  x ( r o i 2 J ) ;
fg_puts_x(FG _W H ITE, FG_MODE_SET, *0, FG_ROTO, x l l + x s ,  y l l - 1 ,  t e m p b u f ,  f g _ d i s p l a y  
b o x ,  FG_ALIGN_TR);
b o x _ c o o rd [F G _ X l]  = x l l ,  b o x _ c o o rd { F G _ Y l] = y l l ;  
b o x _ c o o rd (F G _ X 2 ] = x l l + x s ,  b o x _ c o o r d [ FG_Y2] = y l l + y s ;
fg_drawbox(FG_CYAN, FG_MODE_SET, *0, FG_LINE_SOLID, b o x _ c o o r d ,  f g _ d i s p l a y b o x ) ;
/ ♦  Now p l o t  d a t a  ♦ /
l in e _ c o o r d ( F G _ X l ]  = x l l ,  l i n e _ c o o r d [ F G _ Y l ] = y l l +  ( ( y l  [ r o i l  ] -y_m in)  ♦ y _ s c a l e ) ; 
f o r  ( i = r o i l + l ; i < = r o i 2 ; i + + )  {
l i n a _ c o o r d [ F G _ X 2 ] = x l l + ( i * r o i l ) * x _ s c a l e ,  l i n e _ c o o r d [ F G _ Y 2 ] = y l l + ( ( y l ( i ] - y _  
m i n ) ♦ y _ s c a l e ) ;
fg _ d raw lin e (F G _ B L U E , FG_MODE_SET, ' 0 ,  FG_LINE_SOLID, l i n e _ c o o r d ) ; 
l i n e _ c o o r d [ F G _ X l ]  = l i n e _ c o o r d [ F G _ X 2 ] ,  l i n e _ c o o r d [ F G _ Y l ] = l i n e _ c o o r d [ F G _ Y 2 ]
}
f o r  ( i = r o i l ; i < = r o i 2 ; i + + )
fg_drawdot(FG_GREEN, FG_MODE_SET, ' 0 ,  x l l + ( i - r o i l ) ♦ x _ s c a l e , y l l + ( ( y 2 [ i ] - y _ m i  
n ) * y _ s c a l e ) ) ;
fg_puts(FG _W H ITE, FG_MODE_SET, *0, FG_ROT0, 0 ,  0 ,  ' P l e a s e  p r e s s  SPACE BAR t o  c o n  
t i n u e . * ,  f g _ d i s p l a y b o x ) ; 
do  {
t e m p _ c h = g e t c h ( ) ;
} w h i l e  ( t e m p _ c h  != ' ' ) ;  
f g _ t e r m ( ) ;  
f r e e ( t e m p b u f ) ;
}
/ ♦ S e r v i c e  r o u t i n e  f o r  r e a d _ c o n f i g  - r e a d s  a n  i t e m  f ro m  f i l e  * /
/*========================================================= * /
i n t  r e a d _ i t e m ( d o u b l e  * p ,  FILE * f p ,  i n t  p a rm _num ber)
{
i n t  n _ i t e m s ;
n _ i t e m s  = f s c a n f ( f p ,  ' % l f ' ,  p ) ; 
i f  ( n _ i t e m s  != 1) {
f p r i n t f ( s t d e r r ,  ' E r r o r  i n  r e a d i n g  p a r a m e t e r  %d f ro m  c o n f i g u r a t i o n  f i l e \ n ' ,  p  
a r m _ n u m b e r ) ;
} e l s e
r e t u r n  FALSE;
}
/ ♦ R o u t i n e  t o  e x t r a c t  c o n f i g u r a t i o n  f ro m  d i s k  ♦ /  
/*===========================================*/
i n t  r e a d _ c o n f i g ( d o u b l e  ^ p l ,  d o u b l e  ♦p2,  d o u b l e  ♦pS, d o u b l e  ^ p 4 ,  d o u b l e  ♦pS ,  i n t  ♦ i t e  
r ,  i n t  l i s t [ ] )
{
FILE ♦ f p ;
i n t  i ,  n _ i t e r n s ;
i f  ( ( f p  = f o p e n ( 'A N A L Y S E . C F G ' , ' r ' ) ) == NULL) 
r e t u r n  FALSE; 
i f  ( r e a d _ i t e m ( p l ,  f p ,  1 ) )  r e t u r n  FALSE;
i f  ( r e a d _ i t e m ( p 2 ,  f p ,  2 ) )  r e t u r n  FALSE;
i f  ( r e a d _ i t e m ( p 3 ,  f p ,  3 ) )  r e t u r n  FALSE;
i f  ( r e a d _ i t e m ( p 4 , f p ,  4 ) )  r e t u r n  FALSE;
i f  ( r e a d _ i t e m ( p 5 ,  f p ,  5 ) )  r e t u r n  FALSE;
n _ i t e m s  = f s c a n f ( f p , ' t d ' ,  i t e r ) ;  
i f  ( n _ i t e m s  1= 1) {
f p r i n t f ( s t d e r r ,  ' E r r o r  i n  r e a d i n g  num ber o f  p a r a m e t e r s  t o  i t e r a t e  f r o m  c o n f i  
g u r a t i o n  f i l e \ n ' ) ;
r e t u r n  FALSE;
}
f o r  ( i = l ;  i<=N_PARMS; i+ + )  {
n _ i t e m s  = f s c a n f ( f p ,  '% d ' ,  & l i s t [ i ] ) ;  
i f  ( n _ i te r n s  != 1) {
f p r i n t f ( s t d e r r ,  ' E r r o r  i n  r e a d i n g  l i s t  i t e m  %d f r o m  c o n f i g u r a t i o n  f i l e \ n
i ) ;




f c l o s e ( f p )  ; 
r e t u r n  TRUE;
/ ♦ R o u t i n e  t o  e x t r a c t  d a t a  f ro m  DATA f i l e  o n  d i s k  * /  
/*===============================================*/
i n t  d a t a _ f e t c h ( c h a r  * f i l e ,  i n t  * n o f c h a n s ,  d o u b l e  c h a n _ d a t a [ ] ,  c h a r  d e s c ] ] ,  c h a r  d e t e  
c t [ ] ,  c h a r  d a t e ] ] ,  c h a r  t i m e [ ] ,  d o u b l e  * l i v e _ t i m e ,  d o u b l e  * r e a l _ t i m e ,  d o u b l e  * c a l _ q u  
a d ,  d o u b l e  * c a l _ s l o p e ,  d o u b l e  * c a l _ i n t )
{
FILE * f i l e p ;
c h a r  b u f f e r [ MAX_CHN_FILE_LEN] ;  
i n t  n o r e a d ,  hh ,  mm, y y ,  s s ,  i ;  
l o n g  11 ;
i f  ( ( f i l e p  = f o p e n ( f i l e , ' r b ' ) )== NULL) { 
d i s p _ p r i n t f ( ' F i l e  n o t  f o u n d \ n ' ) ;  
r e t u r n  NULL;
}
n o r e a d  = f r e a d ( & b u f f e r [ 0 ] ,  s i z e o f ( b u f f e r [ 0 ] ) ,  MAX_CHN_FILE_LEN, f i l e p ) ;  
d i s p _ p r i n t f ( '%d b y t e s  r e a d  f ro m  f i l e . \ n * , n o r e a d ) ; 
i f  ( ( ( i n t ) b u f f e r ( O ] 1=0x00) | |  ( ( i n t ) b u f f e r [ 0 ) 1= 0x00))  { 
d i s p _ p r i n t f ( ' T h i s  i s  n o t  a  A c cu s p e c  d a t a  f i l e ' ) ;  
r e t u r n  NULL;
}
/ *  S e t  up  t im e  * /
11 = i n t _ d e c o d e ( & b u f f e r [ 8 4 ] ) ;
hh  = ( i n t ) ( 1 1 / 3 6 0 0 L ) , 1 1 -=  ( l o n g ) ( h h ) * 3 6 0 0 L ;
mm = ( i n t ) ( 1 1 / 6 0 L ) , 1 1 -=  ( lo n g ) (m m )* 6 0 L ;
s s  = ( i n t ) ( 1 1 ) ;
t i m e [0]  = ( h h / 1 0 )  1 0 x 3 0 ;
t i m e (1]  = (hh%10) | 0x 3 0 ;
t i m e {2) = ' : ' ;
t i m e (3]  = (mm/10) 1 0x 3 0 ;
t i m e [ 4 ]  =.(mm%10) | 0 x 3 0 ;
t i m e [5]  = ' s ' ;
t i m e [6]  = ( s s / 1 0 )  | 0 x 3 0 ;
t i m e ] 7] = (ss%10) | 0 x 3 0 ;
t i m e [8] = ( c h a r ) ( 0 ) ;
/ *  S e t  up  d a t e  * /
d a t e _ d e c o d e ( w o r d _ d e c o d e ( & b u f f e r [ 8 0 ] ) ,  &mm, S h h ) ;
d a t e [0] = ( h h / 1 0 )  | 0x 3 0 ;
d a t e [1] = ( hh%10) | 0 x 3 0 ;
d a t e [2] = ' / ' ;
d a t e ] 3] = (mm/10) | 0 x 3 0 ;
d a t e [ 4 ]  = (mm%10) | 0x 3 0 ;
d a t e [5] = ' / ' ;
yy  = ( i n t ) ( w o r d _ d e c o d e ( & b u f f e r [ 8 2 ] ) ) ;
yy  %= 1 0 0 ;  / *  Make t h e  y e a r  tw o  d i g i t s  o n l y  * /
d a t e ] 6] = ( y y /1 0 )  | 0 x 3 0 ;
d a t e ] 7] = (yy%10) I 0 x 3 0 ;
d a t e ] 8] = ( c h a r ) ( 0 ) ;
♦ n o f c h a n s  = ( i n t ) ( w o r d _ d e c o d e ( & b u f f e r ( 3 6 ] ) ) ;  
i f  (*nofchans>CHANNELS) * n o f c h a n s  = CHANNELS;
* l i v e _ t i m e  = i n t _ d e c o d e ( & b u f f e r ] 4 8 ] ) + ( d o u b l e ) ( w o r d _ d e c o d e ( & b u f f e r [ 2 0 ] ) ) / 1 0 0 . 0 ;  
* r e a l _ t i m e  = i n t _ d e c o d e ( & b u f f e r [ 5 6 ] ) + ( d o u b l e ) ( w o r d _ d e c o d e ( & b u f f e r [ 2 2 ] ) ) / 1 0 0 . 0 ;  
* c a l _ q u a d  = ( d o u b l e ) f l o a t _ d e c o d e ( & b u f f e r ] 1 1 6 ] ) ;
♦ c a l _ s l o p e  = ( d o u b l e ) f l o a t _ d e c o d e ( & b u f f e r ] 1 1 2 ] ) ;
* c a l _ i n t  = ( d o u b l e ) f l o a t _ d e c o d e ( & b u f f e r [ 1 0 8 ] ) ;
/ *  Copy d e t e c t o r  d e s c r i p t i o n  * /  
f o r  ( i = 0 ; i < 1 5 ; i + + )
d e t e c t ] i ]  = b u f f e r [ 4 7 6 + i ] ;  
d e t e c t ] 15] = ( c h a r ) O ;
/ *  Copy saunple d e s c r i p t i o n  * /  
f o r  ( i = 0 ; i < 6 3 ; i + + )
d e s c [ i ]  = b u f f e r ] 3 3 2 + i ] ; 
d e s c ] 6 3 ]  = (ch cu :)0 ;
/ *  D ecode  t h e  a c t u a l  c h a n n e l  d a t a  * /
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f o r  ( i = l ; i < = * n o f c h a n s ; i + + )
c h a n _ d a t a ( i ] = ( d o u b l e ) ( i n t _ d e c o d e ( & b u f f e r [ 1 0 2 0 + 1 * 4 ] ) ) ;  
i f  ( f c l o s e ( f i l e p )  != NULL) d i s p _ p r i n t f ( 'U n a b l e  t o  c l o s e  f i l e ! * ) ;  
r e t u r n  -1 ;
}
v o i d  d o u b l e _ p e a k ( d o u b l e  x ,  d o u b l e  a [ ] ,  d o u b l e  * y ,  d o u b l e  d y d a [ ] ,  
i n t  na)
{
/ *  Fn i s  a l * ( e x p ( ( ( ( x - a 2 ) / a 3 ) * 2 ) / 2 ) + a 6 * e r f c ( ( x - a 2 ) / s q r t 2 / a 3 ) ) * /
/ *  + a 4 * a l* e x p (  ( ( (x* (a 2 + a 5 )  ) / a 3 )  *2) + a 6 * e r f c (  ( x -  (a 2 + a 5 )  ) / s q r t 2 / a 3 ) ) * /
/ *  + a 7 + a8 * x + a 9 * x ‘ 2 + a l0 * x * 3  * /
d o u b l e  e l , e 2 , e x l , e x 2 , e f l , e f 2 ;
i f  ( n a  != 10) n r e r r o r ( ' I n v a l i d  number o f  a r g s  i n  DOUBLE_PEAK*) ;  
e x l - - ( x - a [ 2 ] ) * ( x - a [ 2 ] ) / a [ 3 ] / a [ 3 ] / 2 . 0 ;  
ex2= - ( x - ( a [ 2 ) + a [ 5 ] ) ) * ( x - ( a [ 2 ] + a [ 5 ] ) ) / a [ 3 ] / a [ 3 ] / 2 . 0 ;  
e l = a ( l ] * e x p ( e x l ) ; 
e 2 = a [ 4 ] * a [ 1 ] * e x p ( e x 2 ) ;
e f l = a ( 1 ] * a ( 6 J * e r f c c ( ( x - a [ 2 ] ) /S Q R T 2 /a (3 ] ) ;  
e f 2 = a ( l ] * a [ 4 ] * a ( 6 ] * e r f c c ( ( x - ( a [ 2 ] + a [ 5 J ) ) /S Q R T 2 /a [ 3 ] ) ;
* y = e l+ e 2 + a [ 7 ]  +a[ 8] *x--a[ 9] *x*x+a(  10] * x * x * x + e f  l + e f 2 ;  
d y d a [ 1 ] = ( e l + e 2 + e f 1 + e f 2 ) / a [ 1 ] ;
d y d a [ 2 ) = ( ( x - a [ 2 ] ) / a [ 3 ] - 2 * a ( 6 ] / S Q R T _ 2 P I ) / a [ 3 ] * e l + ( ( x - ( a ( 2 ] + a [ 5 1 ) ) / a [ 3 ] - 2 * a l6 ] / S Q R  
T _ 2 P I ) / a [ 3 ] * e 2 ;
d y d a [ 3 ] = ( ( x - a [ 2 ] ) / a [ 3 ] + 2 * a [ 6 ] /S Q R T _ 2 P I)* ( x * a [ 2 ] ) / a ( 3 ] / a [ 3 ) * e l + ( ( x - ( a ( 2 ] + a [ 5 ] ) ) / a  
[ 3 ] + 2 * a ( 6 ] / S Q R T _ 2 P I ) * ( x - ( a ( 2 ] + a [ 5 ] ) ) / a ( 3 ) / a ( 3 ] * e 2 ; 
i f  ( a [ 4 ] = = 0 . 0 )  
d y d a (4 ]=  0 . 0 ;
e l s e
d y d a [ 4 ] = ( e 2 + e f 2 ) / a [ 4 ] ; 
d y d a [ 5 J = ( ( x . ( a [ 2 ] +a [ 5 ] ) ) / a [ 3 1 - 2 * a [ 6 ] / S Q R T _ 2 P I ) / a [ 3 ] * e 2 ;  
d y d a [ 6 ) = ( e f l + e f 2 ) / a [ € ] ; 
d y d a ( 7 ] = 1 . 0 ;  
d y d a [ 8 ] = x ; 
d y d a [ 9 ] = x * x ;  
d y d a [ 1 0 ] = x*x*x ;
}
l o n g  i n t _ d e c o d e ( c h a r  * c o ce d )
{
u n s i g n e d  s h o r t  *w ord ;  
l o n g  d e c o d e d ,  h ig h _ w c r d ;
w o rd  = ( u n s i g n e d  s h o r t  * ) c o d e d ;  
d e c o d e d  = ( l o n g ) w o r d } 1 ] ;  
d e c o d e d  |=  ( ( l o n g ) w o r d [ 0 ] )< <16 ;  
r e t u r n  d e c o d e d ;
}
s h o r t  w o r d _ d e c o d e ( c h a r  *co d ed )
{
s h o r t  *w ord ;
w ord  = ( s h o r t  * ) c o d e d ;  
r e t u r n  w o r d ( 0 ) ;
}
f l o a t  f l o a t _ d e c o d e ( c h a r  ’ c o d e d )
{
/ *  T h i s  i s  o n l y  c o r r e c t  i f  c o m p i l e r  u s e s  IEEE f l o a t s  * /  
f l o a t  d e c o d e d ;  
c h a r  * c o d e d _ c o p y ;  
i n t  j ;
s h o r t  * i ,  i e x p ,  i tm p ;
c o d e d _ c o p y  = ( c h a r  * ;& d e c o d e d ;  
f o r  ( j  = 0 ;  j <4; j  + + )
A6
coded_copy[ j ] = cod ed [ j ];
i  = ( s h o r t  * ) c o d e d _ c o p y ;
i f  ( i [0] = = 0)
i [ D = 0;
e l s e  {
i e x p = i [ 0 ]  & 0 x 7 f 80
i e x p -= 2 56;
i [ 0 ] &= 0 x f f f f 8 0 7 f ;
i [ 0 ] 1= i e x p ;
i tm p = i l l ) ;
i l l ] = i  10 J ;
i [ 0 ] = i tm p ;
}
r e t u r n  d e c o d e d ;
v o i d  p a r m a _ d i a p l a y ( d o u b l e  p a r m s [ ] ,  d o u b l e  " c o v a r ,  i n t  e r r o r _ d i s p l a y )
{
d i s p _ m o v e ( 1 3 , 0 ) ;  
d i s p _ s e ta t t r (D IS P _ N O R M A L ) ; 
d i a p _ _ p r i n t f  ( ' P a r a m e t e r s : \ n ' ) ; 
i f  ( e r r o r _ d i s p l a y )  {
d i s p _ p r i n t f ( 'K  a l p h a  1 :  P o s . :  % 7 .2 f  (% 6 .2 f )  k e V \ n ' , ( p a r m s ( 2 ] + p a r m s ( 5 ] ) , s q r t ( c
o v a r ( 2 ] ( 2 ] + c o v a r [ 5 ] ( 5 ] ) ) ;
d i s p _ p r i n t f ( '  W id th ;  \ 1 . 1 1  (% 6 .2 f )  k e V \ n ' , p a r m s [ 3 ) , s q r t ( c o v a r { 3 ] ( 3 ] )
) ;
d i s p j p r i n t f ( '  Amp.: % 7 .2 f  ( %6. 2 f ) ( p a r m s { 1 J ' p a r m s [ 4 ] ) , s q r t ( c o v a r [1
] [ 1 ) / p a r m s [ 1 ] / p a r m s ( 1 ] + c o v a r ( 4 1 ( 4 ] / p a r m s ( 4 ] / p a r m s [4 J ) ' p a r m s [ 1 J * p a rm s  14 ] ) ;  
d i s p _ m o v e ( 1 4 , 4 2 ) ;
d i s p _ p r i n t f ( 'K  a l p h a  2 ;  P o s . ;  XI . 1 1  (% 6 .2 f )  k e V \ n ' , p a r m s [ 2 ] , s q r t ( c o v a r [ 2 ] [ 2 ] )
)
d i s p _ m o v e ( 1 5 , 4 2 ) ;
d i s p _ p r i n t f ( '  W id th :  %7.2£ (% 6 .2 f )  k e V \ n ' , p a r m s ( 3 ] , s q r t ( c o v a r [ 3 ] [ 3 ] )
d i s p _ m o v e ( 1 6 , 4 2 ) ;
d i s p _ p r i n t f ( '  Amp.: % 7 .2 f  ( %6. 2 f ) \ n ' , p a r m s [ 1 ] , s q r t ( c o v a r ( 1 ] ( 1 ] ) ) ;
d i s p _ p r i n t f ( 'P e a k  s h e l f  h t .  : % 7 .2 f  (% 6 .2 f )  % % \n ' , ( p a r m s [ 6 J* 1 0 0 ) , s q r t ( c o v a r [6
] I 6 ] ) * 1 0 0 ) ;
d i s p _ p r i n t f ( ' B a c k g r o u n d :  % .2 f  %+.2fE %+.2fE*2 % +.2fE*3  \ n ' , p a r m s ( 7 ] , p a
r m s [ 8 ] , p a r m s [ 9 ] , p a r m s ( 1 0 ] ) ;
} e l s e  {
d i s p _ p r i n t f ( 'K  a l p h a  1: P o s . :  % 7.2f  k e V \ n ' , ( p a r m s [ 2 ] + p a r m s [ 5 ] ) ) ;
d i s p _ p r i n t f ( '  W id th :  % 7.2f  k e V \ n ' , p a r m s ( 3 ] ) ;
d i s p _ p r i n t f ( '  Amp.: %7. 2 f ' , ( p a r m s ( 1 ] ' p a r m s ( 4 ] ) ) ;
d i s p _ m o v e ( 1 4 , 4 2 ) ;
d i s p _ p r i n t f ( 'K  a l p h a  2 :  P o s . :  % 7 .2 f  k e V \ n ' , p a r m s [ 2 ] ) ;
d i s p _ m o v e ( 1 5 , 4 2 ) ;
d i s p _ p r i n t f ( '  W id th :  % 7 .2 f  k e V \ n ' , p a r m s ( 3 ] ) ;
d i s p _ m o v e ( 1 6 , 4 2 ) ;
d i s p _ p r i n t f ( '  Amp.: % 7 . 2 f \ n ' , p a r m s [ 1 ] ) ;
d i s p _ j p r i n t f  ( ' P e a k  s h e l f  h t .  : % 7 .2 f  % % \n ' , ( p a rm s  (6 ] * 1 0 0 ) )  ;
d i s p _ p r i n t f ( 'B a c k g r o u n d :  % .2 f  %+.2fE % +.2fE*2 % +.2fE*3  \ n ' , p a r m s (7]
, p a r m s [ 8 ] , p a r m s ( 9 ] , p a r m s [ 1 0 ] ) ;
}
d i s p _ f l u s h ( ) ;
}
v o i d  p e a k _ c o u n t ( i n t  mean, i n t  e x t e n t ,  d o u b l e  x [ ] ,  d o u b l e  r o i _ d a t a [ ] ,  d o u b l e  p a r m s [ ] ,  
d o u b l e  * p e a k ,  d o u b l e  ' b a c k )
{
i n t  i ;
d o u b l e  b tem p ;
* p e a k = 0 . 0 ;
* b a c k = 0 . 0 ;
f o r  ( i= m e a n -e x te n t ; i< = m ea n -* -ex te n t ; i ' i - - i - )  {
b tem p z p a rm s  (7 ] f p a rm s  [ 8 ] *x [ i  ] t p a r m s  [ 9 ] *x [ i  ] *x ( i  ] + pair ms [ 10 ] *x [ i  ] *x ( i  ] *x [ i  ] ; 
* p e a k + = r o i _ d a t a [ i ] -b te m p ;




v o i d  t e x t _ d i s p l a y ( c h a r  ‘ f i l e n a m e ,  c h a r  ‘ s a m p le ,  c h a r  ‘ d e t e c t o r ,  c h a r  ‘ d a t e ,  chau: * t i  
me, d o u b l e  l i v e _ t i m e ,  d o u b l e  r e a l _ t i m e ,  i n t  n o f c h a n s )
{
d i s p _ m o v e ( 0 , 0 ) ;  
d i s p _ e e o p ( ) ;
d isp _ se ta t t r (D IS P _ N O R M A L  | DISP_INTENSITY); 
d i s p _ p r i n t f ( ' D a t a  a n a l y s i s  p r o g r a m . \ n ' ) ;  
d i s p _ p r i n t f ( '= == == = == == = = = = = = = = = = = = \n \n ') ;
d is p _ s e ta t t r ( D I S P _ N O R M A L ) ;
d i s p _ p r i n t f ( ' F i l e :  t s \ n S a m p l e :  % s \ n D e t e c t o r : % s \ n \ n ' ,  f i l e n a m e ,  s a m p le ,  d e t e c t o r
>;
d i s p _ p r i n t f ( 'R e c o r d e d  on  %s a t  % s . \ n ' ,  d a t e ,  t i m e ) ;  
d i s p _ p r i n t f ( ' C h a n n e l s :  1 t o  % d \ n \ n ' ,  n o f c h a n s ) ;
d i s p _ p r i n t f { ' L i v e  T ime: % .21f  s e c s . \ n ' ,  l i v e _ t i m e ) ;  
d i s p j p r i n t f ( ' R e a l  T ime: % .21f  s e c s . \ n \ n ' ,  r e a l _ t i m e ) ;
}
i n t  m a i n ( i n t  a irg c ,  c h a r  * a r g v [ ) )
{
/ *  V a r i a b l e s  r e a d  i n  f ro m  f i l e  /  u s e d  i n  i n i t i a l i s a t i o n  * /
i n t  n o f c h a n s ;
d o u b l e  * x ,  * c h a n _ d a t a ;
d o u b l e  c a l i b _ q u a d ,  c a l i b _ s l o p e ,  c a l i b _ i n t ,  l i v e _ t i m e ,  r e a l _ t i m e ;  
s t a t i c  c h a r  t im e  [ 9 ] ,  d a t e  [ 9 ] ,  d e s c  [ 64 ] ,  d e t e c t  (16  ] ;
/ *  V a r i a b l e s  u s e d  s o l e l y  by  M a rq u a d t  f i t t i n g  r o u t i n e  * /  
s t a t i c  i n t  l i s t_ p a rm s[N _ P A R M S + 1 ] ;  
s t a t i c  d o u b l e  parms[N_PARMS+1] ,  dummy[N_PARMS+l); 
d o u b l e  “ c o v a r , “ a l p h a ;
d o u b l e  * r a w _ d a t a ,  ‘ m o d e l _ d a t a ,  * x _ b a c k ,  ‘ s ig m a ;  
d o u b l e  a l a m d a , c h i s q , o l d _ c h i s q , d e l t a _ c h i s q ;
/ *  V a r i a b l e s  u s e d  t o  d e n o t e  r e g i o n  o f  i n t e r e s t  * /  
i n t  r o i l , r o i 2 , n p t s _ r o i , r o i _ o f f s e t ;
/ *  Loop o r  t e m p o r a r y  v a r i a b l e s  * /  
i n t  i , r e s u l t , i t e r a t i o n = l ;  
c h a r  tem p _ c h ;
d o u b l e  d l , d 2 , d 3 , d 4 , d 5 , q l , q r , e , f , g , h , d e l t a _ x ;
/ *  V a r i a b l e s  u s e d  i n  a r e a  c a l c u l a t i o n s  * /
d o u b l e  a r e a _ K a 2 , a r e a _ K a l , b a ck _ K a 2 , b a c k _ K a l , d e l t a _ a r e a 2 , d e l t a _ a r e a l ; 
d o u b l e  a r e a _ K a 2 F , a r e a _ K a l F ;  
i n t  m e a n , e x t e n t ;
/ *  C o n f i g u r a t i o n  p a r a m e t e r s  * /
d o u b l e  a l p h a 2 _ e n e r g y ,  p e a k _ e _ d i f f ,  r e l _ p e a k _ h e i g h t ;  
d o u b l e  d e t e c t o r _ r e s o l n ,  s h e l f _ h e i g h t ,  a l p h a l _ e n e r g y ;  
i n t  i t e r j p a r m s ;
/ ‘  L i s t  o f  p a r a m e t e r s  t o  i t e r a t e  w i t h  b a c k g r o u n d  ‘ /
s t a t i c  i n t  l i s t _ b a c k ( 11] = { - 1 ,  7, 8 ,  9 ,  10 ,  1 ,  2 ,  3,  4 ,  5 ,  6};
/ *  G r a p h i c s  s y s t e m  v a r i a b l e s  * /  
i n t  g e r r o r ;
/ *  D e c l a r e  s p a c e  t o  p u t  d a t a  f ro m  MCA f i l e  * /  
x = v e c t o r ( 1 ,  CHANNELS) ;  
c h a n _ d a t a = v e c t o r ( 1 ,  CHANNELS) ;
/ ‘  C heck  command l i n e  s y n t a x  * /  
i f  ( a r g c  != 2) {
f p r i n t f ( s t d e r r ,  ' S y n t a x :  a n a l y s e  < D ata  P i l e > \ n ' ) ;  
e x i t ( l ) ;
}
/ *  I n i t i a l i s e  g r a p h i c s  a n d  d i s p l a y  p a c k a g e s  * /  
d i s p _ s e t m o d e ( 3 ) ;  
d i s p _ o p e n ( ) ;  
d i s p _ u s e b i o s ( ) ;
g e r r o r  = f g _ i n i t _ a l l ( ) ;  / *  S e t  up g r a p h i c s  s y s t e m  * /
i f  ( g e r r o r  < FG_EGACOLOR ) {
f p r i n t f ( s t d e r r ,  ' A n a l y s i s  p r o g r a m  r e q u i r e s  EGA. ( % d ) \ n # , g e r r o r ) ;
/ *  e x i t (2)  * / ;
}
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f g _ t e r m ( ) ;
d isp _ se ta t t r (D IS P _ N O R M A L  | DISP_INTENSITY); 
d i s p _ p r i n t f ( ' D a t a  a n a l y s i s  p r o g r a m . \ n * ) ;  
d i s p _ p r i n t f ( '= = = = = = = = = = = == == = == == = =\n \n ') ;
i f  ( r e a d _ c o n f i g ( & a l p h a 2 _ e n e r g y ,  & p e a k _ e _ d i f f , & d e t e c t o r _ r e s o l n ,  & r e l _ p e a k _ h e i g h t  
, & s h e l f _ h e i g h t ,  & i t e r _ p a r m s , l i s t _ p a r m s )  i= TRUE) {
f p r i n t f ( s t d e r r ,  ' F a i l e d  t o  r e a d  c o n f i g u r a t i o n  f ro m  AN ALYSE.C FG.\n ') ; 
e x i t ( 6 ) ;
}
a l p h a l _ e n e r g y  * a l p h a 2 _ e n e r g y  + p e a k _ e _ d i f f ;
d i s p _ p r i n t f ( 'W o rk in g  o n  f i l e  % s \ n ' , a r g v [ l ] ) ;  / *  P r i n t  f i l e n a m e  * /
d isp _ s e t a t t r ( D I S P _ N O R M A L ) ;
/ *  F i r s t  r e a d  i n  d a t a  * /
r e s u l t  = d a t a _ f e t c h ( a r g v [ 1 ] ,  & n o f c h a n s ,  c h a n _ d a t a ,  d e s c ,  d e t e c t ,  d a t e ,  t i m e ,  & l i  
v e _ t i m e ,  & r e a l _ t i m e ,  & c a l ib _ q u a d ,  & c a l i b _ s l o p e ,  & c a l i b _ i n t ) ;
i f  ( r e s u l t  == NULL) e x i t ( 3 ) ;  / *  I f  e r r o r  t h e n  e x i t  * /
t e x t _ d i s p l a y ( a r g v [ 1 ] ,  d e s c ,  d e t e c t ,  d a t e ,  t i m e ,  l i v e _ t i m e ,  r e a l _ t i m e ,  n o f c h a n s ) ;  
i f  ( c a l i b _ s l o p e = » l .0 )  { 
d i s p _ m o v e ( 1 7 , 0 ) ;
d i s p _ p r i n t f ( ' P l e a s e  e n t e r  c a l i b r a t i o n  d a t a : \ n a  = ' ) ;
s c a n f ( ' % l f ' ,  & c a l i b _ q u a d ) ;
d i s p _ p r i n t f ( ' b  = ' ) ;
s c a n f ( ' % l f ' ,  & c a l ib _ _ s lo p e ) ;
d i s p _ _ p r i n t f  ( ' c  * ' ) ;
s c a n f ( ' % l f ' , & c a i i b _ i n t ) ;
}
/ *  S e t  up x v a l u e s  r e a d y  f o r  s e n d i n g  t o  t h e  g r a p h  * /
/ *  d r a w i n g  r o u t i n e .  * /
f o r  ( i = l ; i < = n o f c h a n s ; i + + )
x [ i ] = ( d o u b l e ) ( i * i ) * c a l i b _ q u a d + ( d o u b l e ) ( i ) * c a l i b _ s l o p e + c a l i b _ i n t ;
/ *  Now s e t  up a r r a y s  c o n t a i n i n g  d a t a  t o  be  f i t t e d  * /
r o i l = ( i n t ) ( ( a l p h a 2 _ e n e r g y - 3 . O * d e t e c t o r _ r e s o l n * l . 0E* 3 - c a l i b _ i n t ) / c a l i b _ s l o p e • (dou  
b l e ) N_BACK_FIT) ;
r o i 2 = ( i n t ) { ( a l p h a l _ e n e r g y + 3 . O * d e t e c t o r _ r e s o l n * l . O E - 3 - c a l i b _ i n t ) / c a l i b _ s l o p e + (dou  
b l e ) N_BACK_FIT) ;
r o i _ o f f s e t = r o i l -1 ;  
n p t s _ r o i = r o i 2 - r o i l + 1 ;
f i t ( & x [ r o i l  - 4 ] , & c h a n _ d a t a [ r o i l - 4 ] , 8 , r a w _ d a t a , 0 , & d l , & q l ,& d 2 , & d3 ,& d4 , & d 5 ) ; 
f i t ( & x [ r o i 2 • 4 ] , & c h a r _ d a t a [ r o i 2 * 4 ] , 8 , r a w _ d a t a , 0 , & d l ,& q r ,& d 2 ,& d 3 ,& d 4 , &d5) ;
/ *  D e c l a r e  s p a c e  t o  s t o r e  ROI c o u n t s  * /  
r a w _ d a t a  = v e c t o r (1 ,  n p t s _ r o i ) ;
/ *  T r a n s f e r  ROI i n f o  * /  
f o r  ( i = 0 ; i < n p t s _ r o i ; i + + ) { 
x [ i + 1 ] = x [r o i l + i ] ;  
r a w _ d a t a [ i + l ] = c h a n _ d a t a [ r o i l + i ) ;
}
r o i l = l ;
r o i 2 = n p t s _ r o i ;
/ *  P e r f o r m  a  few c h e c k s  on  t h e  ROI s e l e c t e d  * /  
i f  ( ( ( r o i 2 - r o i l ) < 3 0 )  | |  ( ( r o i 2 - r o i l ) > 2 0 0 ))  { 
d i s p _ m o v e ( 2 1 , 0 ) ;
d i s p _ p r i n t f ( ' I n v a l i d  number o f  p o i n t s  i n  R O I . \ n ' ) ;  
e x i t ( 4 ) ;
}
/ *  F r e e  s p a c e  u s e d  i n  ROI c a l c u l a t i o n  * /  
f r e e _ v e c t o r ( c h a n _ d a r a ,  1 ,  CHANNELS);
/ *  Now c a l c u l a t e  t e r m s  f o r  c u b i c  a s  d o c u m e n te d  i n  PMB V o l  33#7 * /
/ *  pp84 7 - 857 * /
/ *  e=PL f=QL g = [ ( -C 2 -2 Q L ) / (E R - E L ) + 3 ( P R - P L ) / ( E R - E L ) *2] * /
/ *  h = [ (QL+QR)/ ( E R -EL )‘ 2 + 2 ( P L - P R ) / ( E R - E L ) * 3] * /
/ *  Use q u a d r a t i c  f i r t e d  a b o v e  t o  f i n d  s l o p e s  * /
d e l t a _ x = x [ n p t s _ r o i ] - x [ 1 ] ;  
e = r a w _ d a t a [ 1 ] ;  
f = q l ;
g = ( - q r - 2 * q l ) / d e l t a _ x * 3 * ( r a w _ d a t a [ n p t s _ r o i ] - r a w _ d a t a [ 1 ] ) / d e l t a _ x / d e l t a _ x ;  
h = ( q l + q r ) / d e l t a _ x / d e l t a _ x + 2 * ( r a w _ d a t a [ 1 ] - r a w _ d a t a [ n p t s _ r o i ) ) / d e l t a _ x / d e l t a _ x / d e l  
t a _ x ;
/ *  Now s e t  up p a r a m e t e r s  f o r  f i t  * /
p a r m s [1]  = c h a n _ d a t a [ ( i n t ) ( ( a l p h a l _ e n e r g y - c a l i b _ i n t ) / c a l i b _ s l o p e ) ] ;
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/ *  A lp h a 2  a m p l i t u d e  
p a r m s [2]  = a l p h a 2 _ e n e r g y ;  / *  A lp h a 2  p o s i t i o n
p a r m s [3]  = d e t e c t o r _ r e s o l n * l . 0 E - 3;  / *  A l p h a l / 2  w i d t h
p a r m s [ 4 ]  = r e l _ p e a k _ h e i g h t ;  / *  ( A l p h a l  a m p ) / ( A l p h a 2  amp)
p a r m s [5]  = p e a k _ e _ d i f f ;  / *  ( A l p h a l  p o s ) * ( A l p h a 2  p o s )
p a r m s [6]  = s h e l f _ h e i g h t ;  / *  S t e p  h e i g h t  u n d e r  a  p e a k
p a r m s (7)  = e - f * x [ 1 ] + g * x [ 1 ) * x [ 1 ] - h * x [ 1 ] * x ( 1 ] * x [ 1 ] ;
/ *  C o n s t a n t  b a c k g r o u n d  
p a r m s [8]  = f - 2 * g * x [ 1 ] + 3 * h * x [ 1 ] * x ( 1 ] ;  / *  L i n e a r  c o m p o n e n t
p a r m s [9 ]  = g - 3 * h * x [ l j ;  / *  Q u a d r a t i c  c o m p o n e n t
p a r m s [1 0 ]  = h ;  / *  C u b ic  c o m p o n e n t
/ *  D e c l a r e  a r r a y s  r e q u i r e d  by  M a rq u a d t  r o u t i n e  * /
a l p h a  = m a t r i x  ( 1 ,  N_PARMS, 1 ,  N_PARMS) ;
c o v a r  = m a t r i x ( l ,  N_PARMS, 1 ,  NJPARMS);
s ig m a  * v e c t o r ( l ,  n p t s _ r o i ) ;
/ *  D e c l a r e  s p a c e  f o r  a r r a y  f o r  i n i t i a l  g u e s s  a n d  b a c k g r o u n d  i t e r a t i o n  * /  
m o d e l _ d a t a  = v e c t o r ( 1 ,  n p t s _ r o i ) ;  
x _ b a c k  = v e c t o r ( l ,  n p t s _ r o i ) ;  
f o r  ( i = l ; i  < =N_BACK_FIT; 1 + +) { 
x _ b a c k ( i ] = x ( i ] ;
x _ b a c k (N_BACK_?IT+i) = x [ n p t s _ r o i - N _ B A C K _ F I T t i ] ; 
m o d e l _ d a t a [ i ) = r a w _ d a t a [ i ] ;
m odel_data[N_B AC K _FIT+i]  = r a w _ d a t a ( n p t s _ r o i - N _ B A C K _ P I T + i ) ;
} . - 
/ *  S e t  up s tandeurd  d e v i a t i o n  o f  a l l  p o i n t s  a s s u m in g  P o i s s o n  * /  
f o r  ( i= l ; i< = N _ B A C K _ F IT * 2 ; i+ + )  {
i f  ( m o d e l _ d a t a ( i ] < 1 . 0 E - 50) m o d e l _ d a t a [ i ] = 1 . 0 E - 5 0 ;  
s i g m a [ i ] = s q r t ( m o d e l _ d a t a [ i ] ) ;
}
/ *  I t e r a t e  b a c k g r o u n d  u s i n g  M a rq u a d t  * /  
d i  sp _ m o v e ( 2 3 , 0 ) ;
d i s p _ p r i n t f ( ' P l e a s e  w a i t  - I t e r a t i n g  b a c k g r o u n d . \ n ' ) ;
/ *  S a v e  p e a k  a m p l i t u d e  a n d  a m p l i t u d e  t o  z e r o  f o r  i t e r a t i o n  * /  
d l  = p a r m s [ 1 ] ;  
p a r m s [1 ]  = 0 . 0 ;  
a l a m d a = - 1 . 0 ;
m rq m in (x _ b a c k ,  m o d e l _ d a t a ,  s i g m a ,  2*N_BACK_FIT, p a r m s ,  N_PARMS, l i s t _ b a c k ,  4 ,  co  
v a r ,  a l p h a ,  & c h is q ,  d o u b l e _ p e a k ,  & a la m d a ) ; 
do  {
o l d _ c h i s q = c h i s q ;
m rq m in (x _ b a c k ,  m o d e l _ d a t a ,  s i g m a ,  2 *N_BACK_FIT, p a r m s ,  N_PARMS, l i s t _ b a c k ,  4 
, c o v a r ,  a l p h a ,  & c h isq ,  d o u b l e _ p e a k ,  & a la m d a ) ; 
p c u :m s _ d i s p l a y ( p a r m s , covar ,FA L SE ) ; 
d e l t a _ c h i s q = f a b s ( ( c h i s q - o l d _ c h i s q ) / c h i s q ) ;
} w h i l e  ( ( ( d e l t a _ c h i s q > 0 . 00001) | |  ( d e l t a _ c h i s q < l . 0 E - 5 0 ) )  && a l a m d a < l E 1 5 ) ; 
a l a m d a = 0 . 0;
m rq m in (x _ b a c k ,  m o c e l _ d a t a ,  s i g m a ,  2*N_BACK_FIT, p a r m s ,  N_PARMS, l i s t _ b a c k ,  4 ,  co  
v a r ,  a l p h a ,  & c h is q ,  d o a b l e _ p e a k ,  & a la m d a ) ;
/ *  R e s t o r e  o r i g i n a l  v a l u e  o f  p e a k  a m p l i t u d e  * /  
p a r m s ( l )  = d l ;
/ *  S u b t r a c t  e s t i m a t e d  b a c k g r o u n d  o f f  p e a k  a m p l i t u d e  * /
p a rm s  (1 ] - = pa rm s  [ 7 ] t-parms [ 8) * a l p h a l _ e n e r g y + p a r m s  (9 ] * a l p h a l _ e n e r g y * a l p h a l _ e n e r g y  
♦ p a r m s [ 1 0 ] * a l p h a l _ e n e r g y * a l p h a l _ e n e r g y * a l p h a l _ e n e r g y ;
/ *  p a r m s [1] s h o u l d  c o n t a i n  a l p h a  2 a m p l i t u d e ,  was s e t  t o  a l p h a  1 * /  
p a r m s [ l ]  /=  r e l _ p e a k _ h e i g h t ;
/ *  S e t  up a r r a y  c o n t a i n i n g  i n i t i a l  g u e s s  * /  
f o r  ( i = l ; i < = n p t s _ r o i ; i + + )
d o u b l e _ p e a k ( x [ i ] , p a r m s , & m o d e l_ d a t a [ i ] , dummy,N_PARMS) ;
/ *  D i s p l a y  d a t a  g r a p h i c a l l y  * /  
d i s p _ m o v e ( 2 3 , 0 ) ;
d i sp _ se ta t t r (D IS P _ R E V E R S E V ID E O );
d i s p _ p r i n t f ( ' P l e a s e  p r e s s  SPACE BAR t o  s e e  d i s p l a y  o f  d a t a . ' ) ;  
d i s p _ se ta t t r (D IS P _ N O R M A L ) ; 
do  {
t e m p _ c h = g e tc h { ) ;
} w h i l e  ( t e m p _ c h  i= ' ' ) ;
l i n _ l i n ( x ,  m o d e l _ d a ta ,  r a w _ d a t a ,  n p t s _ r o i ,  r o i l ,  r o i 2 ) ;
/ *  R e s e l e c t  t e x t  d i s p l a y  * /
t e x t _ d i s p l a y ( a r g v [ 1 ] ,  d e s c ,  d e t e c t ,  d a t e ,  t i m e ,  l i v e _ t i m e ,  r e a l _ t i m e ,  n o f c h a n s ) ;
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/ *  S e t  up s t a n d a r d  d e v i a t i o n  o f  a l l  p o i n t s  a s s u m in g  P o i s s o n  * /  
f o r  ( i = l ; i < = n p t s _ r o i ; i + + )  {
i f  ( r a w _ d a t a ( i ] < 1 . 0 E * 5 0 )  r a w _ d a t a [ i ] = 1 . 0 E - 50;  
s ig m a  I i ] = s q r t { r a w _ d a t a ( i ] ) ;
}
/ *  Maybe g o i n g  r o u n d  t h i s  l o o p  a  s e c o n d  t im e  i f  f i t  i s  p o o r  * /
/ *  T h e r e f o r e  r e s e t  e s t i m a t e d  p e a k  h e i g h t ,  p e a k  p o s i t i o n s  a n d  * /
/ *  r e l a t i v e  p e a k  h e g h t s  * /
do  {
pa rm s  [1]  = c h a n _ d a t a (  ( i n t )  ( ( a l p h a l _ e n e r g y * c a l i b _ i n t ) / c a l i b _ s l o p e )  ] ;
p a r m s [2 J = a l p h a 2 _ e n e r g y ;
p a r m s [4]  = r e l _ p e a k _ h e i g h t ;
p a r m s (5 )  = p e a k _ e _ d i f f ;
p a r m s [6]  = s h e l f _ h e i g h t ;
pa rm s  (1)  -* pa rm s [7 ] tp a rm s  [ 8 ] * a l p h a l _ e n e r g y + p a r m s  [ 9) * a l p h a l _ e n e r g y * a l p h a l _ e n
e r g y + p a r m s ( 1 0 ) * a l p h a l _ e n e r g y * a l p h a l _ e n e r g y * a l p h a l _ e n e r g y ;  
p a r m s (1)  /=  r e l _ p e a k _ h e i g h t ;  
a lam da=  - 1 . 0 ;
m rq m in (x ,  r a w _ d a t a ,  s ig m a ,  n p t s _ r o i ,  p a r m s ,  N_PARMS, l i s t _ p a r m s ,  i t e r _ p a r m s ,  
c o v a r ,  a l p h a ,  & c h i s q ,  d o u b l e s p e a k ,  f t a l a m d a ) ; 
do  {
o l d _ c h i s q = c h i s q ;
m rq m in (x ,  r a w _ d a t a f s ig m a ,  n p t s _ r o i ,  p a r m s ,  N_PARMS, l i s t _ p a r m s ,  i t e r _ p a  
r m s ,  c o v a r ,  a l p h a ,  & c h i s q ,  d o u b l e _ p e a k ,  & a la m d a ) ;
p a r m s _ d i s p l a y ( p a r m s , c o v a r , F A L S E ) ; 
d e l t a _ c h i s q = f a b s ( ( c h i s q - o l d _ c h i s q ) / c h i s q ) ;
) w h i l e  ( ( ( d e l t a _ c h i s q > 0 .0 0 0 0 1 )  | |  ( d e l t a _ c h i s q < l . 0 E - 5 0 ) )  && a l a m d a < l E 1 5 ) ; 
a l a m d a = 0 . 0;
m r q m i n ( x , r a w _ d a t a ,  s ig m a ,  n p t s _ r o i , p a r m s  ,N_PARMS, l i s t _ p a r m s , i t e r _ p a r m s , c o v a r ,  a  
l p h a , & c h i s q , d o u b l e _ p e a k , & a l a m d a ) ;
p a r m s _ d i s p l a y { p a r m s , c o v a r ,F A L S E )  ;
i f  ( (p a rm s  (1 ] < 0 .0 )  | |  ( f a b s ( p a r m s [ 2 ] - a l p h a 2 _ e n e r g y ) > 0 . 5 ) )  { 
i t e r a t i o n * * ;  
d isp _ se ta t t r (D IS P _ R E V E R S E V ID E O );
d i s p _ m o v e ( 1 3 , 4 2 ) ;  
d i s p _ p r i n t f ( ' ( I t e r a t i o n ;  %d)' , i t e r a t i o n ) ; 
d i sp _ se ta t t r (D IS P _ N O R M A L ) ;
}
} w h i l e  ( ( ( p a r m s [ 1 ] < 0 . 0 )  | |  ( f a b s ( p a r m s [ 2 ) - a l p h a 2 _ e n e r g y ) > 0 . 5 ) )  && ( i t e r a t i o n < = 5
) )  ;
/ *  P r e e  t e m p o r a r y  w o rk s p a c e  u s e d  d u r i n g  M a rq u a d t  * /  
f r e e _ m a t r i x ( a l p h a ,  1, N_PARMS, 1,  N_PARMS); 
f r e e _ v e c t o r ( s i g m a ,  1, n p t s _ r o i ) ;
/ *  S e t  up a r r a y  c o n t a i n i n g  f i t t e d  m o d e l  * /  
f o r  ( i = l ; i < = n p t s _ r o i ; i + + )
d o u b l e _ p e a k ( x [ i ] , p a r m s , & m o d e l_ d a ta [ i ] , dummy,N_PARMS) ;
/ *  D i s p l a y  d a t a  g r a p h i c a l l y  * /  
d i sp _ se ta t t r (D IS P _ R E V E R S E V ID E O );
d i s p _ p r i n t f ( ' \ n \ n P l e a s e  p r e s s  SPACE BAR t o  s e e  d i s p l a y  o f  d a t a . ' ) ;  
d i s p _ s e t a t t r ( D I S P _ N O R M A L ) ; 
do  {
t e m p _ c h = g e t c h { ) ;
} w h i l e  ( te m p _ c h  i= ' ' ) ;
l i n _ l i n ( x ,  m o d e l _ d a t a ,  r a w _ d a t a ,  n p t s _ r o i ,  r o i l ,  r o i 2 ) ;
t e x t _ d i s p l a y ( a r g v [ 1 ] ,  d e s c ,  d e t e c t ,  d a t e ,  t i m e ,  l i v e _ t i m e ,  r e a l _ t i m e ,  n o f c h a n s ) ;  
p a r m s _ d i s p l a y ( p a r m s , c o v a r ,  TRUE);
/ *  Now c a l c u l a t e  p e a k  a r e a s  * /
m e a n = ( i n t ) ( ( p a r m s [ 2 ) - c a l i b _ i n t ) / c a l i b _ s l o p e - r o i _ o f f s e t ) ; 
e x t e n t = ( i n t ) ( 2 . 0 * p a r m s [ 3 ] / c a l i b _ s l o p e ) ;
p e a k _ c o u n t ( m ean , e x t e n t , x , r a w _ d a t a , p a r m s , & a r e a _ k a 2 , & back_K a2) ;  
m e a n = ( i n t ) ( ( p a r m s [ 2 ] + p a r m s [ 5 ] - c a l i b _ i n t ) / c a l i b _ s l o p e - r o i _ o f f s e t ) ; 
e x t e n t s ( i n t ) ( 2 . 0 * p a r m s (3 J / c a l i b _ s l o p e ) ;
p e a k _ c o u n t ( m e a n , e x r e n t , x , r a w _ d a t a , p a r m s , & a r e a _ K a l , & b a c k _ K a l ) ;  
a r e a _ K a 2 F sS Q R T _ 2 P I* p a rm s( 3 ] * p a r m s ( 1 ] / c a l i b _ s l o p e ; 
a r e a _ K a lF sS Q R T _ 2 P I* p a rm s  [ 3 ) *pairms [ 1 ] * p a rm s (4 J / c a l i b _ s l o p e ;
d e l t a _ c u r e a 2 s s q r t ( c o v a r  [ 1 ] 11 ] / p a r m s (1 ] / p a r m s  [ 1) + o o v a r  [ 3] [ 3 ] / p a r m s  ( 3 ] / p a r m s  ( 3 ] )  * a r  
e a_ K a2 F ;
d e l t a _ a r e a l s s q r t  ( c o v a r  (1 )  [ 1 ] / p a r m s  [ 1 ] / p a r m s  [ 1 ] + c o v a r  (4 ] (4 ] / p a r m s  (4 ) / p a r m s  [ 4 ] +cov
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a r [ 3 ] ( 3 ] / p a r m s ( 3 ] / p a r m s { 3 ] ) * a r e a _ K a l F ; 
d i s p _ m o v e ( 2 0 , 0 ) ;
i f  ( a rea_ K a2 > T W IC E _ S Q R T 2 * sq r t(b ack _ K a2 ))
d i sp _ se ta t t r (D IS P _ N O R M A L  | DISP_INTENSITY); 
e l s e
d i sp _ s e t a t t r ( D I S P _ N O R M A L ) ; 
d i s p _ p r i n t f ( 'K  a l p h a  2 :  A r e a :  % 8 .2 f  + / -  % 7 .2 f  B a c k . :  % 1 0 .2 f  \ n ' , a r e a _ K a 2 F , d e l
t a _ a r e a 2 , b a ck _ K a 2 ) ;
i f  ( a re a _ K a l> T W IC E _ S Q R T 2 * sq r t (b a c k _ K a l ) )
d i s p _ s e t a t t r (DISP_NORMAL | DISP_INTENSITY); 
e l s e
d i sp _ s e t a t t r ( D I S P _ N O R M A L ) ; 
d i s p _ p r i n t f ( * K  a l p h a  1: A r e a :  % 8 .2 f  + / -  % 7 .2 f  B a c k . :  t l 0 . 2 f  \ n \ n ' , a r e a _ K a l F , d
e l t a _ a r e a l , b a c k _ K a l ) ;
d isp _ se ta t t r (D IS P _ R E V E R S E V ID E O );
d i s p _ p r i n t f { ' P l e a s e  p r e s s  SPACB BAR t o  e x i t  a n a l y s i s  p r o g r a m . ' ) ;  
d i s p _ s e t a t t r ( D I S P _ N O R M A L ) ; 
d o  {
t e m p _ c h = g e t c h ( ) ;
} w h i l e  ( t e m p _ c h  1= ' ' ) ;  
f r e e _ v e c t o r ( x ,  1 ,  CHANNELS); 
f r e e _ v e c t o r ( r a w _ d a t a ,  1 ,  n p t s _ r o i ) ; 
f r e e _ v e c t o r ( m o d e l _ d a t a ,  1 ,  n p t s _ r o i ) ;  
f r e e _ v e c t o r ( x _ b a c k ,  1, n p t s _ r o i ) ;  
f r e e _ m a t r i x ( c o v a r ,  1 ,  N_PARMS, 1 ,  N_PARMS); 
d i s p _ c l o s e ( ) ;  
r e t u r n  0 ;
}
A2 analycfg.c
/ *  P r o g r a m  t o  g e n e r a t e  c o n f i g u r a t i o n  f i l e  f o r  a n a l y s i s  p r o g r a m  * /
/ *  O r i g i n a l  v e r s i o n  1 2 / 0 3 / 9 2  * /
/ *  M o d i f i e d  1 5 / 0 7 / 9 2 :  Read o l d  CFG f i l e  f r o m  d i s k  * /
^ d e f i n e  TRUE 1 
# d e f i n e  FALSE 0
# d e f i n e  N_PARMS 10
/ *  D e f i n e  d e f a u l t s  f o r  peurcuneters * /
^ d e f i n e  ALPHA2 6 6 .9 9 0  
# d e f i n e  DALPHA 1 .8 1 4  
(jfdef ine  RESLN 370 
/( (def ine  RELPK 1 . 6 9  
^ d e f i n e  SHELF 0 .0 0 9
((( inc lude  < s t d i o . h >  
( (( inc lude  < s t d l i b . h >  
( (( inc lude  < d i s p .h >  
( (( inc lude  < c o n io .h >
/ *  ANSI s t a n d a r d  * /
/ *  ANSI s t a n d a r d  * /
/ *  Z o r t e c h  C d i s p l a y  r o u t i n e s  * /  
/ *  Z o r t e c h  C * /
/ ♦ S e r v i c e  r o u t i n e  f o r  r e a d _ o o n f i g  • r e a d s  a n  i t e m  f r o m  f i l e  * /
/ * = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =  * /
i n t  r e a d _ i t e m ( d o u b l e  *p ,  FILE * f p ,  i n t  p«Lrm_number)
{
i n t  n i t e m s ;
n _ i t e m s  = f s c a n f ( f p ,  
i f  ( n _ i t e m s  1= 1) { 
f p r i n t f ( s t d e r r ,  
a r m _ n u m b e r ) ;
} e l s e
r e t u r n  FALSE;
}
' % l f ' ,  p ) ;
' E r r o r  i n  r e a d i n g  p a r a m e t e r  %d f ro m  c o n f i g u r a t i o n  f i l e \ n '
/ ♦ R o u t i n e  t o  e x t r a c t  c o n f i g u r a t i o n  f r o m  d i s k  ♦ /  
/ * = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = v
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v o i d  r e a d _ c o n f i g ( d o u b l e  * p l ,  d o u b l e  *p2 ,  d o u b l e  * p 3 ,  d o u b l e  * p 4 ,  d o u b l e  * p 5 ,  c h a r  l i  
e t ( J )
{
FILE * f p ;
i n t  i ,  n _ i t e m s ,  i t e r ,  t e m p ;
f o r  ( i = l ;  i<=N_PARMS; i+ + )
l i s t [ i ]  = ' N ' ;  
i f  ( ( f p  = f o p e n ( 'A N A L Y S E .C F G * , ' r ' ) ) == NULL) {





} e l s e  {
i f  ( r e a d _ i t e m ( p l ,  f p ,  1 ) )  * p l  = ALPHA2;
i f  ( r e a d _ i t e m ( p 2 ,  f p ,  2 ) )  *p2 = DALPHA;
i f  ( r e a d _ i t e m ( p 3 ,  f p ,  3 ) )  *p3 = RESLN;
i f  ( r e a d _ i t e m ( p 4 ,  f p ,  4 ) )  *p4 = RELPK;
i f  ( r e a d _ i t e m ( p 5 ,  f p ,  5 ) )  *p5 = SHELF;
n _ i t e m s  = f s c a n f ( f p , * % d * ,  & i t e r ) ; 
i f  (n _ i t e r n s  != 1) {
f p r i n t f ( s t d e r r ,  ' E r r o r  i n  r e a d i n g  num ber  o f  p a r a m e t e r s  t o  i t e r a t e  f ro m  c 
o n f i g u r a t i o n  f i l e \ n ' ) ;
r e t u r n ;
}
f o r  ( i = l ; i<  = i t e r ;  i+  + ) {
n _ i te rn s  = f s c a n f ( f p ,  '% d ' ,  & tem p);  
i f  ( n _ i t e m s  1= 1) {
f p r i n t f ( s t d e r r ,  ' E r r o r  i n  r e a d i n g  l i s t  i t e m  %d f r o m  c o n f i g u r a t i o n  f i
l e \ n ' ,  i )
}
r e t u r n ;
} e l s e  {
i f  ( tem p <» N_PARMS) l i s t [ t e m p ]
}
' Y ' ;
f c l o s e ( f p ) ;
v o i d  p a r m _ i t e r a t e ( c h a r  * f o r m a t ,  d o u b l e  v a l u e ,  c h a r  o l d ,  i n t  p a rm ,  i n t  l i s t [ ] ,  i n t  * t  
o p _ s e t ,  i n t  t o t a l _ s e t )
c h a r  r e s p o n s e ;
d i s p _ p r i n t f ( f o r m a t ,  v a l u e ,  o l d ) ;  
do {
r e s p o n s e  = ( c h a r ) ( g e t c h ( ) & 0x5f) ;
} w h i l e  ( ( r e s p o n s e  != ' Y ' )  && ( r e s p o n s e  != ' N ' ) ) ;  
d i s p _ p u t c ( r e s p o n s e ) ; 
d i s p _ p u t c ( ' \ n ' ) ;  
i f  ( r e s p o n s e  == 'Y ' )  {
( * t o p _ s e t ) -+ ;
l i s t [ * t o p _ s e t ]  = p a rm ;
} e l s e  {
l i s t [ N_PARKS- ( t o t a l _ s e t - * t o p _ s e t ) ] = p a rm ;
}
v o i d  w r i t e _ f i l e ( d o u b l e  p i ,  d o u b l e  p 2 ,  d o u b l e  p 3 ,  d o u b l e  p 4 ,  d o u b l e  p 5 ,  i n t  i t e r ,  i n t  
l i s t [ ] )
{
FILE * f p ; 
i n t  i ;
i f  ( ( f p  = fo p e n ( 'A N A L Y S E .C F G ', ' W ' ) ) == NULL) { 
d i s p _ p r i n t f ( ' F a i l e d  t o  o p e n  ANALYSE.CFG\n') ;  
r e t u r n ;
}
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f p r i n t f ( f p , ' % l f \ n ' , p l ) ; 
f p r i n t f ( f p , ' % l f \ n ' , p 2 ) ; 
f p r i n t f ( f p , ' % l f \ n ' , p 3 ) ; 
f p r i n t f ( f p , ' % l f \ n ' , p 4 ) ; 
f p r i n t f ( f p , * % l f \ n ' , p 5 ) ; 
f p r i n t f ( f p , * % d \ n ' ,  i t e r ) ;  
f o r  ( i = l ; i<=N_PARMS; i  + +)
f p r i n t f ( f p ,  ' * d \ n ' ,  l i s t [ i ] ) ;  
f c l o s e ( f p ) ;
d i s p _ p r i n t f  ( 'ANALYSE.CFG w r i t t e n  t o  d i s k . \ n ' ) ;
}
i n t  m a i n ( )
{
d o u b l e  a l p h a 2 _ e n e r g y ,  p e a k _ e _ d i f f ,  r e l _ p e a k _ h e i g h t ;  
d o u b l e  d e t e c t o r _ r e s o l n ,  s h e l f _ h e i g h t ;  
c h a r  d e f a u l t_ i t e r ( N _ P A R M S + 1 ] ,  r e s p o n s e ;
s t a t i c  i n t  l is t_ p a rm s(N _ P A R M S + 1 ] = {0, 1, 0 ,  0,  0 ,  0,  0 ,  0 ,  0 ,  0 ,  0} ; 
i n t  i t e r _ p a r m s  = 1;
d i s p _ s e t m o d e ( 3 ) ;  
d i s p _ o p e n ( ) ;  
d i s p _ u s e b i o s ( ) ;  
d i s p _ m o v e ( 0 , 0 ) ;  
d i s p _ e e o p ( ) ;
d isp _ se ta t t r (D IS P _ N O R M A L  | DISP_INTENSITY); 
d i s p _ p r i n t f ( ' A n a l y s i s  p r o g r a m  c o n f i g u r a t i o n \ n ' ) ; 
d i s p _ p r in t f ( '= = = = = = = = = = = = = = = = = = = = = = = = = = = r= = \n ' ) ;
d i s p _ s e t a t t r ( DISP_NORMAL);
r e a d _ c o n f i g ( & a l p h a 2 _ e n e r g y ,  & p e a k _ e _ d i f f , & d e t e c t o r _ r e s o l n ,  & r e l _ p e a k _ h e i g h t ,  &s 
h e l f _ h e i g h t ,  d e f a u l t _ i t e r ) ;
d i s p _ p r i n t f ( ' P l e a s e  e n t e r  t h e  e n e r g y  o f  t h e  K a l p h a  2 p e a k  [ % .3 1 f k e V ] :  *,  a l p h a
2 _ e n e r g y ) ;
s c a n f ( ' % l f ' ,  & a l p h a 2 _ e n e r g y ) ;
d i s p _ p r i n t f ( f \ n P l e a s e  e n t e r  t h e  e n e r g y  o f  t h e  K a l p h a  1 p e a k  [ % .3 1 fk e V ]s  ' ,  p e a
k _ e _ d i f f + a l p h a 2 _ e n e r g y ) ;
s c a n f ( ' % l f ' ,  & p e a k _ e _ d i f f ) ;  
p e a k _ e _ d i f f  *= a l p h a 2 _ e n e r g y ;
d i s p _ p r i n t f ( ' \ n P l e a s e  e n t e r  t h e  r e l a t i v e  p e a k  h e i g h t s  ( K a l /K a 2 )  [ % . 2 1 f ] :  ' ,  r e l
_ p e a k _ h e i g h t ) ;
s c a n f ( ' % l f " ,  & r e l _ p e a k _ h e i g h t ) ;
d i s p _ p r i n t f ( ' \ n P l e a s e  e n t e r  t h e  d e t e c t o r  r e s o l u t i o n  a t  % . l l f k e V  [% .0 1 f e V ] :  ' ,  a
l p h a 2 _ e n e r g y + p e a k _ e _ d i f f / 2 . 0 ,  d e t e c t o r _ r e s o l n ) ; 
s c a n f ( ' % l f ' ,  & d e t e c t o r _ r e s o l n ) ;
d i s p _ p r i n t f ( ' \ n P l e a s e  e n t e r  t h e  s h e l f  h e i g h t  u n d e r  a  p e a k  a t  % . l l f k e V  [%.21f%%]) 
s ' ,  a l p h a 2 _ e n e r g y T p e a k _ e _ d i f f / 2 . 0 ,  s h e l f _ h e i g h t * 1 0 0 ) ;  
s c a n f ( ' % l f ' ,  & s h e l f _ h e i g h t ) ; 
s h e l f _ h e i g h t  /=  100;  
d i s p _ m o v e ( 2 , 0 ) ;  
d i s p _ e e o p ( ) ;  
d i s p _ m o v e ( 2 , 0 ) ;
d isp _ se ta t t r (D IS P _ R E V E R S E V ID E O ) ;
d i s p _ p r i n t f ( 'D o you w i s h  t o  i t e r a t e  t h e  f o l l o w i n g  p a r a m e t e r s ? \ n " ) ; 
d i sp _ s e t a t t r ( D I S P _ N O R M A L ) ;
p a r m _ i t e r a t e ( 'K  a l p h a  2 e n e r g y  = % .21fkeV? [%c] ' ,  a l p h a 2 _ e n e r g y , d e f a u l t _ i t e r  
[ 2 ] ,  2 ,  l i s t _ p a r m s ,  & i t e r _ p a r m s ,  1 ) ;
p a r m _ i t e r a t e ( ' K a l  * Ka2 e n e r g y  = % .21fkeV? [%c] ' ,  p e a k _ e _ d i f f ,  d e f a u l t _ i t e r [5 
] ,  5 ,  l i s t _ p a r m s ,  & ite r_p«urm s,  2 ) ;
p a r m _ i t e r a t e ( ' D e t e c t o r  r e s o l n  = % .21feV? (%c] ' ,  d e t e c t o r _ r e s o l n ,  d e f a u l t _ i t e
r [ 3 ] ,  3, l i s t _ j ? a r m s ,  & i te r_ p « i rm s , 3 ) ;
p a r m _ i t e r a t e ( ' R e l a t i v e  p e a k  h t  = % .2 1 f?  (%c) ' ,  r e l _ p e a k _ h e i g h t , d e f a u l t _ i t e r (
4 ] ,  4 ,  l i s t _ p a r m s ,  4 i t e r _ p a r m s ,  4 ) ;
p « L r m _ i t e r a t e ( 'P e a k  s h e l f  h e i g h t  = %.21f%%? [%c] ' ,  s h e l f _ h e i g h t * 1 0 0 . 0 ,  d e f a u l t _
i t e r [ 6 ] ,  6,  l i s t _ p a r m s ,  & ite r_p«u :m s ,  5 ) ;
/ *  B a c k g ro u n d  p a r a m e t e r s  * /  
l i s t _ p a r m s  [ i te r_p«L rm s + l  ] = 7 ;  
l i s t _ p a r m s [ i t e r _ p a r m s + 2 ) = 8; 
l i s t _ p a r m s ( i t e r _ p a r m s + 3 ]  = 9 ;  
l i s t _ p a r m s ( i t e r _ p a r m s + 4 ] = 10 ;
A14
d i s p _ p r i n t f ( 'B a c k g r o u n d ?  [%cj *, d e f a u l t _ i t e r { 7 ] ) ;  
do {
r e s p o n s e  = ( c h a r ) ( g e t c h ( ) & 0 x 5 f ) ;
} w h i l e  ( ( r e s p o n s e  i= ' Y ' )  && ( r e s p o n s e  != ' N ' ) ) ;  
d i s p _ p u t c ( r e s p o n s e ) ; 
d i s p _ p u t c ( ' \ n ' ) ;  
i f  ( r e s p o n s e  == 'Y ' )  
i t e r _ p a r m s  -= 4;
w r i t e _ f i l e ( a l p h a 2 _ e n e r g y ,  p e a k _ e _ d i f f ,  d e t e c t o r _ r e s o l n ,  r e l _ p e a k _ h e i g h t ,  s h e l f _ h  
e i g h t ,  i t e r _ p a r m s , l i s t _ p a r m s ) ;  




* Monte C a r l o  P h o t o n  T r a c k i n g  Model
* P u r p o s e :  To f i n d  r e l a t i v e  g o l d  s e n s i t i v i t i e s  i n  a  s c a t t e r  medium
* J o h n  S h a k e s h a f t
* S e n s i t i v i t y  o v e r  w h o le  k i d n e y  vo lum e  a d d e d  2 4 / 1 0 / 9 1
* S e n s i t i v i t y  u n c e r t a i n t i e s  a d d e d  3 0 / 1 0 /9 1
* T h i s  p r o g r a m  m u st  be  l i n k e d  w i t h  a  d o u b l e  p r e c i s i o n  v e r s i o n  o f
* a  l i b r a r y  o f  t h e  r o u t i n e s  f ro m  N u m e r ic a l  R e c i p e s  i n  C * The a r t
* o f  s c i e n t i f i c  c o m p u t in g  by  P r e s s  WH e t  a l  (CUP)
*
* I n  t h e  d o u b l e  p r e c i s i o n  v e r s i o n  f l o a t  = > d o u b l e
* d o u b l e  => l o n g  d o u b l e
((( include  < s t d i o . h >  / *  ANSI S t a n d a r d  * /
# i n c l u d e  < m ath .h>  / *  ANSI S t a n d a r d  * /
# i n c l u d e  " n r . h *  / *  N u m e r i c a l  R e c i p e s  L i b r a r y  * /
((( include  " n r u t i l . h '  / *  N u m e r i c a l  R e c i p e s  L i b r a r y  * /
/ *  I n c r e a s e  s t a c k  s i z e  i n  Z o r t e c h  C * /  
u n s i g n e d  _ s t a c k  = 32 7 6 8 ;
j jfde f ine  P I  3 .1 4 1 5 9 2 6 5 3 5 8 9 7 9 3 2 3 8 4 6 2 6 4 3 3 8 3 2 7 9
(((define  TRUE 1 
#d e f i n e  FALSE 0
/ *  E l e m e n t a r y  c h a r g e  o v e r  P l a n c k s  c o n s t a n t  * s p e e d  o f  l i g h t  * 1 . 0 e 3  * /
( ( /define  E_HC 8 .0 6 5753E + 08
/ *  D e f i n e  Maximum a n d  Minimum e n e r g i e s  o f  i n t e r e s t  * /
/ *  Maximum e n e r g y  m u s t  be  maximum e n e r g y  o f  s o u r c e  * /
/ *  Minimum e n e r g y  i s  minimum e n e r g y  o f  i n t e r e s t  * /
(((define  MIN_ENERGY 6 5 .0  
j jfde f ine  MAX_ENERGY 1 0 5 .0
/ *  D e f i n e  c o n s t a n t s  f o r  i n t e r p o l a t i o n  o f  s c a t t e r i n g  c r o s s  s e c t i o n s  * /
/ *  T h e s e  h a v e  b e e n  f o u n d  by  l o g - l o g  l i n e a r  r e g r e s s i o n  o f  s ig m a  * /
/ *  a g a i n s t  E: l n ( s i g m a )  = A + B I n  E * /
/ *  V a l u e s  a r e :  W a te r  S o f t  t i s s u e  * /
/ *  Coh_A, Coh_B 5 . 6 9 2 ,  - 1 .8 7 6  5 . 6 5 9 ,  - 1 .8 8 7  * /
/ *  In c o h _ A ,  In c o h _ B  1 . 3 1 5 ,  - 0 .1 8 4 5  1 . 4 4 0 ,  - 0 .2 1 2 4  * /
/ *  P h o to _ A ,  P h o to _ B  1 1 .5 4 9 ,  - 3 .2 9 5  1 0 . 7 4 6 ,  - 3 .1 3 2  * /
/ *  T h e s e  a r e  i n  b a r n s  p e r  a to m  * /
/ *  RAM ( a v e r a g e )  5 .9 6  6 . 0 5  * /
/ *  D e n s i t y  (kg  m-3) 1000 1 000?  * /
Hd e f i n e  COH_A 5 .6 9 2  
)((define C0H_B ( - 1 . 8 7 6 )
(((define  INCOH_A 1 .3 1 5  
(((define  INCOH_B ( - 0 . 1 8 4 5 )
(((define  PHOTO_A 1 1 .5 4 9  
(((define  PHOTO_B ( - 3 . 2 9 5 )  
l((define  RAM 5 . 9 6  
(((define DENSITY 1 0 0 0 .0
/ *  Now d e f i n e  s i m i l a r  c o n s t a n t s  f o r  g o l d .  T h e r e  a r e  tw o  v a l u e s :  o n e  * /  
/ *  f o r  b e lo w  t h e  K a b s o r p t i o n  e d g e  (LOW), a n d  o n e  f o r  a b o v e  (HIGH) * /  
/ *  A l s o  d e f i n e  t h e  v a l u e  o f  t h e  K a b s o r p t i o n  e d g e  * /
j jfde f ine  AU_COH_A 1 1 .5 5  
(((define AU_C0H_B ( - 1 . 6 2 0 )
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j j f d e f i n e  AU_INCOH_LOW_A 2 . 4 0 0  
j j f d e f i n e  AU_INCOH_LOW_B 0 .2 6 2 4  
j j f d e f i n e  AU_INCOH_HIGH_A 4 . 1 5 7 7  
j j f d e f i n e  AU_INCOH_HIGH_B ( - 0 . 1 4 2 9 )  
j j f d e f i n e  AU_PHOTO_LOW_A 1 7 .9 9 2  
j j f d e f i n e  AU_PHOTO_LOW_B ( - 2 . 9 2 6 2 )  
j j f d e f i n e  AU_PHOTO_HIGH_A 2 0 .1 0 1  
J j f d e f i n e  AU_PHOTO_HIGH_B ( - 2 . 9 7 9 3 )  
Hd e f i n e  AU_K_ABS 8 0 .7 2 3  
J j f d e f i n e  AU_K_ALPHA 6 8 .8 0 4  
J j f d e f i n e  AU_RAM 1 9 7 .0  
J j f d e f i n e  AU DENSITY 1 9 3 2 0 .0
/ *  D e f i n e  c o n s t a n t s  f o r  c a l c u l a t i n g  e l a s t i c  s c a t t e r i n g  p r o b a b i l i t i e s * /
/ *  A dded  1 / 8 / 9 1 ★ i
/ *  V a l u e s  a r e f o r  u s e  i n  e q u a t i o n ★ /
/ *  x2 = e x p ( a l  +a2x +a3x2 ■*-a4x3 + . . . . ik /
/ *  V a l u e s  cLre ★ /
/* Gold T i s s u e W a te r  * /
/ *  a l - 7 . 0330e  + 0 -8 .3 7 0 5 e + 0 - 8 . 3890e  + 0 * /
/ *  a2 + 1 . 6 8 6 9 e -2 + 3 . 1 3 2 3 e + l + 2 . 8 6 5 5 e + l  * /
/ *  a3 - 1 . 5 0 0 8 e -5 • 6 . 1 2 4 7 e + l - 5 . 1 5 0 6 e + l  * /
/ *  a4 ♦ 5 .8 9 2 8 e - 9 ♦ 5 . 0 7 2 1 e + l + 3 .9 1 2 8 e + l  * /
/ *  a 5 - 1 . 0 1 0 8 e -12 • 1 .7 8 0 4 e + l - 1 . 2 5 7 7 e + l  * /
/ *  a 6 + 6 . 3 1 6 7 e -17 + 2 .2 0 9 9 e + 0 + 1 .4 2 8 4 e + 0  * /
/ *  a b s .m a x + 7 . 061e+3 3 .4 3 1 3 .7 5 3  * /
/ *  120kVmax) + 4 . 8 3 7 e + l 1 . 5 3 5 e -1 1 . 6 2 4 e - l  * /
j j fde f ine  EL_M_A1 ( - 8 .3 8 9 0 e + 0 )  
j j fde f ine  EL_M_A2 ( 2 .8 6 5 5 e + l )  
j j fde f ine  EL_M_A3 ( - S .1 5 0 6 e + 1 )  
j j fde f ine  EL_M_A4 3 . 9 1 2 8 e  + l  
j j fde f ine  EL_M_A5 ( - 1 . 2 5 7 7 e t l )  
j j fd e f in e  EL_M_A6 1 .4 2 8 4 e + 0  
j jfd e f in e  EL_M_MAX 1 . 6 2 4 e - l  
j j fd e f in e  EL_A_A1 ( - 7 . 0330e  + 0) 
j j fd e f in e  EL_A_A2 1 .6 8 6 9 e - 2  
Jjfdefine  Ei T a_A3 ( - 1 . 5 0 0 8 e - 5 )  
j j fd e f in e  EL_A_A4 5 . 8 9 2 8 e - 9  
j j fd e f in e  EL_A_A5 ( - 1 .  0108e  -12 )  
Jjfdefine  EL_A_A6 6 . 3 1 6 7 e - 1 7  
Jjfdefine  EL_A_MAX 4 8 .3 7
/ *  Now d e f i n e  g o l d  c o n c e n t r a t i o n  by  w e i g h t  (%) * /
/ *  lOOOug g * - l  = 0.1% * /
j jfd e f in e  AU_CN 0 .1
/ *  D e f i n e  s o u r c e  c o l l i m a t o r  p a r a m e t e r s  * /
/ *  A l l  d i s t a n c e s  i n  m e t r e s ,  A l l  a n g l e s  i n  r a d i a n s  * /
Jjfdefine  SOURCE_COLLIMATE_ANGLE ( 7 . 0 / 1 8 0 .  0 * P I )  / *  O r i g i n a l l y  ( 1 2 . 0 / . . * /  
j j fd e f in e  SSD 0 .1 5 2  / *  O r i g i n a l l y  0 .0 4 5  - Now 0 . 2 - L a t  d e p t h  * /
/ *  D e f i n e  o t h e r  g e o m e t r i c a l  p a r a m e t e r s  * /
j j fd e f in e  X_SKIN 0 .0 5 3  / *  O r i g i n a l l y  0 .0 5 5  - Now 0 . 0 2 5 + P o s t  d e p t h  * /
/ *  D e f i n e  d e t e c t o r  c o l l i m a t o r  p a r a m e t e r  * /
j j fd e f in e  DETECT_X (X_SKIN+0.035) 
j j fd e f in e  DETECT_Y 0 .0
j jfde f ine  DETECT_Z 0 . 2 2 5  / *  O r i g i n a l l y  (SSD +0.075)  * /
J j f d e f i n e  DETECT_RAD 0 .0 1 6
j jfd e f in e  DETECT_COLLIMATE_ANGLE ( 6 .  0 / 1 8 0 .  0 *PI)
/ *  D e f i n e  s i z e  o f  a r e a  o f  s e n s i t i v i t y  i n t e r e s t  ( i n  s i z e  G_UNIT) * /
j j fd e f in e  G_UNIT 0 .0 1
j jfde f ine  X_MIN ( - 7 )
j j fde f ine  X_SIZE 15
j jfde f ine  Y_MIN 0
j jfde f ine  Y_SIZE 1
j jfde f ine  Z_MIN 15 /*  O r i g i n a l l y  4 * /  
j j fd e f in e  Z_SIZE 13
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/ *  Number o f  p h o t o n s  t o  be  c o n s i d e r e d  * /
^ d e f i n e  N_PHOTONS 1000000
/ *  D e c l a r e  t y p e  f o r  c u r r e n t  c o o r d s  o f  p h o t o n  * /
/ *  NBs S o u r c e  i s  a t  x  = y = z = 0 * /
t y p e d e f  s t r u c t  p h o t o n _ c o o r d  { d o u b l e  x ;  d o u b l e  y ;  d o u b l e  z ;  } p h o t o n _ c o o r d ;  
/ *  D e c l a r e  t y p e  f o r  d i r e c t i o n  c o - s i n e  s t o r a g e  * /
t y p e d e f  s t r u c t  d i r _ c o s i n e  { d o u b l e  u ;  d o u b l e  V; d o u b l e  w; } d i r _ c o s i n e ;
/ *  V a r i a b l e  u s e d  by r a n 3  r o u t i n e  * /
s t a t i c  i n t  idum = -1 ;
/ *  V a r i a b l e  u s e d  t o  s t o r e  l i m i t i n g  c o s i n e  f o r  p h o t o n  d i r e c t i o n  * /
s t a t i c  d o u b l e  m i n _ s o u r c e _ c o s ;
/ *  V a r i a b l e s  u s e d  t o  s t o r e  l i m i t i n g  t a n g e n t  f o r  d e t e c t o r  a c c e p t e n c e  * /  
s t a t i c  d o u b l e  m a x _ d e t e c t _ t a n ,  t a n _ p e n u m b ra _ a n g ;
/* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * /
/ *  T h i s  r o u t i n e  r e t u r n s  t h e  i n i t i a l  p h o t o n  e n e r g y  * /
/ *  a n d  i s  s o u r c e  s p e c i f i c  * /
/ * * * * * * * * * * * * * * * * . * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * /
d o u b l e  g e t _ p h o t o n _ e n e r g y ( v o i d )  
{
i f  ( r a n 3 ( & i d u m ) < 0 .6 0 )  
r e t u r n  ( 9 7 . 0 ) ;
e l s e
r e t u r n  ( 1 0 3 . 0 ) ;
}
d o u b l e  g e t _ a n g ( v o i d )
{
/ *  R e t u r n s  a  r an d o m  a n g l e  b e tw e e n  - P I  a n d  P I  * /
r e t u r n  ( ( 2 . 0 * r a n 3 ( & i d u m ) - 1 . 0 ) * P I ) ;
}
v o i d  g e t _ i s o t r o p i c _ d i r e c t i o n ( d o u b l e  *cos_gamma, d o u b l e  * p h i ,
d o u b l e  min_cos_gamma)
{
/ *  On e n t r y :  min_cos_gamma c o n t a i n s  t h e  minimum v a l u e  o f  * /
/ *  c o s ( g a m m a ) . T h i s  a l l o w s  c o n i c a l  c o l l i m a t i o n  t o  b e  * /
/ *  im p le m e n te d .  I t  s h o u l d  be  s e t  t o  - 1 . 0  f o r  a  t r u l y  i s o t r o p i c * /
/ *  d i s t r i b u t i o n  * /
/ *  R e t u r n s  cos(gam m a) a n d  p h i  * /
/ *  P h i  i s  a n g l e  f ro m  x a x i s  i n  x y  p l a n e  ( l o n g t i t u d e )  * /
/ *  Gamma i s  a n g l e  f ro m  z a x i s  * /
/ *  See  C a s h w e l l  & E v e r e t t  C h a p t e r  2 ,  P a g e  19 * /
*cos_gamma = 1 . 0  - ( 1 . 0 - m in _ c o s_ g a m m a )* ra n 3 (& id u m ) ;
* p h i  = g e t _ a n g ( ) ;
}
v o i d  g e t _ c o m p t o n ( d o u b l e  e n e r g y _ i n ,  d o u b l e  * e n e r g y _ o u t ,  d o u b l e  * c o s _ a n g )  
{
/ *  On e n t r y :  e n e r g y _ i n  c o n t a i n s  t h e  e n e r g y  o f  t h e  p h o t o n  b e in g *
/ *  s c a t t e r e d
/ *  On e x i t :  e n e r g y _ o u t  c o n t a i n s  e n e r g y  o f  s c a t t e r e d  p h o t o n  
/ *  c o s _ a n g  c o n t a i n s  t h e  c o s i n e  o f  t h e  s c a t t e r i n g
/ *  a n g l e
/ *  The f o l l o w i n g  r o u t i n e  f ro m  C a s h w e l l  a n d  E v e r e t t  C h a p t e r  6 
/ *  c a n  be  u s e d .  B u t  o n l y  g i v e s  a  f a i r l y  a p p r o x i m a t e  d i s t r i b .  
/ ♦ d o u b l e  r ,  a,  e n e r g y ;
/ *
/ *  r  = r a u 3 (& id u m ) ;
/ ♦ e n e r g y  = e n e r g y _ i n / 5 1 0 . 83 ;  C r e a t e  d i m e n s i o n l e s s  p a r a m e t e r
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/ *  a = e n e r g y / ( 1 . 0 + 0 . 5 6 2 5 * e n e r g y ) ; * /
/ *  * e n e r g y _ o u t  = e n e r g y _ i n / ( 1 . 0 + s * r + ( 2 . 0 * e n e r g y - s ) * r * r * r ) ; * /
/ *  * c o a _ a n g  = 1 . 0 + 1 . 0 / e n e r g y - 5 1 0 . 8 3 / ( * e n e r g y _ o u t ) ; * /
/ *  T h e r e f o r e  u s e  vo n  Neumann t e c h n i q u e  a s  d e s c r i b e d  i n  * /
/ *  C a s h w e l l  a n d  E v e r e t t  C h a p t e r  1 p a g e  9 .  * /
/ *  a  i s  u s e d  t o  s t o r e  c o s _ a n g  * /
/ *  e n e r g y  i s  a  d i m e n s i o n l e s s  p a r a m e t e r  - e n e r g y _ i n /m c 2  * /
/ *  e _ l _ a  = e n e r g y (1 - a )  * /
/ *  e _ l _ a _ l  = 1 + e n e r g y ( l - a )  * /
/ *  a 2 _ l  = 1 + a2  * /
d o u b l e  a ,  e n e r g y ,  y ,  e _ l _ a ,  e _ l _ a _ l ,  a 2 _ l ;
e n e r g y  = e n e r g y _ i n / 5 1 0 . 83 ;  / *  D i m e n s i o n l e s s  p a r a m e t e r  * /
do {
/ *  S e l e c t  a  random  c o s ,  c a n  be b e tw e e n  -1 a n d  +1 * /
a  = - 1 . 0  + 2 . 0 * r a n 3 (& id u m ) ;
/ *  C a l c u l a t e  t h e  v a l u e s  u s e d  f o r  c a l c u l a t i n g  t h e  X * s e c t i o n * /
a 2 _ l  = a * a  + 1 . 0 ;
e _ l _ a  = e n e r g y * ( 1 . 0  - a ) ;
e _ l _ a _ l  = 1 . 0  + e _ l _ a ;
/ *  C a l c u l a t e  t h e  c r o s s  s e c t i o n  * /
y = a 2 _ l / e _ l _ a _ l / e _ l _ a _ l *  ( 1 . 0  + e _ l _ a * e _ l _ a / a 2 _ l / e _ l _ a _ l ) ;
} w h i l e  ( r a n 3 ( & i d u m ) * 2 . 0 > y ) ; / *  Maxium v a l u e  o f  y  i s  2 . 0  * /
* c o s _ a n g  = a ;
* e n e r g y _ o u t  = e n e r g y _ i n / e _ l _ a _ l ;
d o u b l e  g e t _ x 2 ( d o u b l e  e n e r g y ,  d o u b l e  p e r c _ a u )  
{
/ * R e t u r n s  a  v a l u e  o f  x2 f o r  e l a s t i c  s c a t t e r i n g * /
/ * On e n t r y  e n e r g y  c o n t a i n s  e n e r g y  o f  p h o t o n  i n  i n t e r a c t i o n V
/ * Added 1 / 8 / 9 1 V
/ * d e c l a r e  t e m p o r a r y  v a r i a b l e s * /
/ * x2 h o l d s  v a l u e  o f  x*2 t o  r e t u r n * /
/ * x2_max c o n t a i n s  t h e  maximum a l l o w e d  v a l u e  o f  x~2 a t  t h e * /
/ * e n e r g y  o f  t h e  p h o t o n * /
/ * r , r 2 , r 4  a r e  u s e d  t o  s t o r e  t h e  ran d o m  number e t c * /
d o u b l e  x 2 ,  x2_max, r ,  r 2 ,  r 4 ;
/ *  C a l c u l a t e  t h e  maximum v a l u e  o f  x2 a l l o w e d  * /
/*  NB: l e - 2 0  b e c a u s e  x i s  i n  A n g s t ro m s  * /
x2_max = e n e r g y  * e n e r g y  * E_HC * E_HC * 1 . 0 e - 2 0 ;
/ *  I s  i t  g o l d  o r  medium? * /
i f  ( r a n 3 ( & i d u m ) < p e r c _ a u )  {
/*  R o u t i n e  f o r  e l a s t i c  i n t e r a c t i o n  w i t h  g o l d  * /
do {
r  = ran3(&idum)*EL_A_MAX; 
r 2  = r  * r ;  
r 4  = r 2  * r 2 ;
x2 = e x p ( EL_A_A1 + EL_A_A2*r + EL_A_A3*r2 + EL_A_A4*r2*r + EL_A_A5*r4 
+ E L _ A _ A 6 * r4 * r ) ;
} w h i l e  (x2 > x 2 _ m ax ) ;
} e l s e  {
/ *  R o u t i n e  f o r  e l a s t i c  i n t e r a c t i o n  w i t h  medium * /
do {
r  = r a n 3 ( &idum )* EL_M_MAX; 
r 2  = r  * r ;  
r 4  = r 2  * r 2 ;
x2  = e x p ( EL_M_A1 + EL_M_A2*r + EL_M_A3*r2 + EL_M_A4*r2*r + EL_M_A5*r4 
+ E L_M _A 6*r4*r) ;
} w h i l e  (x 2 > x 2 _ m ax ) ;
}
r e t u r n  x 2 ;
d o u b l e  g e t _ e l a s t i c ( d o u b l e  e n e r g y ,  d o u b l e  p e r c _ a u )  
{
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/ *  R e t u r n s  a n g l e  f o r  E l a s t i c  s c a t t e r i n g  w e i g h t e d  * /
/ *  a p p r o p i a t e l y  f o r  a n g l e  d e p e n d e n c e  * /
/ ‘  See  P e r s l i d e n  1983 * /
/ *  On e n t r y :  e n e r g y  c o n t a i n s  e n e r g y  o f  p h o t o n  b e i n g  * /
/ *  s c a t t e r e d  * /
/ *  R e t u r n s :  c o s  o f  s c a t t e r i n g  a n g l e  * /
/ *  C o m p le t e l y  r e w r i t t e n  1 / 8 / 9 1  * /
/ *  D e c l a r e  v a r i a b l e s  * /
/ *  V a r i a b l e  t o  h o l d  x s q u a r e d  (x  = s i n  ( t h e t a / 2 ) / w a v e l e n g t h )  * /  
/ *  W a v e le n g th  i s  i n  A n g s tro m s  * /
d o u b l e  x 2 ;
/ *  V a r i a b l e  t o  h o l d  s i n 2  o f  ( a n g l e / 2 )  a n d  c o s  a n g l e  * /
d o u b l e  s i n 2 _ a n g _ 2 ,  c o s _ a n g ;
do  {
x2 = g e t _ x 2 ( e n e r g y ,  p e r c _ a u ) ;
/ *  1 . 0 e - 2 0  f a c t o r  b e c a u s e  x i s  i n  a n g s t r o m s  * /
s in 2 _ a n g _ 2  = x 2 / E _ H C /E _ H C / l .O e - 2 0 / e n e r g y / e n e r g y ;  
c o s _ a n g  = 1 . 0 - 2 * s i n 2 _ a n g _ 2 ;
} w h i l e  ( r a n 3 ( & i d u m ) > ( ( l + c o s _ a n g * c o s _ a n g ) / 2 . 0 ) ) ;  
r e t u r n  c o s _ a n g ;
d o u b l e  g e t _ p a t h l e n g t h ( d o u b l e  e n e r g y ,  d o u b l e  m e a n _ p a t h [ ] )
{
/ *  G e t s  random  p a t h  l e n g t h  o f  a  p h o t o n  * /
/ *  On e n t r y :  e n e r g y  c o n t a i n s  e n e r g y  o f  p h o t o n  * /
/ *  m e a n _ p a th  c o n t a i n s  t a b l e  o f  mean f r e e  p a t h s  * /
/ *  ( 1 / a b s  c o e f f )  a s  a  f u n c t i o n  o f  e n e r g y  * /
/ *  R e t u r n s :  p a t h  l e n g t h  o f  p h o t o n  i n  s c a t t e r i n g  m e d i u m  * /
/ *  S ee  C a s h w e l l  a n d  E v e r e t t  C h a p t e r  3 ,  p a g e s  2 8 - 2 9  * /
r e t u r n  ( - m e a n _ p a t h [ ( i n t ) ( e n e r g y ) ] * l o g ( r a n 3 ( & i d u m ) ) ) ;
}
d o u b l e  g e t _ d i s t _ s q ( p h o t o n _ c o o r d  p i ,  p h o t o n _ o o o r d  p 2 ,
d o u b l e  * t a n _ e d g e _ a n g ,  d o u b l e  * w e i g h t )
{
/ *  R e t u r n s  t h e  s q u a r e  o f  t h e  d i s t a n c e  b e tw e e n  tw o p o s t i o n s  * /
/ *  p i  a n d  p 2 .  F o r  w e i g h t  a n d  t a n _ e d g e _ a n g  t o  b e  m e a n i n g f u l  p2 * /
/ *  m u s t  b e  t h e  d e t e c t o r  p o s i t i o n .  T hen  t h e  t a n g e n t  o f  t h e  * /
/ *  t h e  a n g l e  b e tw e e n  t h e  e d g e  o f  t h e  d e t e c t o r  a n d  p i  i s  * /
/ *  r e t u r n e d  i n  t a n _ e d g e _ a n g . And t h e  p r o p o r t i o n  o f  t h e  d e t e c t  * /
/ *  t h a t  c a n  be  s e e n  a t  p i  i s  r e t u r n e d  i n  w e i g h t  * /
d o u b l e  d x ,  d y ,  d z ,  d y 2 ,  d z 2 ;
d o u b l e  p e r p _ d i s t ;
d o u b l e  w e i g h t_ t e m p ,  w e i g h t_ a n g ;
d x  = f a b s ( p 2 . x  - p l . x ) ;  
d y  = p 2 . y  - p l . y ;  
d z  = p 2 . z  • p l . z ;  
dy2 = dy  * d y ;  
d z 2  = dz  * d z ;
/ *  F i n d  d i s t a n c e  o f  p i  f ro m  a x i s  o f  d e t e c t  i n  p l a n e  o f  d e t e c t  * /  
p e r p _ d i s t  = s q r t ( d y 2  + d z 2 ) ;
* t a n _ e d g e _ a n g  = ( p e r p _ d i s t  - DETECT_RAD)/dx;
* w e i g h t  = 1 . 0 ;
i  f  ( p e r p _ d i  s t  > = ta n _ p e n u m b r a _ a n g * d x -DETECT_RAD)
‘ w e i g h t  = 0 . 0 ;
e l s e
i f  ( * t a n _ e d g e _ a n g > m a x _ d e t e c t _ t a n )  {
‘ w e i g h t  • = ( * t a n _ e d g e _ a n g - m a x _ d e t e c t _ t a n )  / ( tan__penum bra_ang  -m «oc_detec t  
t a n  - 2 . 0*DETECT_RAD/dx) ;
/ *  T h i s  i s  p r o p o r t i o n  o f  d i a m e t e r  t h a t  c a n  be  s e e n  * /
/ ‘  c h a n g e  t o  p r o p o r t i o n  o f  a r e a  * /
w e i g h t_ t e m p  = 2 . 0  ‘  ‘ w e i g h t  - 1 . 0 ;  
w e i g h t _ a n g  = a s i n ( w e i g h t _ t e m p ) ;
‘ w e i g h t  = ( w e i g h t_ a n g  + s i n ( w e i g h t _ t e m p ) ‘ c o s ( w e i g h t _ a n g ) ) / P I  + 0 .5 ;
} e l s e  i f  ( * t a n _ e d g e _ a n g < 0 .0 )  * t a n _ e d g e _ a n g = 0 . 0 ;  
r e t u r n  ( ( d x * d x )  + (d y 2 )  + ( d z 2 ) ) ;
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}d o u b l e  g e t _ c r o s s 2 ( i n t  e n e r g y ,  d o u b l e  p e r c _ a u ,  d o u b l e  a_medium, 
d o u b l e  b_medium, d o u b l e  a _ a u ,  d o u b l e  b _ a u )
{
/ *  Does i n t e r p o l a t i o n  on  l o g - l o g  c o e f f i c i e n t s  t o  f i n d  c r o s s  * /
/ *  c r o s s  s e c t i o n  * /
/ *  On e n t r y :  p e r c _ a u  i s  number p e r c e n t a g e  o f  g o l d  a to m s  * /
/ *  a_medium, b_medium Medium l i n  r e g r e s s  c o e f f s  * /
/ *  a _ a u ,  b _ a u  G o ld  l i n  r e g r e s s  c o e f f s  * /
/ *  e n e r g y  i s  e n e r g y  o f  p h o t o n  * /
/ *  R e g r e s s i o n  d o n e  i n  b a r n s  p e r  a to m .  C o n v e r t  t o  m * - l  b y  * /
/ *  * 0 .0 6 0 2 3  /  ram  * d e n s i t y  * /
d o u b l e  g o l d ,  medium, e n g y ;
e n g y  = ( d o u b l e ) ( e n e r g y ) ;
g o l d  = e x p ( a _ a u  b _ a u * l o g ( e n g y ) ) * p e r c _ a u  /  AU_RAM * AU_DENSITY;
medium = e x p (a_ m ed iu m  + b _ m e d i u m * lo g ( e n g y ) ) * ( 1 . 0 - p e r o _ a u )  /  RAM * DENSITY;
r e t u r n  ( 0 . 0 6 0 2 3 * (g o ld + m e d iu m ) ) ;
}
v o i d  g e t _ c r o s s ( d o u b l e  * s _ e l a s t i c ,  d o u b l e  * s_ o o m p to n ,  d o u b l e  * s _ p h o t o e l ,  
d o u b l e  * s _ p e _ g o l d ,  d o u b l e  * m e a n _ p a th ,  i n t  m in _ e n e r g y ,  
i n t  m a x _ e n e rg y ,  d o u b l e  p e r c _ a u )
{
/ *  R o u t i n e  t o  c a l c u l a t e  a n d  s t o r e  c r o s s - s e c t i o n s  f o r  * /
/ *  d i f f e r e n t  e v e n t s  f o r  a l l  r e l e v a n t  e n e r g i e s  * /
/ *  D e c l a r e  c o u n t e r  v a r i a b l e  * /
i n t  i ;
f o r  ( i= m in _ en e rg y ,-  i< = m a x _ e n e rg y ;  i  + + ) {
s _ e l a s t i c [ i j  = g e t _ c r o s s 2 ( i ,  p e r c _ a u ,  C0H_A, C0H_B, AU_C0H_A, AU_COH_B); 
i f  ( ( d o u b l e ) ( i )<AU_K_ABS) {
s _ c o m p t o n [ i ]  = g e t _ c r o s s 2 ( i ,  p e r c _ a u ,  INC0H_A, INC0H_B, AU_INCOH_LOW_A 
, AU_INCOH_LOW_B);
s _ p h o t o e l [ i )  = g e t _ c r o s s 2 ( i ,  p e r c _ a u ,  PHOTO_A, PHOTO_B, AU_PHOTO_LOW_A 
, AU_PHOTO_LOW_B);
s _ p e _ g o l d [ i ]  = 0 .0 6 0 2 3  * exp(AU_PHOTO_LOW_A + AU_PHOTO_LOW_B*log((doub 
l e ) ( i ) ) )  * p e r c _ a u  /  AU_RAM * AU_DENSITY;
} e l s e  {
s _ c o m p to n { i )  = g e t _ c r o s s 2 ( i ,  p e r c _ a u ,  INC0H_A, INC0H_B, AU_INCOH_HIGH_ 
A, AU_INCOH_HIGH_B);
s _ p h o t o e l ( i ]  = g e t _ c r o s s 2 ( i ,  p e r c _ a u ,  PHOTO_A, PHOTO_B, AU_PHOTO_HIGH_ 
A, AU_PH0T0_HIGH_B);
s _ p e _ g o l d ( i ] = 0 .0 6 0 2 3  * exp(AU_PHOTO_HIGH_A + AU_PHOTO_HIGH_B*log((do 
u b l e ) ( i ) ) )  * p e r c _ a u  /  AU_RAM * AU_DENSITY;
}
m e a n _ p a t h [ i ]  * 1 . 0 / ( s _ c o m p t o n ( i )  + s _ e l a s t i c [ i ]  ♦ s _ p h o t o e l [ i ) ) ;
}
}
v o i d  f i r s t _ p h o t o n ( p h o t o n _ c o o r d  * x y z ,  d i r _ c o s i n e  *uvw, d o u b l e  * e n e r g y ,  
d o u b l e  * m ea n _ p a th )
{
/ *  R o u t i n e  t o  g e t  i n i t i a l  i n t e r a c t i o n  s i t e  * /
/ *  On e n t r y :  m e a n _ p a th ,  i s  a r r a y  o f  mean p a t h s  w i t h  e n e r g y  * /
/ *  On e x i t :  uvw r e t u r n s  i n i t i a l  d i r e c t i o n  c o s i n e s  * /
/ *  x y z  r e t u r n s  p o s i t i o n  o f  f i r s t  i n t e r a c t i o n  * /
/ *  e n e r g y  r e t u r n s  t h e  e n e r g y  o f  t h e  p h o t o n  b e f o r e  * /
/ *  t h e  i n t e r a c t i o n  * /
/ *  D e c l a r e  v a r i a b l e s  f o r  d i s t a n c e  o f  t r a v e l  * /
d o u b l e  t o t a l _ t r a v e l ,  m e d i u m _ t r a v e l ;
/ *  D e c l a r e  v a r i a b l e s  f o r  d i r e c t i o n  c o s  c a l c u l a t i o n  * /
/ *  S ee  C a s h w e l l  a n d  E v e r e t t  C h a p t e r  2 ,  p a g e  20 * /
d o u b l e  p h i ,  c o s _ p h i ,  s i n _ p h i ,  cos_gamm a, s in_gam m a;
/ *  F i r s t  n e e d  t o  g e t  a  d i r e c t i o n  * /
/ *  Some a n g l e s  n o t  a l l o w e d  by  c o l l i m a t o r  * /
g e t _ i s o t r o p i c _ d i r e c t i o n ( 4 c o s _ g a m m a ,  & p h i ,  m i n _ s o u r c e _ c o s ) ;
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c o a _ p h i  = c o s ( p h i ) ;  
s i n _ p h i  = s i n ( p h i ) ;
s in_gam m a = a q r t (  1 . 0  * cos_gamma * coa_ g am in a ) ;
/ *  G e t  e n e r g y  o f  t h e  p h o t o n  * /
♦ e n e r g y  = g e t _ p h o t o n _ e n e r g y ( ) ;
/ *  G e t  t h e  d i a t a n c e  t r a v e l l e d  i n  t h e  medium * /
m e d i u m _ t r a v e l  = g e t _ p a t h l e n g t h ( * e n e r g y ,  m e a n _ p a t h ) ;
/ *  W i l l  t r a v e l  some d i a t a n c e  i n  a i r  b e f o r e  a n  i n t e r a c t i o n  * /
t o t a l _ t r a v e l  = SSD/cos_gamma ♦ m e d i u m _ t r a v e l ;
x y z - > x  * x y z - > y  = t o t a l _ t r a v e l  * s in_gam m a;
x y z - > x  ** c o a j p h i ;
x y z - > y  ♦* a i n _ p h i ;
x y z « > z  * t o t a l _ t r a v e l  * cos_gamma;
uvw*>u = sin_gamm a * c o s _ p h i ;
uvw->v  = ain_gamma * s i n _ p h i ;
uvw->w * coa_gamma;
v o i d  g e t _ n e w _ p o s ( p h o t o n _ c o o r d  * x y z ,  d i r _ c o a i n e  *uvw, d o u b l e  c o s _ p s i ,  
d o u b l e  e n e r g y ,  d o u b l e  * m ea n _ p a th )
{
/ *  See  C a s h w e l l  a n d  E v e r e t t  C h a p t e r  7 ,  p a g e  106 * /
/ *  On e n t r y t  x y z  a n d  uvw a r e  c u r r e n t  p o s i t i o n  a n d  d i r e c t i o n  * /
/ +  c o s _ p a i  i s  c o s i n e  o f  t h e  s c a t t e r i n g  a n g l e  * /
/ *  e n e r g y  i s  t h e  e n e r g y  o f  t h e  p h o t o n  a f t e r  * /
/ *  s c a t t e r  m e a n _ p a th  i s  t h e  t a b l e  o f  mean p a t h  * /
/ *  l e n g t h s  * /
/ *  On e x i t :  x y z  a n d  uvw r e t u r n  t h e  new p o s i t i o n  a n d  * /
/ *  d i r e c t i o n  r e s p e c t i v e l y  * /
/ *  T e m p o ra ry  v a r i a b l e s  u s e d  f o r  c a l c u l a t i n g  new d i r e c t i o n  * /
/ *  c o s i n e s  * /
d o u b l e  s in _ w ,  b e ,  b d ,  bcw;
/ *  P a t h  l e n g t h  o f  p h o t o n  a f t e r  i n t e r a c t i o n  * /
d o u b l e  p a t h _ l e n g t h ;
/ *  S c a t t e r  a n g l e s  * /
d o u b l e  a i n _ p 8 i ,  p h i ,  c o s _ p h i ,  s i n _ p h i ;
/ *  T e m p o ra ry  v a r i a b l e  f o r  new d i r e c t i o n  * /
d i r _ c o s i n e  new_uvw;
p a t h _ l e n g t h  = g e t _ p a t h l e n g t h ( e n e r g y ,  m e a n _ p a t h ) ;
s i n _ p s i  = s q r t ( 1 . 0  • c o s _ p s i * c o s _ p s i ) ;
p h i  = g e t _ a n g ( ) ;
c o s _ p h i  = c o s ( p h i ) ;
s i n _ p h i  = s i n ( p h i ) ;
be  = s i n _ p s i  * c o s _ p h i ;
bd  = s i n j p s i  * s i n _ j p h i ;
i f  ( f a b s ( u v w - > w ) < 0 .9 9 )  {
s i n _ w  = s q r t ( 1 . 0 - u v w - > w * u v w - > w ) ; 
bcw = be  * u v w - > W ;
new_uvw.u = ((bcw *uvw -> u  * b d * u v w - > v ) / s in _ w )  + c o s _ p s i * u v w - > u  
new_uvw.v  = ( (bcw *uvw -> v  + b d * u v w - > u ) / s in _ w )  ♦ c o s _ p s i * u v w - > v  
new_uvw.w = ( - b e  * s in _ w )  + ( c o s _ p s i  * uvw->w);
} e l s e  {
new_uvw. u = b e ; 
new_uvw.v = b d ;  
new_uvw.w = c o s _ p s i  * uvw->w;
}
*uvw = new_uvw;
xy z* > x  •*■= uvw->u * p a t h _ l e n g t h ;  
x y z o y  ♦= uvw->v * p a t h _ l e n g t h  
x y z - > z  ♦= uvw*>w * p a t h _ l e n g t h
i n t  m a i n ( i n t  a r g c ,  c h a r  * a r g v [ J )
{
/ *  T a b l e s  o f  v a l u e s  o f  a b s o r p t i o n  c o e f f i c i e n t ,  mean f r e e  * /
/ *  p a t h s  e t c  * /
d o u b l e  * m e a n _ p a th ,  * s _ p h o t o e l ,  * s _ e l a s t i o ,  * s _ o o m p to n ,  * s _ p e _ g o l d
/ *  Minimum a n d  maximum e n e r g y  a s  i n t e g e r  c o n s t a n t s  
i n t  m i n _ e n e r g y = ( i n t )  MIN_ENERGY, m a x _ e n e r g y = ( i n t )  MAX_ENERGY;
/ *  Number p e r c e n t a g e  o f  g o l d  a to m s 
d o u b l e  p e r c _ a u  = (AU_CN/AU_RAM)/ ( AU_CN/AU_RAM+( 1 0 0 . 0 - AU_CN)/RAM 
/ *  D i r e c t i o n  o f  t r a v e l  
d i r _ c o s i n e  d i r e c t i o n ,  o l d _ d i r e c t i o n ;
/ *  C o s i n e  o f  a n g l e  t h r o u g h  w h ic h  t h e  p h o t o n  w as  s c a t t e r e d  
d o u b l e  c o s _ p s i ;
/ *  P h o t o n  e n e r g y  
d o u b l e  e n e r g y ;  
i n t  i n t _ e n e r g y ;
/ *  P h o t o n  a n d  d e t e c t o r  p o s i t i o n s
p h o t o n _ c o o r d  p h o t o n _ x y z ,  o l d _ x y z ,  d e l t a _ x y z ,  d e t e c t _ x y z ;
/ *  Random num ber  f o r  i n t e r a c t i o n  t y p e  
d o u b l e  i n t e r a c t i o n ;
/ *  F l a g  t o  c h e c k  i f  p h o t o n  h a s  d i e d  e . g .  By p h o t o e l e c t r i c  
i n t  p h o t o n _ d e a d  = FALSE;
/ *  D e c l a r e  v a r i a b l e  f o r  c a l c u l a t i n g  r e l a t i v e  i m p o r t a n c e  o f  
/ *  p h o t o e l e c t r i c  i n t e r a c t i o n  
d o u b l e  p e ;
/ *  V a r i a b l e s  u s e d  when c a l c u l a t i n g  t h e  d i s t a n c e  f r o m  t h e  
/ *  d e t e c t o r
d o u b l e  d e t e c t _ d i s t _ s q ,  d e t e c t _ d i s t ;
/ *  T e m p o ra ry  v a r i a b l e s  u s e d  f o r  c h e c k i n g  i f  p h o t o n  e n t e r e d  
/ *  d e t e c t o r
d o u b l e  tem p _ y ,  tem p _ z ,  s c a l e ;
/ *  C o u n t e r  f o r  num ber  o f  p h o t o n s  
i n t  p h o t o n _ c o u n t ;
/ *  C o u n t e r  f o r  number o f  u s e d  p h o t o n s  
i n t  p h o t o n _ s e n s _ c o u n t  = 0 ,  p h o t o n _ s p e c t _ c o u n t  = 0 ;
/ *  Sum o f  s e n s i t i v i t y  i n  k i d n e y  
d o u b l e  k id _ s e n s _ s u m  = 0 . 0 ;
/ *  T a n g e n t  o f  a n g l e  b e tw e e n  d e t e c t o r  e d g e  a n d  i n t e r a c t i o n  
d o u b l e  t a n _ e d g e _ a n g ;
/ *  P r o p o r t i o n  o f  t h e  d e t e c t o r  t h a t  c a n  be  s e e n  b y  t h e  p h o t o n  
d o u b l e  w e i g h t ;
/ *  A r r a y s  f o r  s t o r i n g  r e s u l t s  
d o u b l e  s e n s [ X _ S I Z E ] [ Y _ S I Z E ] [ Z _ S I Z E ] ; 
i n t  u n c e r [X _ S IZ E ] [Y _ S IZ E ] [Z _ S IZ E ]  ; 
i n t  * c s p e c t r u m ;
/ *  C o u n t e r  v a r i a b l e s  
i n t  i , j , k ;
/ *  F i l e  p o i n t e r ,  u s e d  t o  s a v e  r e s u l t s  
FILE * f p ;
I n i t i a l i s a t i o n
/ *  Make s p a c e  f o r  t a b l e  s t o r a g e  
m e a n _ p a th  = v e c t o r ( m i n _ e n e r g y ,  m a x _ e n e r g y ) ; 
s _ p h o t o e l  = v e c t o r ( m i n _ e n e r g y ,  m a x _ e n e r g y ) ; 
s _ e l a s t i c  = v e c t o r ( m i n _ e n e r g y ,  m a x _ e n e r g y ) ; 
s _ c o m p to n  = v e c t o r ( m i n _ e n e r g y ,  m a x _ e n e r g y ) ; 
s _ p e _ g o l d  = v e c t o r ( m i n _ e n e r g y ,  m cuc_energy); 
c s p e c t r u m  = i v e c t o r ( m i n _ e n e r g y ,  m a x _ e n e r g y ) ;
/ *  Now c a l c u l a t e  t h e  v a r i o u s  v a l u e s  a n d  s t o r e  i n  t a b l e s  * /
g e t _ c r o s s ( s _ e l a s t i c ,  s _ c o m p to n ,  s _ p h o t o e l ,  s _ p e _ g o l d ,  m e a n _ p a th ,  m in _ e n e r g y ,  m 
a x _ e n e r g y ,  p e r c _ a u ) ;
/ *  I n i t i a l i s e  v a r i a b l e  f o r  s o u r c e  c o l l i m a t i o n  * /
m i n _ s o u r c e _ c o s  = c o s ( SOURCE_COLLIMATE_ANGLE) ;
/ *  I n i t i a l i s e  v a r i a b l e s  f o r  d e t e c t o r  c o l l i m a t i o n  * /
m a x _ d e t e c t _ t a n  = t a n ( DETECT_COLLIMATE_ANGLE) ;
t a n _ p e  n u m b ra_ an g  = 2 . 0*DETECT_RAD/(DETECT_X-X_SKIN) + m a x _ d e t e c t _ t a n ;
/ *  I n i t i a l i s e  d e t e c t o r  p o s i t i o n  * /
d e t e c t _ x y z . x  = *DETECT_X; 
d e t e c t _ x y z . y  = DETECT_Y; 
d e t e c t _ x y z . z  = DETECT_Z;
/ *  Z e r o  s e n s i t i v i t y  t a b l e  * /
f o r  ( i = 0 ;  i<X _SIZE; i+ + )
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f o r ( j = 0 ;  j<Y_SIZE; j++ )
f o r ( k = 0 ;  k<Z_SIZE; k+ + )
s e n s [ i ] [ j ] ( k ]  = 0 . 0 ,  u n c e r [ i ] [ j ] [ k ]  = 0 ;  
f o r  ( i = m i n _ e n e r g y ;  i< m a x _ e n e r g y ;  i+  + ) 
c s p e c t r u m [ i ]  = 0 ;/**************************************************************/
/ *  Main m o d e l l i n g  lo o p  * /
/ *  Loop f o r  a s  many p h o t o n a  a a  r e q u i r e d  * /
f o r  ( p h o t o n _ c o u n t = l ;  photon_count<*N_PHOTONS; p h o to n _ o o u n t« -  + ) {
/ *  Now m o d e l  t h e  l i f e  h i a t o r y  o f  a  p h o t o n  * /
f i r a t _ p h o t o n ( & p h o t o n _ x y z ,  S d i r e c t i o n ,  S e n e r g y ,  m e a n _ p a t h ) ; 
p h o t o n _ d e a d  = FALSE;
/ *  Loop u n t i l  p h o t o n  i a  no l o n g e r  o f  a n y  i n t e r e a t  * /
w h i l e  ( ! p h o to n _ d e a d )  {
/ *  G e t  i n t e r a c t i o n  t y p e  a n d  p r o c e a a  * /
i n t e r a c t i o n  = r a n 3 (& id u m ) ;  
i n t _ e n e r g y  = ( i n t ) ( e n e r g y ) ;
/ *  Save  d i r e c t i o n  a n d  p o a i t i o n  o f  p h o t o n  * /
o l d _ d i r e c t i o n  * d i r e c t i o n ;  
o l d _ x y z  = p h o t o n _ x y z ;
i f  ( i n t e r a c t i o n a _ p h o t o e l [ i n t _ e n e r g y ] * m e a n _ p a t h [ i n t _ e n e r g y ] ) {
/ *  P h o t o e l e c t r i c  t r a n a i t i o n  * /
photon_dead=TR U E; 
p e  = 0 . 0 ;
/ *  Assume p h o t o e l e c t r i c  t r a n a i t i o n  waa w i t h  g o l d  * /
/ *  a n d  t h e n  w e i g h t  a c c o r d i n g l y  * /
/ *  F i r s t l y  may h a v e  b e e n  medium t h a t  i n t e r a c t i o n  * /
/ *  was w i t h  * /
i f  ( energy>=AU_K_ABS)
p e  = a _ p e _ g o l d [ i n t _ e n e r g y ] / a _ p h o t o e l [ i n t _ e n e r g y ) * 1 0 0 0 . 0 ;
/ *  Amount o f  s i g n a l  e n t e r i n g  t h e  d e t e c t o r  w i l l  * /
/ *  be  r e d u c e d  by  a t t e n u a t i o n ,  a n d  t h e  s o l i d  * /
/ *  a n g l e  s u b t e n d e d  by  t h e  d e t e c t o r .  A l s o  b y  * /
/ *  d e t e c t o r  c o l l i m a t i o n , -  A l lo w  f o r  t h i s  * /
/ *  * /
/ *  F i r s t l y  a t t e n u a t i o n :  * /
/ *  C a l c u l a t e  d i s t a n c e  o f  c e n t r e  o f  d e t e c t o r  * /
d e t e c t _ d i a t _ s q  ■ g e t _ d i s t _ s q ( p h o t o n _ x y z ,  d e t e o t _ x y z ,  & ta n _ e d g e _ a n g
, & w e i g h t ) ;
/ *  A l lo w  f o r  p r o p o r t i o n  o f  t h e  d e t e c t o r  t h a t  c a n  * /
/ *  be  s e e n  * /
pe  *= w e i g h t ;
/ *  C heck  t o  s e e  i f  p h o t o n  a c c e p t e d  b y  d e t e c t o r  * /
/ *  c o l l i m a t o r ,  i f  n o t  i g n o r e  t h i s  i n t e r a c t i o n  * /
i f  ( ( w e i g h t > 0 . 1) && (p e  > 0 . 0 ) )  (
d e t e c t _ d i s t  * s q r t ( d e t e c t _ d i s t _ a q ) ;
pe  *= e x p ( ( * d e t e c t _ d i a t ) * ( 1 . 0  - (DETECT_X*X_SKIN)/ ( p h o t o n _ x y z .  
x - d e t e c t _ x y z . x  ) ) /m e a n _ p a th ( ( in t ) (A U _ K _ A L P H A )] ) ;
/ *  S e c o n d l y  s o l i d  a n g l e  s u b t e n d e d  * /
/ *  T h i s  f a l l s  a s  * /
/ *  (1 - l / s q r t ( l + ( D E T E C T _ R A D / d e t e o t _ d i s t ) * 2 ) ) * /
/ *  A l lo w  f o r  o f f  a x i s  p o i n t  by  m u l t i p l y i n g  p e  * /
/ *  by  t h e  c o s i n e  o f  t h e  a n g l e  o f f  t h e  * /
/ *  d e t e c t o r  a x i s  * /
pe  *= ( 1 . 0  - 1 . 0 / s q r t ( 1 . 0  + DETECT_RAD*DETECT_RAD/detect_dist_ 
fl<I ) ) * ( p h o t o n _ x y z . x - d e t e c t _ x y z . x ) / d e t e c t _ d i s t ;
i  = ( i n t ) ( p h o t o n _ x y z . x / G _ U N I T - 0 . 5 - ( d o u b l e ) (X_MIN)) ; 
j  = ( i n t ) ( p h o t o n _ x y z . y / G _ U N I T - 0 . 5 * ( d o u b l e ) ( Y _ M I N ) ) ;  
k = ( i n t ) ( p h o t o n _ x y z . z/G_UNIT- 0 . 5  - ( d o u b l e ) ( Z_MIN))  ; 
i f  ( ( i>  = 0) && ( i<X_SIZE) && ( j>  = 0) && (j<Y _SIZ E )  && ( k> = 0) && (k<Z_
S I Z E ) )  (
p h o t o n _ s e n s _ c o u n t + + ; 
s e n s ( i ] I j ] ( k )  += p e ;  
u n c e r [ i ] ( j ] [ k ] + + ;
}
/ *  Now sum t o t a l  s e n s i t i v i t y  i n  k i d n e y  * /
i f  ( (p h o ton_xyz .z> D E T E C T _Z *0 .0 2 5 )  && (pho ton_xyz .z< D E T E C T _Z + 0 .  
025) && (pho to n _ x y z .y > D E T E C T _ Y -0 .0 5 )  && (p ho ton_xyz .y<D E T E C T _Y +0 .05)  && ( p h o t o n _ x y z .
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x > - 0 . 0 2 5 )  && ( p h o t o n _ x y z . x < 0 . 0 2 5 ) )  k id _ s e n s _ s u m  += p e ;
}
} e l s e  {
i f  ( i n t e r a o t i o n <  ( s _ p h o t o e l ( i n t _ e n e r g y )  + s _ e l a s t i c [  i n t _ e n e r g y ] ) *mean
_ p a t h [ i n t _ e n e r g y ])  {
/ *  E l a s t i c  i n t e r a c t i o n  * /
/* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * /
c o s _ p s i  = g e t _ e l a s t i c ( e n e r g y ,  p e r c _ a u ) ;
} e l s e  {
/ *  Compton I n t e r a c t i o n  * /
/**********************************************/
g e t _ c o m p t o n ( e n e r g y ,  S e n e r g y ,  & c o s _ p s i ) ;
}
}
/ *  I f  p h o t o n  s t i l l  a l i v e  g e t  n e x t  c o o r d s  * /
i f  ( i p h o to n _ d e a d )
g e t_ n e w _ p o s (& p h o to n _ x y z ,  & d i r e c t i o n ,  c o s _ p s i ,  e n e r g y ,  m e a n _ p a t h ) ; 
/ *  C heck  i t  s t i l l  h a s  s u f f i c i e n t  e n e r g y  t o  b e  o f  * /
/ *  i n t e r e s t  * /
i f  (energy<=MIN_ENERGY) 
p h o t o n _ d e a d  * TRUE;
/ *  C heck  t h a t  t h i s  i s  s t i l l  w i t h i n  t h e  medium o n  * /
/ *  s o u r c e  s i d e  * /
i f  (p h o to n _ x y z .z < S S D )  
p h o t o n _ d e a d  = TRUE;
/ *  C heck  t o  s e e  i f  p h o t o n  h a s  l e f t  t h e  medium o n  t h e  * /
/ *  d e t e c t o r  s i d e ,  a n d  i f  s o  w h e t h e r  i t  e n t e r e d  t h e  * /
/ *  d e t e c t o r  * /
i f  ( p h o t o n _ x y z . x < ( -X_SKIN) && ( I p h o t o n _ d e a d ) ) { 
p h o t o n _ d e a d  = TRUE;
/ *  C a l c u l a t e  t h e  s q u a r e  o f  t h e  d i s t a n c e  f r o m  t h e  * /
/ *  c e n t r e  o f  t h e  d e t e c t o r  w i t h i n  w h ic h  t h e  * /
/ *  p h o t o n  p a s s e s  * /
d e l t a _ x y z . x  ■ p h o t o n _ x y z . x  - o l d _ x y z . x ;  
d e l t a _ x y z . y  = p h o to n _ x y z , .y  - o l d _ x y z . y ;  
d e l t a _ x y z . z  * p h o t o n _ x y z . z  - o l d _ x y z . z ;  
s c a l e  * ( d e t e c t _ x y z . x  - o l d _ x y z . x ) / d e l t a _ x y z . x ;
t em p _ y  * d e t e c t _ x y z . y  - ( o l d _ x y z . y  + s c a l e  * d e l t a _ x y z . y ) ; 
t em p _ z  = d e t e c t _ x y z . z  - ( o l d _ x y z . z  + s c a l e  * d e l t a _ x y z . z ) ;
/ *  a n d  s t o r e  i t  * /
d e t e c t _ d i s t _ s q  = tem p _ y * tem p _ y +1emp_z * t e m p _ z ;
/ *  G e t  a n g l e  b e w te e n  i n t e r a c t i o n  p o i n t  a n d  t h e  * /
/ *  e d g e  o f  t h e  d e t e c t o r  * /
g e t _ d i s t _ s q ( o l d _ x y z ,  d e t e c t _ x y z ,  & ta n _ e d g e _ a n g ,  S w e i g h t ) ; 
/ *  I f  p h o t o n  c o u l d  hav e  p a s s e d  t h r o u g h  d e t e c t o r  * /
/ *  a n d  c o l l i m a t i o n  OK t h e n  a d d  t o  s p e c t r u m  * /
i f  ( ( t a n _ e d g e _ a n g < m a x _ d e t e c t _ t a n )  && (de tect_d is t_sq<D E TE C T _R A D *D E
TECT_RAD)) {
c s p e c t r u m [ ( i n t ) ( e n e r g y ) ]++; 





f p  = f o p e n ( ' s p e c t r u m * , " w " ) ;
f o r  ( i = m i n _ e n e r g y ;  i<m«oc_energy; i  + + )
f p r i n t f ( f p , ' % d ,  % d \ n ' , i ,  c s p e c t r u m ( i ) ) ;  
f c l o s e ( f p ) ;
f p  * f o p e n ( ' s e n s * , ' w " ) ;
f p r i n t f ( f p , ' P r e d i c t e d  s e n s i t i v i t i e s i \ n * ) ; 
f o r  ( i = 0 ;  i< Z _ S IZ E ;  i+ + )  { 
f o r  ( j  = 0 ; j<X_SIZE; j  + + )
f p r i n t f ( f p ,  ' % 8 . 2 1 f , ' , s e n s  I j ] [ - (Y_MIN)] [ i ] ) ;  
f p u t c t ' X n ' ,  f p ) ;
}
f p r i n t f ( f p , ' \ n U n o e r t a i n t i e s  d u e  t o  c o u n t i n g  s t a t i s t i c s : \ n ' ) ;  
f o r  ( i * 0 ; i< Z _ S IZ E ;  i+  + ) { 
f o r  ( j = 0 ;  j<X_SIZE; j+ + )
i f  ( u n c e r ( j ] [ * ( Y_MIN) ] [ i ]<1) f p r i n t f ( f p , '  * . * * ,  ' ) ;
BIO
e l s e
f p r i n t f ( f p ,  * % 8 .2 1 f , ' ,  s e n s [ j  J ( - (Y_MIN)] I i ] / s q r t ( ( d o u b l e ) ( u n c e r ( j ]
I * (Y_MIN) J [ i ] ) ) ) ;
f p u t c ( ' \ n ' ,  f p ) ;
}
f c l o s e ( f p ) ;
f p  = f o p e n ( ' c o u n t ' , ' w ' ) ;
f p r i n t f ( f p , ' T o t a l  num ber o f  p h o t o n s  = %d\n',N_PHOTONS);
f p r i n t f ( f p , ' P h o t o n s  u s e d  f o r  s e n s i t i v i t y  d a t a  = % d \ n ' ,  p h o t o n _ s e n s _ c o u n t ) ; 
f p r i n t f ( f p , ' P h o t o n s  u s e d  i n  b a c k g r o u n d  s p e c t r u m  = % d \ n ' ,  p h o t o n _ s p e c t _ c o u n t ) ; 
f p r i n t f ( f p , ' K i d n e y  summed s e n s i t i v i t y  = %le p e r  i n c i d e n t  p h o t o n \ n ' , k i d _ s a n s _ s u  
m / ( d o u b l e ) ( N_PHOTONS) ) ;  
f c l o s e ( f p ) ;
/ *  P r e e  s p a c e  d e c leu re d  f o r  t a b l e s  * /
f r e e _ i v e c t o r ( c s p e c t r u m ,  m in _ e n e r g y ,  m a x _ e n e r g y ) ;
f r e e _ v e c t o r ( s _ p e _ g o l d ,  m i n _ e n e r g y ,  m «uc_energy);
f r e e _ v e c t o r ( s _ c o m p t o n ,  m in _ e n e r g y ,  m «uc_energy);
f r e e _ v e c t o r ( s _ e l a s t i c ,  m in _ e n e r g y ,  m a x _ e n e r g y ) ;
f r e e _ v e c t o r ( s _ p h o t o e l ,  m in _ e n e r g y ,  m «oc_energy);




AAS: Atomic Absorption Spectroscopy.
Agranulocytosis: A symptom complex characterised by a marked decrease in 
the number of granulocytes and by lesions of the throat and other mucous 
membranes, of the gastrointestinal tract, and of the skin.
Aplasia: Lack of development of an organ or tissue, or of the cellular products 
from an organ or tissue. (Adjective: Aplastic).
Arthritis: Inflammation of a joint.
Bacillus: A rod shaped bacterium.
Chromatin: The substance of chromosomes, the portion of the cell nucleus 
that stains with basic dyes.
Chrysiasis: Deposition of gold in living tissue.
Chrysotherapy: Gold therapy.
Cortex: An outer layer.
Cutaneous: Pertaining to the skin.
Cytoplasm: The protoplasm of a cell exclusive of that of the nucleus. 
Dermatitis: Inflammation of the skin.
DL: Detection Limit.
Eosinophil: A granular leukocyte having a nucleus with two lobes connected 
by a thread of chromatin, and cytoplasm containing coarse round granules of 
uniform size.
Cl
Eosinophilia: The formation and accumulation of an abnormally large 
number of eosinophils in the blood.
Exfoliation: A falling off in scales or layers (Adjective: Exfoliative)
Granulocyte: Any cell containing granules. Especially a granular leukocyte.
Jaundice: A yellowness of the skin, scleras, mucous membranes and 
excretions due to deposition of bile pigments.
Leukocyte: A type of white blood cell.
Macrophage: Any of the large mononuclear cells derived from monocytes that 
occur in the walls of blood vessels and loose connective tissue.
MCA: Multi-Channel Analyzer
MDL: Minimum Detectable Limit. The minimum concentration that can be 
qualitatively detected.
Medulla: The innermost part.
Monocyte: A mononuclear leukocyte, 13pm to 25pm in diameter with an ovoid 
or kidney-shaped nucleus. Monocytes develop into macrophages.
NAA: Neutron Activation Analysis.
Nephropathy: Disease of the kidney.
Nephrosis: Any kidney disease. (Adjective: Nephrotic).
Nephrotoxic: Destructive to kidney cells.
NPL: National Physical Laboratory.
Nucleoplasm: The protoplasm of the nucleus of a cell.
Parenteral: Not through the alimentary canal, but rather by injection through
C2
some other route, such as subcutaneously, intramuscularly, etc.
PEXE: Proton-Induced X-ray Emission analysis.
Proteinuria: An excess of serum proteins in the urine.
Protoplasm: Translucent colloid material, the essential constituent of the 
living cell, including cytoplasm and nucleoplasm.
Pruritus: Itching. (Adjective: Pruritic.)
RA: Rheumatoid Arthritis.
Renal: Pertaining to the kidney.
Rheumatism: Any of a variety of disorders marked by inflammation, 
degeneration, or metabolic derangement of connective tissue structures, 
especially the joints and related structures, and attended by pain, stiffness, or 
limitation of motion.
Rheumatoid: Resembling Rheumatism.
RNHRD: Royal National Hospital for Rheumatic Diseases.
RUH: Royal United Hospital.
Sclera: The tough white outer coating of the eyeball. (Adjective: Scleral.) 
SIVARG: Swansea In Vivo Analysis Research group
Thrombocytopenia: Decrease in the number of platelets in circulating blood. 
TLD: ThermoLuminescent Dosimeter/Dosimetry.






wTcm R a d i o - p h a r m a c e u t i c a l s  f o r  t h e  x - r a y  f l u o r e s c e n c e  a s s e s s m e n t  o f
GOLD IN VIVO
(Published in Physics in Medicine and Biology 36 Pages 531-536)
1. Introduction
The use of X-ray fluorescence (XRF) for the determination of heavy metals such 
as lead (Ahlgren and Mattsson, 1979; Somervaille et a l, 1985; Price et al, 1984), 
cadmium (Ahlgren and Mattsson, 1981), platinum (Jonson et al, 1987), mercuiy 
(Bloch and Shapiro, 1981) and gold (Scott and Lillicrap, 1988) in vivo is now a 
fairly widespread technique. Radiation sources used to produce the 
characteristic fluorescence have included many radio-isotopes with low energy 
photons such as 109Cd, "Tcm, 241Am, 67Co and 133Xe and more recently both 
unpolarised and partially polarised X-ray sources.
The use of external radio-isotope sources has been very successful for the 
determination of metals in organs with little overlying tissue such as lead in 
tibia. However for organs at larger depths much higher skin doses and longer 
irradiation times are required for the same source activity. This has led to the 
use of X-ray sources which can be placed at some distance from the skin while 
maintaining a good photon flux, thus giving a larger absorbed dose to the organ 
of interest for a given skin dose. A greater sensitivity and uniformity of 
response is therefore achieved since the amount of fluorescence is 
approximately proportional to organ dose for a given radiation source.
There is, however, another possibility for organs lying at a depth, which is to 
use a radio-labelled pharmaceutical which is specific to the organ of interest, 
such as those used for imaging in nuclear medicine studies. One advantage of 
an internal source is that it should lead to a better uniformity of organ
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irradiation than external sources, as it is distributed through the organ of 
interest. The questions to be considered are whether sufficient activity is 
present in the organ for a sufficient length of time to make a measurement, and 
whether the required measurement sensitivity can be achieved. The following 
work describes a feasibility study carried out to establish whether a 99rpcm 
radio-labelled pharmaceutical would be a suitable source for X-ray fluorescence 
studies of gold in the kidney.
There are very few quantitative data on the deposition of gold in body tissues 
during chiysotherapy to decide on a required measurement sensitivity. Gottlieb 
et al (1972) measured the gold concentration at autopsy in various organs from 
a patient who had received chrysotherapy. They found gold concentrations in 
the renal cortex between 120pg gJ and 130pg gJ. Thus to be useful for in vivo 
measurements a technique would need a detection limit below about 50pg gJ.
2. Experimental Work
The experimental work was divided into two parts. Firstly, a measurement was 
made to establish the activity that would be required in the kidney of a patient 
to achieve acceptable detection levels. Secondly, typical kidney activities were 
estimated in patients who were undergoing nuclear medicine studies in order 
to assess whether sufficient activity was present for X-ray fluorescence studies.
The experimental arrangement for the first study is shown in figure 1. The 
detector was a high purity germanium detector, 10mm in diameter and 7mm 
thick with a resolution (FWHM) of 425eV at the 241Am 60keV emission line. 
The kidney was represented by a 150ml, 45mm diameter, polythene bottle 
which contained a solution of chloroauric add, with a concentration of gold of 
500pg g'1. This kidney phantom was placed in a water bath at various depths 
from the wall of the water bath to represent a range of kidney depths which 
may be found in practice. The detector collimator was placed against the wall of 
the water bath. A small (4.5ml) polythene tube containing approximately 















Gold Kai Peak 
/Counts
MDL
/p g g '1
AAR5
/MBq
2266 15.9 20 3860±212 55 2.7
1800 20.0 30 3305±201 61 3.3
2020 17.8 40 2481±182 73 4.7
2936 12.3 60 1516±153 100 8.9
‘ Anticipated Average Activity required for a  MDL of 50^ig g*1 for a  32mm diameter HPGe detector 
Table 1 - Summary of results using HP Ge detector
the kidney uptake of the radio-pharmaceutical. For an initial activity of 20MBq 
the resultant spectra were recorded over a period of 30 minutes, this represents 
the maximum acceptable time for patient studies. In practice the actual 
irradiation times were adjusted to compensate if the initial activity was 
different from 20MB q. The analysed results from this experiment are given in 
the first five columns of table 1 and a typical signal amplitude spectrum is 
shown in figure 2. The analysis was performed on a region of the recorded 
spectrum bracketing both the gold K« peaks: this portion of the spectrum was 
fitted by an analytical function using a non-linear least squares fit based on the 







Figure 2 - Portion of the signal amplitude spectrum showing the gold Ka peaks for the 20mm depth
result in table 1
With the 10mm diameter detector used minimum detectable levels (MDL) 
close to the target level of 50pg g'1 could only be achieved for kidney depths less 
than 30mm. The MDLs were determined to be approximately two standard 
deviations, as returned by the fitting program, above background.
It is possible to forecast the improvement in MDL from those achieved above if 
a larger diameter detector was used. The MDL will decrease approximately 
with the increase in the square root of the number of counts collected, due to 
the Poisson nature of the counting process involved. A number of predictions on 
how the target MDL of 50pg g*1 could be achieved can therefore be made. (A 
more rigorous discussion of the factors affecting the detection limit is given by 
Mattsson et al (1987)). If the size of the detector is increased, the number of 
counts collected in a given time increases with detector area and therefore the 
MDL decreases with increase in detector diameter. Therefore if a 32mm 
diameter detector were used the achievable MDL would decrease by 
approximately a factor of three and, from table 1, would lead to a MDL of about 
30pg g 1 even at a kidney depth of 60mm with a measurement time of 30 
minutes and 20MBq of "Tcm in the kidney. Similarly the MDL would decrease 
approximately with increase in both the square root of activity found in the
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kidney and with the square root of the scan time. If the maximum seem time is 
limited to 30 minutes but a detector of 32mm diameter is used, it is anticipated 
that the average activity that would be required (AAR) in the kidney under 
investigation to achieve a MDL of 50jig g'1 would be those given in the final 
column of table 1.
In order to establish the activity that is actually in the kidney of a patient at 
any one time during a nuclear medicine investigation, data from patients who 
had undergone investigation were re-examined. The activity found in the 
kidney is obviously dependent on the radio-labelled pharmaceutical used. 
Locally there are two "Tc111 labelled pharmaceuticals used in the nuclear 
medicine department for renal studies, these are diethylenetriamine penta- 
acetic add (DTPA) and dimercapto succinic add (DMSA). Maisey (1980) states 
that with DMSA the injected activity taken up in the renal parenchyma 
remains there indefinitely. However the activity variation of DTPA with time 
in the kidney for healthy kidneys is quite rapid. The count rate variation over 
the region of interest of one kidney with time could be extracted from all 
renogram (DTPA) studies and some DMSA studies performed locally. A 
selection of data from adult patients with apparently healthy kidneys is given 
in tables 2 (DTPA - renograms reported as normal) and 3 (DMSA imaging 
studies). The total activity initially administered to all these patients was 
185MBq.
In order to relate these count rates to the activity of "Tcm in the kidney, a 
polythene bottle identical to the one used as a phantom in the previous 
experiment was filled with a solution containing 20MBq of "Tcm. This was then 
placed in a water bath at various distances from the wall to assess the effect of 
kidney depth on count rate. A study was then made of this phantom using the 
gamma camera in the configuration used for renal studies. The count rate over 
the region of interest of the bottle was around 2100CS1 when the surface of the 
bottle was 30mm from the wall of the water bath falling by 17% to 1750cs-i
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Patient Count Rate from ROI covering / cs'1
Number Right Kidney Left Kidney
5 mins5 40mins5 5 mins5 40mins5
1 450 220 500 240
2 810 200 570 150
3 1070 250 990 250
Average 780 220 690 210
* Time after injection 
Table 2 - Results from patients undergoing DTPA studies
Patient Count Rate from ROI covering / cs'1





Table 3 - Results from patients undergoing DMSA studies
when the depth was 60mm. The kidney depth was not recorded in the patient 
records. However from these results the uncertainty in the estimated activity 
because of this is not likely to exceed ±10% from the mean. Averaging the data 
in table 2 over apparently healthy kidneys of DTPA patients gives a count 
rate of 740CS'1 5 minutes after injection falling to a rate of 220CS'1 40 minutes 
after injection. Using the phantom data above these count rates are equivalent 
to 7-8V£MBq of "Tcm in the kidney 5 minutes after injection and 2-2V£MBq of
"Tcm after 40 minutes for DTPA patients.
Averaging the data in table 3 over reportedly normal patients undergoing 
DMSA scans gives a count rate of 1490cs l over each kidney approximately 3 
hours after injection. As previously stated the biological half-life of DMSA is 
much longer than the physical half-life and therefore the count rate variation 
with time is small. Allowing for the uncertainty in kidney depth this count rate 
is equivalent to 14-17MBq of "Tcm in each kidney. Such activities are well 
above those that would be required (AAR - table 1) to reach detection levels of 
50pg g'1 even for kidneys lying at a depth of 60mm. The proportion of injected 
DMSA reaching the patients kidneys in these studies is therefore
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approximately 24%. Thus for a detection level of 50pg g*1 for kidneys lying at 
60mm an injected activity of about 100MBq is required, much less than the 185 
to 200MBq administered for imaging studies (Mistry, 1988).
3. Conclusions
From the above work it is concluded that intravenously administered 99^ cm 
radio-labelled pharmaceuticals would be suitable sources for XRF studies of 
gold in the kidney. The target MDL of 50pg g'1 would be achieved with a 
detector of sufficient area using significantly less than the activity 
administered to patients undergoing diagnostic renal studies. Of the two radio- 
pharmaceuticals in routine use locally for kidney studies, DMSA proved to be 
the better drug, as to obtain the same X-ray fluorescence yield higher activities 
of DTPA need to be administered. Although, with its rapid passage through the 
kidney, DTPA produces a lower kidney absorbed dose them DMSA, even with 
the higher initial activities required, this is more than offset by the greater 
- absorbed dose given to the bladder wall (ICRP, 1988).
It is possible to compare the use of "Tcm labelled DMSA with external sources 
for XRF studies with respect to the resulting absorbed dose estimations. With
"Tcm DMSA the kidney receives the highest absorbed dose whereas external 
sources deliver the highest dose to the skin. The absorbed doses will depend on
the source to skin distance of external sources and on the kidney depth. For an
external source, filtered 153Gd has been used locally, positioned 40mm from the
skin. For similar detection sensitivity (SOpgg1), kidney depth (30mm) and
detector diameter (32mm), the "Tcm DMSA would deliver a kidney absorbed
dose of 6mGy and a negligible skin dose (ICRP, 1988), whereas the external
153Gd source would deliver 2mGy to the skin and an average kidney absorbed 
dose of about 0.3mGy. An X-ray source at a larger source to skin distance
would reduce the skin dose further, but would be a more costly system.
Although the local interest of this work relates to the detection of gold in the 
kidney, similar conclusions may be drawn regarding the detection of other
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heavy metals of interest such as platinum and lead which may be found in the 
kidney following medical or industrial exposure, although lower detection 
levels and high higher administered activities would probably be required.
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Measurement Of Tissue Gold Levels In Chyrsotherapy Patients
The purpose of this study in which you are invited to participate is to measure
the retention in the body of the gold that you have received / are receiving. The 
study should enable more information to be’obtained which could be of benefit 
to those receiving this form of treatment in the future. Thus, the study is not 
likely to be of direct benefit to individual participants.
You will be asked to undergo two measurements. These will be carried out in 
the diagnostic centre and the Wolfson centre at the Royal United Hospital. The 
first of these will be a simple ultrasound scan to locate precisely the position of 
your kidneys and the second will be a measurement of the amount of gold in 
your kidney at a soft tissue site. For the gold measurement you will be exposed 
to a small quantity of radiation, about the amount associated with a 
conventional chest X-ray picture. Neither the X-ray nor the ultrasound 
measurement will produce sensations of discomfort.
I
of
confirm that I have had explained to me the nature of the study in which I now 
agree to participate and the explanations have been delivered to my 
satisfaction. I confirm that I have been advised of the possible adverse effects 
and have been given the opportunity to ask questions.
I understand that I am free to withdraw from the study at any time without 
the need to give reason and without prejudice to my treatment. I confirm that I 
am over 18 years of age. I give my consent to participate in the study here 
outlined and to abide by its provisions unless I should choose to withdraw 
before its completion. I agree that the results of my study may be used
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anonymously for the purposes of the general investigation and the publication 
of its results.
Signed: Date:
